id	sid	tid	token	lemma	pos
fnp-2818	1	1	studies	study	NOUN
fnp-2818	1	2	on	on	ADP
fnp-2818	1	3	inflammation	inflammation	NOUN
fnp-2818	1	4	and	and	CCONJ
fnp-2818	1	5	stroke	stroke	NOUN
fnp-2818	1	6	provide	provide	VERB
fnp-2818	1	7	clues	clue	NOUN
fnp-2818	1	8	to	to	ADP
fnp-2818	1	9	pathomechanism	pathomechanism	NOUN
fnp-2818	1	10	of	of	ADP
fnp-2818	1	11	central	central	ADJ
fnp-2818	1	12	nervous	nervous	ADJ
fnp-2818	1	13	system	system	NOUN
fnp-2818	1	14	involvement	involvement	NOUN
fnp-2818	1	15	in	in	ADP
fnp-2818	1	16	covid-19	covid-19	PROPN
fnp-2818	1	17	feel	feel	VERB
fnp-2818	1	18	free	free	ADJ
fnp-2818	1	19	to	to	PART
fnp-2818	1	20	add	add	VERB
fnp-2818	1	21	comments	comment	NOUN
fnp-2818	1	22	by	by	ADP
fnp-2818	1	23	clicking	click	VERB
fnp-2818	1	24	these	these	DET
fnp-2818	1	25	icons	icon	NOUN
fnp-2818	1	26	on	on	ADP
fnp-2818	1	27	the	the	DET
fnp-2818	1	28	sidebar	sidebar	NOUN
fnp-2818	1	29	free	free	ADJ
fnp-2818	1	30	neuropathology	neuropathology	NOUN
fnp-2818	1	31	1:16	1:16	NUM
fnp-2818	1	32	(	(	PUNCT
fnp-2818	1	33	2020	2020	NUM
fnp-2818	1	34	)	)	PUNCT
fnp-2818	1	35	opinion	opinion	NOUN
fnp-2818	1	36	piece	piece	NOUN
fnp-2818	1	37	studies	study	NOUN
fnp-2818	1	38	on	on	ADP
fnp-2818	1	39	inflammation	inflammation	NOUN
fnp-2818	1	40	and	and	CCONJ
fnp-2818	1	41	stroke	stroke	NOUN
fnp-2818	1	42	provide	provide	VERB
fnp-2818	1	43	clues	clue	NOUN
fnp-2818	1	44	to	to	ADP
fnp-2818	1	45	pathomechanism	pathomechanism	NOUN
fnp-2818	1	46	of	of	ADP
fnp-2818	1	47	central	central	ADJ
fnp-2818	1	48	nervous	nervous	ADJ
fnp-2818	1	49	system	system	NOUN
fnp-2818	1	50	involvement	involvement	NOUN
fnp-2818	1	51	in	in	ADP
fnp-2818	1	52	covid-19	covid-19	PROPN
fnp-2818	1	53	ádám	ádám	ADJ
fnp-2818	1	54	dénes	déne	NOUN
fnp-2818	1	55	1	1	NUM
fnp-2818	1	56	,	,	PUNCT
fnp-2818	1	57	stuart	stuart	PROPN
fnp-2818	1	58	m.	m.	PROPN
fnp-2818	1	59	allan	allan	PROPN
fnp-2818	1	60	2	2	NUM
fnp-2818	1	61	,	,	PUNCT
fnp-2818	1	62	tibor	tibor	PROPN
fnp-2818	1	63	hortobágyi	hortobágyi	PROPN
fnp-2818	1	64	3,4	3,4	NUM
fnp-2818	1	65	,	,	PUNCT
fnp-2818	1	66	craig	craig	PROPN
fnp-2818	1	67	j.	j.	PROPN
fnp-2818	1	68	smith	smith	PROPN
fnp-2818	1	69	5	5	NUM
fnp-2818	1	70	1	1	NUM
fnp-2818	1	71	laboratory	laboratory	NOUN
fnp-2818	1	72	of	of	ADP
fnp-2818	1	73	neuroimmunology	neuroimmunology	PROPN
fnp-2818	1	74	,	,	PUNCT
fnp-2818	1	75	institute	institute	NOUN
fnp-2818	1	76	of	of	ADP
fnp-2818	1	77	experimental	experimental	ADJ
fnp-2818	1	78	medicine	medicine	NOUN
fnp-2818	1	79	,	,	PUNCT
fnp-2818	1	80	szigony	szigony	PROPN
fnp-2818	1	81	u.	u.	PROPN
fnp-2818	1	82	43	43	NUM
fnp-2818	1	83	.	.	PUNCT
fnp-2818	1	84	1083	1083	NUM
fnp-2818	1	85	,	,	PUNCT
fnp-2818	1	86	budapest	budapest	PROPN
fnp-2818	1	87	,	,	PUNCT
fnp-2818	1	88	hungary	hungary	PROPN
fnp-2818	1	89	2	2	NUM
fnp-2818	1	90	division	division	NOUN
fnp-2818	1	91	of	of	ADP
fnp-2818	1	92	neuroscience	neuroscience	NOUN
fnp-2818	1	93	and	and	CCONJ
fnp-2818	1	94	experimental	experimental	ADJ
fnp-2818	1	95	psychology	psychology	NOUN
fnp-2818	1	96	,	,	PUNCT
fnp-2818	1	97	lydia	lydia	PROPN
fnp-2818	1	98	becker	becker	PROPN
fnp-2818	1	99	institute	institute	PROPN
fnp-2818	1	100	of	of	ADP
fnp-2818	1	101	immunology	immunology	NOUN
fnp-2818	1	102	and	and	CCONJ
fnp-2818	1	103	inflammation	inflammation	NOUN
fnp-2818	1	104	,	,	PUNCT
fnp-2818	1	105	the	the	DET
fnp-2818	1	106	university	university	PROPN
fnp-2818	1	107	of	of	ADP
fnp-2818	1	108	manchester	manchester	PROPN
fnp-2818	1	109	,	,	PUNCT
fnp-2818	1	110	manchester	manchester	PROPN
fnp-2818	1	111	academic	academic	PROPN
fnp-2818	1	112	health	health	PROPN
fnp-2818	1	113	science	science	NOUN
fnp-2818	1	114	centre	centre	NOUN
fnp-2818	1	115	,	,	PUNCT
fnp-2818	1	116	av	av	PROPN
fnp-2818	1	117	hill	hill	PROPN
fnp-2818	1	118	building	building	PROPN
fnp-2818	1	119	,	,	PUNCT
fnp-2818	1	120	manchester	manchester	PROPN
fnp-2818	1	121	,	,	PUNCT
fnp-2818	1	122	m13	m13	PROPN
fnp-2818	1	123	9pt	9pt	NOUN
fnp-2818	1	124	,	,	PUNCT
fnp-2818	1	125	uk	uk	PROPN
fnp-2818	1	126	3	3	NUM
fnp-2818	1	127	department	department	PROPN
fnp-2818	1	128	of	of	ADP
fnp-2818	1	129	pathology	pathology	PROPN
fnp-2818	1	130	,	,	PUNCT
fnp-2818	1	131	faculty	faculty	NOUN
fnp-2818	1	132	of	of	ADP
fnp-2818	1	133	medicine	medicine	NOUN
fnp-2818	1	134	,	,	PUNCT
fnp-2818	1	135	university	university	PROPN
fnp-2818	1	136	of	of	ADP
fnp-2818	1	137	szeged	szeged	PROPN
fnp-2818	1	138	,	,	PUNCT
fnp-2818	1	139	szeged	szeged	PROPN
fnp-2818	1	140	,	,	PUNCT
fnp-2818	1	141	hungary	hungary	PROPN
fnp-2818	1	142	4	4	NUM
fnp-2818	1	143	mta	mta	PROPN
fnp-2818	1	144	-	-	PUNCT
fnp-2818	1	145	de	de	X
fnp-2818	1	146	cerebrovascular	cerebrovascular	ADJ
fnp-2818	1	147	and	and	CCONJ
fnp-2818	1	148	neurodegenerative	neurodegenerative	ADJ
fnp-2818	1	149	research	research	NOUN
fnp-2818	1	150	group	group	NOUN
fnp-2818	1	151	,	,	PUNCT
fnp-2818	1	152	department	department	NOUN
fnp-2818	1	153	of	of	ADP
fnp-2818	1	154	neurology	neurology	NOUN
fnp-2818	1	155	,	,	PUNCT
fnp-2818	1	156	university	university	PROPN
fnp-2818	1	157	of	of	ADP
fnp-2818	1	158	debrecen	debrecen	PROPN
fnp-2818	1	159	,	,	PUNCT
fnp-2818	1	160	debrecen	debrecen	PROPN
fnp-2818	1	161	,	,	PUNCT
fnp-2818	1	162	hungary	hungary	PROPN
fnp-2818	1	163	5	5	NUM
fnp-2818	1	164	division	division	NOUN
fnp-2818	1	165	of	of	ADP
fnp-2818	1	166	cardiovascular	cardiovascular	ADJ
fnp-2818	1	167	sciences	science	NOUN
fnp-2818	1	168	,	,	PUNCT
fnp-2818	1	169	lydia	lydia	PROPN
fnp-2818	1	170	becker	becker	PROPN
fnp-2818	1	171	institute	institute	PROPN
fnp-2818	1	172	of	of	ADP
fnp-2818	1	173	immunology	immunology	NOUN
fnp-2818	1	174	and	and	CCONJ
fnp-2818	1	175	inflammation	inflammation	NOUN
fnp-2818	1	176	,	,	PUNCT
fnp-2818	1	177	the	the	DET
fnp-2818	1	178	university	university	PROPN
fnp-2818	1	179	of	of	ADP
fnp-2818	1	180	manchester	manchester	PROPN
fnp-2818	1	181	,	,	PUNCT
fnp-2818	1	182	manchester	manchester	PROPN
fnp-2818	1	183	academic	academic	PROPN
fnp-2818	1	184	health	health	PROPN
fnp-2818	1	185	science	science	PROPN
fnp-2818	1	186	centre	centre	PROPN
fnp-2818	1	187	,	,	PUNCT
fnp-2818	1	188	manchester	manchester	PROPN
fnp-2818	1	189	centre	centre	PROPN
fnp-2818	1	190	for	for	ADP
fnp-2818	1	191	clinical	clinical	ADJ
fnp-2818	1	192	neurosciences	neuroscience	NOUN
fnp-2818	1	193	,	,	PUNCT
fnp-2818	1	194	salford	salford	PROPN
fnp-2818	1	195	royal	royal	PROPN
fnp-2818	1	196	nhs	nhs	PROPN
fnp-2818	1	197	foundation	foundation	PROPN
fnp-2818	1	198	trust	trust	PROPN
fnp-2818	1	199	,	,	PUNCT
fnp-2818	1	200	salford	salford	PROPN
fnp-2818	1	201	,	,	PUNCT
fnp-2818	1	202	m6	m6	PROPN
fnp-2818	1	203	8hd	8hd	PROPN
fnp-2818	1	204	,	,	PUNCT
fnp-2818	1	205	uk	uk	PROPN
fnp-2818	1	206	corresponding	corresponding	ADJ
fnp-2818	1	207	author	author	NOUN
fnp-2818	1	208	:	:	PUNCT
fnp-2818	1	209	ádám	ádám	ADJ
fnp-2818	1	210	dénes	déne	NOUN
fnp-2818	1	211	·	·	PUNCT
fnp-2818	1	212	laboratory	laboratory	NOUN
fnp-2818	1	213	of	of	ADP
fnp-2818	1	214	neuroimmunology	neuroimmunology	PROPN
fnp-2818	1	215	·	·	PUNCT
fnp-2818	1	216	institute	institute	NOUN
fnp-2818	1	217	of	of	ADP
fnp-2818	1	218	experimental	experimental	ADJ
fnp-2818	1	219	medicine	medicine	NOUN
fnp-2818	1	220	·	·	PUNCT
fnp-2818	1	221	szigony	szigony	ADJ
fnp-2818	1	222	u.	u.	PROPN
fnp-2818	1	223	43	43	NUM
fnp-2818	1	224	.	.	PUNCT
fnp-2818	1	225	1083	1083	NUM
fnp-2818	1	226	·	·	PUNCT
fnp-2818	1	227	budapest	budapest	X
fnp-2818	1	228	·	·	PUNCT
fnp-2818	1	229	hungary	hungary	PROPN
fnp-2818	1	230	denesa@koki.hu	denesa@koki.hu	PROPN
fnp-2818	1	231	submitted	submit	VERB
fnp-2818	1	232	:	:	PUNCT
fnp-2818	1	233	26	26	NUM
fnp-2818	1	234	may	may	PROPN
fnp-2818	1	235	2020	2020	NUM
fnp-2818	1	236	accepted	accept	VERB
fnp-2818	1	237	:	:	PUNCT
fnp-2818	1	238	28	28	NUM
fnp-2818	1	239	may	may	PROPN
fnp-2818	1	240	2020	2020	NUM
fnp-2818	1	241	copyedited	copyedit	VERB
fnp-2818	1	242	by	by	ADP
fnp-2818	1	243	:	:	PUNCT
fnp-2818	1	244	calixto	calixto	NOUN
fnp-2818	1	245	-	-	PUNCT
fnp-2818	1	246	hope	hope	PROPN
fnp-2818	1	247	g	g	PROPN
fnp-2818	1	248	lucas	lucas	PROPN
fnp-2818	1	249	,	,	PUNCT
fnp-2818	1	250	jr	jr	PROPN
fnp-2818	1	251	.	.	PROPN
fnp-2818	2	1	published	publish	VERB
fnp-2818	2	2	:	:	PUNCT
fnp-2818	2	3	05	05	NUM
fnp-2818	2	4	june	june	PROPN
fnp-2818	2	5	2020	2020	NUM
fnp-2818	3	1	https://doi.org/10.17879/freeneuropathology-2020-2818	https://doi.org/10.17879/freeneuropathology-2020-2818	PRON
fnp-2818	3	2	keywords	keyword	NOUN
fnp-2818	3	3	:	:	PUNCT
fnp-2818	3	4	covid-19	covid-19	PROPN
fnp-2818	3	5	,	,	PUNCT
fnp-2818	3	6	sars	sar	NOUN
fnp-2818	3	7	-	-	PUNCT
fnp-2818	3	8	cov-2	cov-2	NOUN
fnp-2818	3	9	,	,	PUNCT
fnp-2818	3	10	neuro	neuro	NOUN
fnp-2818	3	11	-	-	PUNCT
fnp-2818	3	12	covid	covid	PROPN
fnp-2818	3	13	,	,	PUNCT
fnp-2818	3	14	stroke	stroke	NOUN
fnp-2818	3	15	,	,	PUNCT
fnp-2818	3	16	neuroinflammation	neuroinflammation	NOUN
fnp-2818	3	17	,	,	PUNCT
fnp-2818	3	18	neuropathology	neuropathology	NOUN
fnp-2818	3	19	recent	recent	ADJ
fnp-2818	3	20	data	datum	NOUN
fnp-2818	3	21	,	,	PUNCT
fnp-2818	3	22	including	include	VERB
fnp-2818	3	23	a	a	DET
fnp-2818	3	24	number	number	NOUN
fnp-2818	3	25	of	of	ADP
fnp-2818	3	26	controversial	controversial	ADJ
fnp-2818	3	27	findings	finding	NOUN
fnp-2818	3	28	from	from	ADP
fnp-2818	3	29	clinical	clinical	ADJ
fnp-2818	3	30	covid-19	covid-19	PROPN
fnp-2818	3	31	studies	study	NOUN
fnp-2818	3	32	,	,	PUNCT
fnp-2818	3	33	have	have	AUX
fnp-2818	3	34	initiated	initiate	VERB
fnp-2818	3	35	an	an	DET
fnp-2818	3	36	intense	intense	ADJ
fnp-2818	3	37	debate	debate	NOUN
fnp-2818	3	38	regarding	regard	VERB
fnp-2818	3	39	central	central	ADJ
fnp-2818	3	40	nervous	nervous	ADJ
fnp-2818	3	41	system	system	NOUN
fnp-2818	3	42	(	(	PUNCT
fnp-2818	3	43	cns	cns	NOUN
fnp-2818	3	44	)	)	PUNCT
fnp-2818	3	45	involvement	involvement	NOUN
fnp-2818	3	46	in	in	ADP
fnp-2818	3	47	sars	sar	NOUN
fnp-2818	3	48	-	-	PUNCT
fnp-2818	3	49	cov-2	cov-2	PART
fnp-2818	3	50	infection	infection	NOUN
fnp-2818	3	51	-	-	PUNCT
fnp-2818	3	52	associated	associate	VERB
fnp-2818	3	53	pathologies	pathology	NOUN
fnp-2818	3	54	and	and	CCONJ
fnp-2818	3	55	overall	overall	ADJ
fnp-2818	3	56	outcomes	outcome	NOUN
fnp-2818	3	57	.	.	PUNCT
fnp-2818	4	1	in	in	ADP
fnp-2818	4	2	our	our	PRON
fnp-2818	4	3	opinion	opinion	NOUN
fnp-2818	4	4	,	,	PUNCT
fnp-2818	4	5	involvement	involvement	NOUN
fnp-2818	4	6	of	of	ADP
fnp-2818	4	7	the	the	DET
fnp-2818	4	8	brain	brain	NOUN
fnp-2818	4	9	may	may	AUX
fnp-2818	4	10	be	be	AUX
fnp-2818	4	11	an	an	DET
fnp-2818	4	12	important	important	ADJ
fnp-2818	4	13	contributor	contributor	NOUN
fnp-2818	4	14	to	to	ADP
fnp-2818	4	15	the	the	DET
fnp-2818	4	16	highly	highly	ADV
fnp-2818	4	17	complex	complex	ADJ
fnp-2818	4	18	pathophysiology	pathophysiology	NOUN
fnp-2818	4	19	caused	cause	VERB
fnp-2818	4	20	by	by	ADP
fnp-2818	4	21	sars	sar	NOUN
fnp-2818	4	22	-	-	PUNCT
fnp-2818	4	23	cov-2	cov-2	NOUN
fnp-2818	4	24	and	and	CCONJ
fnp-2818	4	25	lessons	lesson	NOUN
fnp-2818	4	26	from	from	ADP
fnp-2818	4	27	studies	study	NOUN
fnp-2818	4	28	on	on	ADP
fnp-2818	4	29	stroke	stroke	NOUN
fnp-2818	4	30	and	and	CCONJ
fnp-2818	4	31	systemic	systemic	ADJ
fnp-2818	4	32	inflammation	inflammation	NOUN
fnp-2818	4	33	provide	provide	VERB
fnp-2818	4	34	important	important	ADJ
fnp-2818	4	35	clues	clue	NOUN
fnp-2818	4	36	.	.	PUNCT
fnp-2818	5	1	numerous	numerous	ADJ
fnp-2818	5	2	cns	cns	NOUN
fnp-2818	5	3	symptoms	symptom	NOUN
fnp-2818	5	4	,	,	PUNCT
fnp-2818	5	5	including	include	VERB
fnp-2818	5	6	loss	loss	NOUN
fnp-2818	5	7	of	of	ADP
fnp-2818	5	8	smell	smell	NOUN
fnp-2818	5	9	and	and	CCONJ
fnp-2818	5	10	taste	taste	NOUN
fnp-2818	5	11	,	,	PUNCT
fnp-2818	5	12	headache	headache	NOUN
fnp-2818	5	13	,	,	PUNCT
fnp-2818	5	14	dizziness	dizziness	NOUN
fnp-2818	5	15	,	,	PUNCT
fnp-2818	5	16	nausea	nausea	NOUN
fnp-2818	5	17	,	,	PUNCT
fnp-2818	5	18	seizures	seizure	NOUN
fnp-2818	5	19	and	and	CCONJ
fnp-2818	5	20	respiratory	respiratory	ADJ
fnp-2818	5	21	distress	distress	NOUN
fnp-2818	5	22	have	have	AUX
fnp-2818	5	23	been	be	AUX
fnp-2818	5	24	reported	report	VERB
fnp-2818	5	25	in	in	ADP
fnp-2818	5	26	covid-19	covid-19	PROPN
fnp-2818	5	27	.	.	PUNCT
fnp-2818	6	1	several	several	ADJ
fnp-2818	6	2	neurological	neurological	ADJ
fnp-2818	6	3	syndromes	syndrome	NOUN
fnp-2818	6	4	,	,	PUNCT
fnp-2818	6	5	such	such	ADJ
fnp-2818	6	6	as	as	ADP
fnp-2818	6	7	stroke	stroke	NOUN
fnp-2818	6	8	,	,	PUNCT
fnp-2818	6	9	encephalitis	encephalitis	NOUN
fnp-2818	6	10	,	,	PUNCT
fnp-2818	6	11	epilepsy	epilepsy	NOUN
fnp-2818	6	12	,	,	PUNCT
fnp-2818	6	13	and	and	CCONJ
fnp-2818	6	14	guillain	guillain	NOUN
fnp-2818	6	15	-	-	PUNCT
fnp-2818	6	16	barre	barre	NOUN
fnp-2818	6	17	syndrome	syndrome	NOUN
fnp-2818	6	18	have	have	AUX
fnp-2818	6	19	been	be	AUX
fnp-2818	6	20	associated	associate	VERB
fnp-2818	6	21	with	with	ADP
fnp-2818	6	22	covid-19	covid-19	PROPN
fnp-2818	6	23	.	.	PUNCT
fnp-2818	7	1	more	more	ADV
fnp-2818	7	2	recently	recently	ADV
fnp-2818	7	3	,	,	PUNCT
fnp-2818	7	4	large	large	ADJ
fnp-2818	7	5	-	-	PUNCT
fnp-2818	7	6	vessel	vessel	NOUN
fnp-2818	7	7	occlusive	occlusive	ADJ
fnp-2818	7	8	stroke	stroke	NOUN
fnp-2818	7	9	has	have	AUX
fnp-2818	7	10	been	be	AUX
fnp-2818	7	11	described	describe	VERB
fnp-2818	7	12	in	in	ADP
fnp-2818	7	13	younger	young	ADJ
fnp-2818	7	14	patients	patient	NOUN
fnp-2818	7	15	without	without	ADP
fnp-2818	7	16	typical	typical	ADJ
fnp-2818	7	17	covid-19	covid-19	PROPN
fnp-2818	7	18	symptoms1	symptoms1	NOUN
fnp-2818	7	19	-	-	PUNCT
fnp-2818	7	20	3	3	NUM
fnp-2818	7	21	.	.	PUNCT
fnp-2818	8	1	in	in	ADP
fnp-2818	8	2	addition	addition	NOUN
fnp-2818	8	3	,	,	PUNCT
fnp-2818	8	4	history	history	NOUN
fnp-2818	8	5	of	of	ADP
fnp-2818	8	6	stroke	stroke	NOUN
fnp-2818	8	7	is	be	AUX
fnp-2818	8	8	associated	associate	VERB
fnp-2818	8	9	with	with	ADP
fnp-2818	8	10	increased	increase	VERB
fnp-2818	8	11	severity	severity	NOUN
fnp-2818	8	12	of	of	ADP
fnp-2818	8	13	covid-194	covid-194	NOUN
fnp-2818	8	14	.	.	PUNCT
fnp-2818	9	1	these	these	DET
fnp-2818	9	2	observations	observation	NOUN
fnp-2818	9	3	highlight	highlight	VERB
fnp-2818	9	4	the	the	DET
fnp-2818	9	5	brain	brain	NOUN
fnp-2818	9	6	as	as	ADP
fnp-2818	9	7	an	an	DET
fnp-2818	9	8	important	important	ADJ
fnp-2818	9	9	target	target	NOUN
fnp-2818	9	10	of	of	ADP
fnp-2818	9	11	this	this	DET
fnp-2818	9	12	multiorgan	multiorgan	NOUN
fnp-2818	9	13	disease	disease	NOUN
fnp-2818	9	14	.	.	PUNCT
fnp-2818	10	1	while	while	SCONJ
fnp-2818	10	2	neuroinvasion	neuroinvasion	NOUN
fnp-2818	10	3	of	of	ADP
fnp-2818	10	4	sars	sars	PROPN
fnp-2818	10	5	-	-	PUNCT
fnp-2818	10	6	cov-2	cov-2	PART
fnp-2818	10	7	has	have	AUX
fnp-2818	10	8	been	be	AUX
fnp-2818	10	9	associated	associate	VERB
fnp-2818	10	10	with	with	ADP
fnp-2818	10	11	cerebral	cerebral	ADJ
fnp-2818	10	12	thrombosis	thrombosis	NOUN
fnp-2818	10	13	,	,	PUNCT
fnp-2818	10	14	hemorrhagic	hemorrhagic	NOUN
fnp-2818	10	15	infarction	infarction	NOUN
fnp-2818	10	16	,	,	PUNCT
fnp-2818	10	17	demyelinating	demyelinate	VERB
fnp-2818	10	18	lesions	lesion	NOUN
fnp-2818	10	19	and	and	CCONJ
fnp-2818	10	20	encephalopathy	encephalopathy	ADJ
fnp-2818	10	21	(	(	PUNCT
fnp-2818	10	22	termed	term	VERB
fnp-2818	10	23	as	as	ADP
fnp-2818	10	24	neuro	neuro	NOUN
fnp-2818	10	25	-	-	PUNCT
fnp-2818	10	26	covid)5,6	covid)5,6	PROPN
fnp-2818	10	27	,	,	PUNCT
fnp-2818	10	28	it	it	PRON
fnp-2818	10	29	has	have	AUX
fnp-2818	10	30	also	also	ADV
fnp-2818	10	31	been	be	AUX
fnp-2818	10	32	suggested	suggest	VERB
fnp-2818	10	33	that	that	SCONJ
fnp-2818	10	34	some	some	DET
fnp-2818	10	35	respiratory	respiratory	ADJ
fnp-2818	10	36	symptoms	symptom	NOUN
fnp-2818	10	37	in	in	ADP
fnp-2818	10	38	patients	patient	NOUN
fnp-2818	10	39	with	with	ADP
fnp-2818	10	40	covid-19	covid-19	PROPN
fnp-2818	10	41	could	could	AUX
fnp-2818	10	42	indicate	indicate	VERB
fnp-2818	10	43	neurological	neurological	ADJ
fnp-2818	10	44	involvement7	involvement7	NOUN
fnp-2818	10	45	.	.	PUNCT
fnp-2818	11	1	post	post	ADJ
fnp-2818	11	2	-	-	ADJ
fnp-2818	11	3	mortem	mortem	ADJ
fnp-2818	11	4	examination	examination	NOUN
fnp-2818	11	5	of	of	ADP
fnp-2818	11	6	a	a	DET
fnp-2818	11	7	series	series	NOUN
fnp-2818	11	8	of	of	ADP
fnp-2818	11	9	patients	patient	NOUN
fnp-2818	11	10	with	with	ADP
fnp-2818	11	11	positive	positive	ADJ
fnp-2818	11	12	polymerase	polymerase	NOUN
fnp-2818	11	13	chain	chain	NOUN
fnp-2818	11	14	reaction	reaction	NOUN
fnp-2818	11	15	testing	testing	NOUN
fnp-2818	11	16	for	for	ADP
fnp-2818	11	17	covid-19	covid-19	PROPN
fnp-2818	11	18	in	in	ADP
fnp-2818	11	19	pleural	pleural	ADJ
fnp-2818	11	20	effusions	effusion	NOUN
fnp-2818	11	21	revealed	reveal	VERB
fnp-2818	11	22	negative	negative	ADJ
fnp-2818	11	23	testing	testing	NOUN
fnp-2818	11	24	in	in	ADP
fnp-2818	11	25	all	all	DET
fnp-2818	11	26	cerebrospinal	cerebrospinal	ADJ
fnp-2818	11	27	fluid	fluid	NOUN
fnp-2818	11	28	(	(	PUNCT
fnp-2818	11	29	csf	csf	NOUN
fnp-2818	11	30	)	)	PUNCT
fnp-2818	11	31	samples	sample	NOUN
fnp-2818	11	32	along	along	ADP
fnp-2818	11	33	with	with	ADP
fnp-2818	11	34	no	no	DET
fnp-2818	11	35	signs	sign	NOUN
fnp-2818	11	36	of	of	ADP
fnp-2818	11	37	encephalitis	encephalitis	NOUN
fnp-2818	11	38	or	or	CCONJ
fnp-2818	11	39	cns	cns	NOUN
fnp-2818	11	40	vasculitis8	vasculitis8	NOUN
fnp-2818	11	41	.	.	PUNCT
fnp-2818	12	1	this	this	DET
fnp-2818	12	2	data	datum	NOUN
fnp-2818	12	3	may	may	AUX
fnp-2818	12	4	suggest	suggest	VERB
fnp-2818	12	5	that	that	SCONJ
fnp-2818	12	6	brain	brain	NOUN
fnp-2818	12	7	involvement	involvement	NOUN
fnp-2818	12	8	in	in	ADP
fnp-2818	12	9	covid-19	covid-19	PROPN
fnp-2818	12	10	does	do	AUX
fnp-2818	12	11	not	not	PART
fnp-2818	12	12	play	play	VERB
fnp-2818	12	13	a	a	DET
fnp-2818	12	14	major	major	ADJ
fnp-2818	12	15	role	role	NOUN
fnp-2818	12	16	in	in	ADP
fnp-2818	12	17	the	the	DET
fnp-2818	12	18	disease	disease	NOUN
fnp-2818	12	19	pathogenesis	pathogenesis	NOUN
fnp-2818	12	20	.	.	PUNCT
fnp-2818	13	1	however	however	ADV
fnp-2818	13	2	,	,	PUNCT
fnp-2818	13	3	it	it	PRON
fnp-2818	13	4	appears	appear	VERB
fnp-2818	13	5	difficult	difficult	ADJ
fnp-2818	13	6	to	to	PART
fnp-2818	13	7	draw	draw	VERB
fnp-2818	13	8	firm	firm	ADJ
fnp-2818	13	9	conclusions	conclusion	NOUN
fnp-2818	13	10	from	from	ADP
fnp-2818	13	11	these	these	DET
fnp-2818	13	12	observations	observation	NOUN
fnp-2818	13	13	.	.	PUNCT
fnp-2818	14	1	sars	sar	NOUN
fnp-2818	14	2	-	-	PUNCT
fnp-2818	14	3	cov-2	cov-2	NOUN
fnp-2818	14	4	might	might	AUX
fnp-2818	14	5	not	not	PART
fnp-2818	14	6	be	be	AUX
fnp-2818	14	7	detectable	detectable	ADJ
fnp-2818	14	8	in	in	ADP
fnp-2818	14	9	the	the	DET
fnp-2818	14	10	csf	csf	NOUN
fnp-2818	14	11	due	due	ADP
fnp-2818	14	12	to	to	ADP
fnp-2818	14	13	low	low	ADJ
fnp-2818	14	14	viral	viral	ADJ
fnp-2818	14	15	load	load	NOUN
fnp-2818	14	16	,	,	PUNCT
fnp-2818	14	17	increased	increase	VERB
fnp-2818	14	18	clearance	clearance	NOUN
fnp-2818	14	19	,	,	PUNCT
fnp-2818	14	20	or	or	CCONJ
fnp-2818	14	21	the	the	DET
fnp-2818	14	22	sensitivity	sensitivity	NOUN
fnp-2818	14	23	of	of	ADP
fnp-2818	14	24	detection5	detection5	NOUN
fnp-2818	14	25	,	,	PUNCT
fnp-2818	14	26	while	while	SCONJ
fnp-2818	14	27	macroscopic	macroscopic	ADJ
fnp-2818	14	28	analysis	analysis	NOUN
fnp-2818	14	29	may	may	AUX
fnp-2818	14	30	not	not	PART
fnp-2818	14	31	be	be	AUX
fnp-2818	14	32	sufficient	sufficient	ADJ
fnp-2818	14	33	to	to	PART
fnp-2818	14	34	reveal	reveal	VERB
fnp-2818	14	35	the	the	DET
fnp-2818	14	36	presence	presence	NOUN
fnp-2818	14	37	of	of	ADP
fnp-2818	14	38	infection	infection	NOUN
fnp-2818	14	39	in	in	ADP
fnp-2818	14	40	the	the	DET
fnp-2818	14	41	brain	brain	NOUN
fnp-2818	14	42	tissue	tissue	NOUN
fnp-2818	14	43	.	.	PUNCT
fnp-2818	15	1	nevertheless	nevertheless	ADV
fnp-2818	15	2	,	,	PUNCT
fnp-2818	15	3	other	other	ADJ
fnp-2818	15	4	arguments	argument	NOUN
fnp-2818	15	5	also	also	ADV
fnp-2818	15	6	indicate	indicate	VERB
fnp-2818	15	7	that	that	SCONJ
fnp-2818	15	8	neurological	neurological	ADJ
fnp-2818	15	9	symptoms	symptom	NOUN
fnp-2818	15	10	reported	report	VERB
fnp-2818	15	11	to	to	ADP
fnp-2818	15	12	date	date	NOUN
fnp-2818	15	13	may	may	AUX
fnp-2818	15	14	be	be	AUX
fnp-2818	15	15	nonspecific	nonspecific	ADJ
fnp-2818	15	16	and	and	CCONJ
fnp-2818	15	17	not	not	PART
fnp-2818	15	18	necessarily	necessarily	ADV
fnp-2818	15	19	imply	imply	VERB
fnp-2818	15	20	cns	cns	NOUN
fnp-2818	15	21	disease	disease	NOUN
fnp-2818	15	22	,	,	PUNCT
fnp-2818	15	23	while	while	SCONJ
fnp-2818	15	24	respiratory	respiratory	ADJ
fnp-2818	15	25	failure	failure	NOUN
fnp-2818	15	26	alone	alone	ADV
fnp-2818	15	27	does	do	AUX
fnp-2818	15	28	not	not	PART
fnp-2818	15	29	suggest	suggest	VERB
fnp-2818	15	30	cns	cns	NOUN
fnp-2818	15	31	invasion	invasion	NOUN
fnp-2818	15	32	by	by	ADP
fnp-2818	15	33	sars	sar	NOUN
fnp-2818	15	34	-	-	PUNCT
fnp-2818	15	35	cov-29	cov-29	PROPN
fnp-2818	15	36	.	.	PUNCT
fnp-2818	15	37	however	however	ADV
fnp-2818	15	38	,	,	PUNCT
fnp-2818	15	39	in	in	ADP
fnp-2818	15	40	the	the	DET
fnp-2818	15	41	absence	absence	NOUN
fnp-2818	15	42	of	of	ADP
fnp-2818	15	43	comprehensive	comprehensive	ADJ
fnp-2818	15	44	neuropathological	neuropathological	ADJ
fnp-2818	15	45	analysis	analysis	NOUN
fnp-2818	15	46	,	,	PUNCT
fnp-2818	15	47	the	the	DET
fnp-2818	15	48	extent	extent	NOUN
fnp-2818	15	49	and	and	CCONJ
fnp-2818	15	50	anatomical	anatomical	ADJ
fnp-2818	15	51	distribution	distribution	NOUN
fnp-2818	15	52	of	of	ADP
fnp-2818	15	53	sars	sar	NOUN
fnp-2818	15	54	-	-	PUNCT
fnp-2818	15	55	cov-2	cov-2	PART
fnp-2818	15	56	infection	infection	NOUN
fnp-2818	15	57	in	in	ADP
fnp-2818	15	58	the	the	DET
fnp-2818	15	59	cns	cns	NOUN
fnp-2818	15	60	remain	remain	VERB
fnp-2818	15	61	unanswered	unanswered	ADJ
fnp-2818	15	62	.	.	PUNCT
fnp-2818	16	1	the	the	DET
fnp-2818	16	2	robust	robust	ADJ
fnp-2818	16	3	inflammatory	inflammatory	ADJ
fnp-2818	16	4	and	and	CCONJ
fnp-2818	16	5	prothrombotic	prothrombotic	ADJ
fnp-2818	16	6	response	response	NOUN
fnp-2818	16	7	directly	directly	ADV
fnp-2818	16	8	and	and	CCONJ
fnp-2818	16	9	indirectly	indirectly	ADV
fnp-2818	16	10	affecting	affect	VERB
fnp-2818	16	11	the	the	DET
fnp-2818	16	12	cns	cns	NOUN
fnp-2818	16	13	could	could	AUX
fnp-2818	16	14	explain	explain	VERB
fnp-2818	16	15	some	some	PRON
fnp-2818	16	16	of	of	ADP
fnp-2818	16	17	the	the	DET
fnp-2818	16	18	major	major	ADJ
fnp-2818	16	19	neurological	neurological	ADJ
fnp-2818	16	20	complications	complication	NOUN
fnp-2818	16	21	,	,	PUNCT
fnp-2818	16	22	which	which	PRON
fnp-2818	16	23	may	may	AUX
fnp-2818	16	24	be	be	AUX
fnp-2818	16	25	complemented	complement	VERB
fnp-2818	16	26	by	by	ADP
fnp-2818	16	27	effects	effect	NOUN
fnp-2818	16	28	of	of	ADP
fnp-2818	16	29	possible	possible	ADJ
fnp-2818	16	30	sars	sar	NOUN
fnp-2818	16	31	-	-	PUNCT
fnp-2818	16	32	cov-2	cov-2	NOUN
fnp-2818	16	33	infection	infection	NOUN
fnp-2818	16	34	in	in	ADP
fnp-2818	16	35	the	the	DET
fnp-2818	16	36	brain	brain	NOUN
fnp-2818	16	37	.	.	PUNCT
fnp-2818	17	1	coronaviruses	coronaviruse	NOUN
fnp-2818	17	2	have	have	AUX
fnp-2818	17	3	long	long	ADV
fnp-2818	17	4	been	be	AUX
fnp-2818	17	5	recognised	recognise	VERB
fnp-2818	17	6	as	as	ADP
fnp-2818	17	7	potentially	potentially	ADV
fnp-2818	17	8	neurovirulent	neurovirulent	ADJ
fnp-2818	17	9	microorganisms10	microorganisms10	NOUN
fnp-2818	17	10	.	.	PUNCT
fnp-2818	18	1	neuroinvasiveness	neuroinvasiveness	NOUN
fnp-2818	18	2	of	of	ADP
fnp-2818	18	3	severe	severe	ADJ
fnp-2818	18	4	acute	acute	ADJ
fnp-2818	18	5	respiratory	respiratory	ADJ
fnp-2818	18	6	syndrome	syndrome	NOUN
fnp-2818	18	7	coronavirus	coronavirus	NOUN
fnp-2818	18	8	(	(	PUNCT
fnp-2818	18	9	sars	sars	NOUN
fnp-2818	18	10	-	-	PUNCT
fnp-2818	18	11	cov	cov	NOUN
fnp-2818	18	12	)	)	PUNCT
fnp-2818	18	13	and	and	CCONJ
fnp-2818	18	14	middle	middle	PROPN
fnp-2818	18	15	east	east	PROPN
fnp-2818	18	16	respiratory	respiratory	ADJ
fnp-2818	18	17	syndrome	syndrome	NOUN
fnp-2818	18	18	coronavirus	coronavirus	NOUN
fnp-2818	18	19	(	(	PUNCT
fnp-2818	18	20	mers	mer	NOUN
fnp-2818	18	21	-	-	PUNCT
fnp-2818	18	22	cov	cov	NOUN
fnp-2818	18	23	)	)	PUNCT
fnp-2818	18	24	,	,	PUNCT
fnp-2818	18	25	has	have	AUX
fnp-2818	18	26	been	be	AUX
fnp-2818	18	27	previously	previously	ADV
fnp-2818	18	28	reported	report	VERB
fnp-2818	18	29	with	with	ADP
fnp-2818	18	30	pronounced	pronounced	ADJ
fnp-2818	18	31	infection	infection	NOUN
fnp-2818	18	32	in	in	ADP
fnp-2818	18	33	brainstem	brainstem	NOUN
fnp-2818	18	34	nuclei	nucleus	NOUN
fnp-2818	18	35	involved	involve	VERB
fnp-2818	18	36	in	in	ADP
fnp-2818	18	37	respiratory	respiratory	ADJ
fnp-2818	18	38	and	and	CCONJ
fnp-2818	18	39	cardiovascular	cardiovascular	ADJ
fnp-2818	18	40	control2,11	control2,11	NOUN
fnp-2818	18	41	.	.	PUNCT
fnp-2818	19	1	based	base	VERB
fnp-2818	19	2	on	on	ADP
fnp-2818	19	3	these	these	DET
fnp-2818	19	4	data	datum	NOUN
fnp-2818	19	5	,	,	PUNCT
fnp-2818	19	6	sars	sar	NOUN
fnp-2818	19	7	-	-	PUNCT
fnp-2818	19	8	cov-2	cov-2	NUM
fnp-2818	19	9	might	might	AUX
fnp-2818	19	10	also	also	ADV
fnp-2818	19	11	reach	reach	VERB
fnp-2818	19	12	the	the	DET
fnp-2818	19	13	cns	cns	NOUN
fnp-2818	19	14	via	via	ADP
fnp-2818	19	15	multiple	multiple	ADJ
fnp-2818	19	16	routes	route	NOUN
fnp-2818	19	17	.	.	PUNCT
fnp-2818	20	1	in	in	ADP
fnp-2818	20	2	viraemia	viraemia	NOUN
fnp-2818	20	3	,	,	PUNCT
fnp-2818	20	4	sars	sar	NOUN
fnp-2818	20	5	-	-	PUNCT
fnp-2818	20	6	cov-2	cov-2	PART
fnp-2818	20	7	binds	bind	VERB
fnp-2818	20	8	to	to	ADP
fnp-2818	20	9	the	the	DET
fnp-2818	20	10	angiotensin	angiotensin	NOUN
fnp-2818	20	11	-	-	PUNCT
fnp-2818	20	12	converting	convert	VERB
fnp-2818	20	13	enzyme-2	enzyme-2	NUM
fnp-2818	20	14	(	(	PUNCT
fnp-2818	20	15	ace2	ace2	NOUN
fnp-2818	20	16	)	)	PUNCT
fnp-2818	20	17	receptor	receptor	NOUN
fnp-2818	20	18	on	on	ADP
fnp-2818	20	19	the	the	DET
fnp-2818	20	20	endothelium	endothelium	NOUN
fnp-2818	20	21	and	and	CCONJ
fnp-2818	20	22	,	,	PUNCT
fnp-2818	20	23	after	after	ADP
fnp-2818	20	24	crossing	cross	VERB
fnp-2818	20	25	the	the	DET
fnp-2818	20	26	blood	blood	NOUN
fnp-2818	20	27	-	-	PUNCT
fnp-2818	20	28	brain	brain	NOUN
fnp-2818	20	29	barrier	barrier	NOUN
fnp-2818	20	30	(	(	PUNCT
fnp-2818	20	31	bbb	bbb	PROPN
fnp-2818	20	32	)	)	PUNCT
fnp-2818	20	33	,	,	PUNCT
fnp-2818	20	34	also	also	ADV
fnp-2818	20	35	binds	bind	VERB
fnp-2818	20	36	to	to	ADP
fnp-2818	20	37	neurons	neuron	NOUN
fnp-2818	20	38	expressing	express	VERB
fnp-2818	20	39	the	the	DET
fnp-2818	20	40	receptor12	receptor12	NOUN
fnp-2818	20	41	.	.	PUNCT
fnp-2818	21	1	one	one	NUM
fnp-2818	21	2	of	of	ADP
fnp-2818	21	3	the	the	DET
fnp-2818	21	4	currently	currently	ADV
fnp-2818	21	5	available	available	ADJ
fnp-2818	21	6	case	case	NOUN
fnp-2818	21	7	reports	report	NOUN
fnp-2818	21	8	with	with	ADP
fnp-2818	21	9	post	post	ADJ
fnp-2818	21	10	-	-	ADJ
fnp-2818	21	11	mortem	mortem	ADJ
fnp-2818	21	12	neuropathology	neuropathology	NOUN
fnp-2818	21	13	limited	limit	VERB
fnp-2818	21	14	to	to	PART
fnp-2818	21	15	electron	electron	VERB
fnp-2818	21	16	microscopic	microscopic	ADJ
fnp-2818	21	17	examination	examination	NOUN
fnp-2818	21	18	in	in	ADP
fnp-2818	21	19	a	a	DET
fnp-2818	21	20	frontal	frontal	ADJ
fnp-2818	21	21	lobe	lobe	NOUN
fnp-2818	21	22	sample	sample	NOUN
fnp-2818	21	23	demonstrates	demonstrate	VERB
fnp-2818	21	24	the	the	DET
fnp-2818	21	25	virus	virus	NOUN
fnp-2818	21	26	in	in	ADP
fnp-2818	21	27	endothelial	endothelial	ADJ
fnp-2818	21	28	cells	cell	NOUN
fnp-2818	21	29	with	with	ADP
fnp-2818	21	30	features	feature	NOUN
fnp-2818	21	31	suggestive	suggestive	ADJ
fnp-2818	21	32	of	of	ADP
fnp-2818	21	33	transit	transit	NOUN
fnp-2818	21	34	of	of	ADP
fnp-2818	21	35	the	the	DET
fnp-2818	21	36	virus	virus	NOUN
fnp-2818	21	37	towards	towards	ADP
fnp-2818	21	38	the	the	DET
fnp-2818	21	39	neuropil	neuropil	NOUN
fnp-2818	21	40	,	,	PUNCT
fnp-2818	21	41	and	and	CCONJ
fnp-2818	21	42	neuronal	neuronal	ADJ
fnp-2818	21	43	‘	'	PUNCT
fnp-2818	21	44	viral	viral	ADJ
fnp-2818	21	45	-	-	PUNCT
fnp-2818	21	46	like	like	ADJ
fnp-2818	21	47	’	'	PUNCT
fnp-2818	21	48	particles	particle	NOUN
fnp-2818	21	49	in	in	ADP
fnp-2818	21	50	cytoplasmic	cytoplasmic	ADJ
fnp-2818	21	51	vacuoles13	vacuoles13	NOUN
fnp-2818	21	52	.	.	PUNCT
fnp-2818	22	1	via	via	ADP
fnp-2818	22	2	the	the	DET
fnp-2818	22	3	olfactory	olfactory	NOUN
fnp-2818	22	4	route	route	NOUN
fnp-2818	22	5	,	,	PUNCT
fnp-2818	22	6	the	the	DET
fnp-2818	22	7	virus	virus	NOUN
fnp-2818	22	8	infects	infect	VERB
fnp-2818	22	9	the	the	DET
fnp-2818	22	10	olfactory	olfactory	NOUN
fnp-2818	22	11	epithelium	epithelium	NOUN
fnp-2818	22	12	,	,	PUNCT
fnp-2818	22	13	enters	enter	VERB
fnp-2818	22	14	the	the	DET
fnp-2818	22	15	nervous	nervous	ADJ
fnp-2818	22	16	system	system	NOUN
fnp-2818	22	17	across	across	ADP
fnp-2818	22	18	the	the	DET
fnp-2818	22	19	cribriform	cribriform	NOUN
fnp-2818	22	20	plate	plate	NOUN
fnp-2818	22	21	through	through	ADP
fnp-2818	22	22	axons	axon	NOUN
fnp-2818	22	23	of	of	ADP
fnp-2818	22	24	olfactory	olfactory	ADJ
fnp-2818	22	25	bulb	bulb	NOUN
fnp-2818	22	26	neurons	neuron	NOUN
fnp-2818	22	27	,	,	PUNCT
fnp-2818	22	28	and	and	CCONJ
fnp-2818	22	29	then	then	ADV
fnp-2818	22	30	infects	infect	VERB
fnp-2818	22	31	the	the	DET
fnp-2818	22	32	sustentacular	sustentacular	ADJ
fnp-2818	22	33	cells	cell	NOUN
fnp-2818	22	34	that	that	PRON
fnp-2818	22	35	maintain	maintain	VERB
fnp-2818	22	36	the	the	DET
fnp-2818	22	37	integrity	integrity	NOUN
fnp-2818	22	38	of	of	ADP
fnp-2818	22	39	olfactory	olfactory	ADJ
fnp-2818	22	40	sensory	sensory	ADJ
fnp-2818	22	41	neurons	neuron	NOUN
fnp-2818	22	42	.	.	PUNCT
fnp-2818	23	1	sars	sar	NOUN
fnp-2818	23	2	-	-	PUNCT
fnp-2818	23	3	cov-2	cov-2	NUM
fnp-2818	23	4	may	may	AUX
fnp-2818	23	5	also	also	ADV
fnp-2818	23	6	enter	enter	VERB
fnp-2818	23	7	and	and	CCONJ
fnp-2818	23	8	spread	spread	VERB
fnp-2818	23	9	via	via	ADP
fnp-2818	23	10	the	the	DET
fnp-2818	23	11	cerebral	cerebral	ADJ
fnp-2818	23	12	lymphatic	lymphatic	ADJ
fnp-2818	23	13	(	(	PUNCT
fnp-2818	23	14	glymphatic	glymphatic	ADJ
fnp-2818	23	15	)	)	PUNCT
fnp-2818	23	16	drainage	drainage	NOUN
fnp-2818	23	17	system	system	NOUN
fnp-2818	23	18	since	since	SCONJ
fnp-2818	23	19	the	the	DET
fnp-2818	23	20	virus	virus	NOUN
fnp-2818	23	21	can	can	AUX
fnp-2818	23	22	infect	infect	VERB
fnp-2818	23	23	the	the	DET
fnp-2818	23	24	endothelial	endothelial	ADJ
fnp-2818	23	25	cells	cell	NOUN
fnp-2818	23	26	of	of	ADP
fnp-2818	23	27	the	the	DET
fnp-2818	23	28	olfactory	olfactory	ADJ
fnp-2818	23	29	lymphatic	lymphatic	ADJ
fnp-2818	23	30	system	system	NOUN
fnp-2818	23	31	which	which	PRON
fnp-2818	23	32	connect	connect	VERB
fnp-2818	23	33	to	to	ADP
fnp-2818	23	34	the	the	DET
fnp-2818	23	35	brain12,14	brain12,14	ADV
fnp-2818	23	36	-	-	PUNCT
fnp-2818	23	37	16	16	NUM
fnp-2818	23	38	.	.	PUNCT
fnp-2818	24	1	in	in	ADP
fnp-2818	24	2	addition	addition	NOUN
fnp-2818	24	3	,	,	PUNCT
fnp-2818	24	4	similar	similar	ADJ
fnp-2818	24	5	to	to	ADP
fnp-2818	24	6	herpesviruses	herpesviruse	NOUN
fnp-2818	24	7	or	or	CCONJ
fnp-2818	24	8	the	the	DET
fnp-2818	24	9	avian	avian	ADJ
fnp-2818	24	10	influenza	influenza	NOUN
fnp-2818	24	11	virus	virus	PROPN
fnp-2818	24	12	,	,	PUNCT
fnp-2818	24	13	sars	sar	NOUN
fnp-2818	24	14	-	-	PUNCT
fnp-2818	24	15	cov-2	cov-2	PART
fnp-2818	24	16	could	could	AUX
fnp-2818	24	17	reach	reach	VERB
fnp-2818	24	18	the	the	DET
fnp-2818	24	19	brain	brain	NOUN
fnp-2818	24	20	via	via	ADP
fnp-2818	24	21	peripheral	peripheral	ADJ
fnp-2818	24	22	nerves	nerve	NOUN
fnp-2818	24	23	,	,	PUNCT
fnp-2818	24	24	possibly	possibly	ADV
fnp-2818	24	25	via	via	ADP
fnp-2818	24	26	retrograde	retrograde	ADJ
fnp-2818	24	27	transport	transport	NOUN
fnp-2818	24	28	and	and	CCONJ
fnp-2818	24	29	trans	trans	ADJ
fnp-2818	24	30	-	-	ADJ
fnp-2818	24	31	synaptic	synaptic	ADJ
fnp-2818	24	32	spread17	spread17	NOUN
fnp-2818	24	33	-	-	PUNCT
fnp-2818	24	34	19	19	NUM
fnp-2818	24	35	.	.	PUNCT
fnp-2818	24	36	deficient	deficient	ADJ
fnp-2818	24	37	systemic	systemic	ADJ
fnp-2818	24	38	immune	immune	ADJ
fnp-2818	24	39	response	response	NOUN
fnp-2818	24	40	due	due	ADP
fnp-2818	24	41	to	to	ADP
fnp-2818	24	42	older	old	ADJ
fnp-2818	24	43	age	age	NOUN
fnp-2818	24	44	,	,	PUNCT
fnp-2818	24	45	chronic	chronic	ADJ
fnp-2818	24	46	disease	disease	NOUN
fnp-2818	24	47	or	or	CCONJ
fnp-2818	24	48	immunosuppressive	immunosuppressive	ADJ
fnp-2818	24	49	therapy	therapy	NOUN
fnp-2818	24	50	,	,	PUNCT
fnp-2818	24	51	altered	alter	VERB
fnp-2818	24	52	ace2	ace2	NOUN
fnp-2818	24	53	expression	expression	NOUN
fnp-2818	24	54	in	in	ADP
fnp-2818	24	55	diabetic	diabetic	ADJ
fnp-2818	24	56	or	or	CCONJ
fnp-2818	24	57	hypertensive	hypertensive	ADJ
fnp-2818	24	58	patients	patient	NOUN
fnp-2818	24	59	,	,	PUNCT
fnp-2818	24	60	cerebrovascular	cerebrovascular	ADJ
fnp-2818	24	61	disease	disease	NOUN
fnp-2818	24	62	(	(	PUNCT
fnp-2818	24	63	major	major	ADJ
fnp-2818	24	64	risk	risk	NOUN
fnp-2818	24	65	factors	factor	NOUN
fnp-2818	24	66	for	for	ADP
fnp-2818	24	67	covid-19	covid-19	PROPN
fnp-2818	24	68	-	-	PUNCT
fnp-2818	24	69	associated	associate	VERB
fnp-2818	24	70	mortality)1,4	mortality)1,4	NOUN
fnp-2818	24	71	,	,	PUNCT
fnp-2818	24	72	as	as	ADV
fnp-2818	24	73	well	well	ADV
fnp-2818	24	74	as	as	ADP
fnp-2818	24	75	vascular	vascular	ADJ
fnp-2818	24	76	inflammation	inflammation	NOUN
fnp-2818	24	77	or	or	CCONJ
fnp-2818	24	78	impaired	impaired	ADJ
fnp-2818	24	79	blood	blood	NOUN
fnp-2818	24	80	-	-	PUNCT
fnp-2818	24	81	brain	brain	NOUN
fnp-2818	24	82	barrier	barrier	NOUN
fnp-2818	24	83	(	(	PUNCT
fnp-2818	24	84	bbb	bbb	NOUN
fnp-2818	24	85	)	)	PUNCT
fnp-2818	24	86	function	function	NOUN
fnp-2818	24	87	in	in	ADP
fnp-2818	24	88	aged	aged	ADJ
fnp-2818	24	89	or	or	CCONJ
fnp-2818	24	90	comorbid	comorbid	NOUN
fnp-2818	24	91	patients	patient	NOUN
fnp-2818	24	92	could	could	AUX
fnp-2818	24	93	also	also	ADV
fnp-2818	24	94	increase	increase	VERB
fnp-2818	24	95	the	the	DET
fnp-2818	24	96	risk	risk	NOUN
fnp-2818	24	97	and	and	CCONJ
fnp-2818	24	98	severity	severity	NOUN
fnp-2818	24	99	of	of	ADP
fnp-2818	24	100	infection	infection	NOUN
fnp-2818	24	101	.	.	PUNCT
fnp-2818	25	1	if	if	SCONJ
fnp-2818	25	2	cns	cns	PROPN
fnp-2818	25	3	infection	infection	NOUN
fnp-2818	25	4	occurs	occur	VERB
fnp-2818	25	5	,	,	PUNCT
fnp-2818	25	6	the	the	DET
fnp-2818	25	7	outcome	outcome	NOUN
fnp-2818	25	8	largely	largely	ADV
fnp-2818	25	9	depends	depend	VERB
fnp-2818	25	10	on	on	ADP
fnp-2818	25	11	the	the	DET
fnp-2818	25	12	ability	ability	NOUN
fnp-2818	25	13	of	of	ADP
fnp-2818	25	14	the	the	DET
fnp-2818	25	15	cns	cns	PROPN
fnp-2818	25	16	immune	immune	ADJ
fnp-2818	25	17	system	system	NOUN
fnp-2818	25	18	to	to	PART
fnp-2818	25	19	control	control	VERB
fnp-2818	25	20	the	the	DET
fnp-2818	25	21	spread	spread	NOUN
fnp-2818	25	22	of	of	ADP
fnp-2818	25	23	the	the	DET
fnp-2818	25	24	virus	virus	NOUN
fnp-2818	25	25	.	.	PUNCT
fnp-2818	26	1	studies	study	NOUN
fnp-2818	26	2	on	on	ADP
fnp-2818	26	3	neurotropic	neurotropic	PROPN
fnp-2818	26	4	virus	virus	PROPN
fnp-2818	26	5	infection	infection	NOUN
fnp-2818	26	6	suggest	suggest	VERB
fnp-2818	26	7	that	that	SCONJ
fnp-2818	26	8	microglia	microglia	NOUN
fnp-2818	26	9	,	,	PUNCT
fnp-2818	26	10	the	the	DET
fnp-2818	26	11	main	main	ADJ
fnp-2818	26	12	inflammatory	inflammatory	ADJ
fnp-2818	26	13	cells	cell	NOUN
fnp-2818	26	14	of	of	ADP
fnp-2818	26	15	the	the	DET
fnp-2818	26	16	cns	cns	NOUN
fnp-2818	26	17	,	,	PUNCT
fnp-2818	26	18	are	be	AUX
fnp-2818	26	19	important	important	ADJ
fnp-2818	26	20	in	in	ADP
fnp-2818	26	21	controlling	control	VERB
fnp-2818	26	22	both	both	CCONJ
fnp-2818	26	23	the	the	DET
fnp-2818	26	24	spread	spread	NOUN
fnp-2818	26	25	of	of	ADP
fnp-2818	26	26	the	the	DET
fnp-2818	26	27	virus	virus	NOUN
fnp-2818	26	28	and	and	CCONJ
fnp-2818	26	29	shaping	shape	VERB
fnp-2818	26	30	the	the	DET
fnp-2818	26	31	cerebral	cerebral	ADJ
fnp-2818	26	32	inflammatory	inflammatory	ADJ
fnp-2818	26	33	response	response	NOUN
fnp-2818	26	34	.	.	PUNCT
fnp-2818	27	1	this	this	DET
fnp-2818	27	2	key	key	ADJ
fnp-2818	27	3	role	role	NOUN
fnp-2818	27	4	of	of	ADP
fnp-2818	27	5	microglia	microglia	NOUN
fnp-2818	27	6	has	have	AUX
fnp-2818	27	7	been	be	AUX
fnp-2818	27	8	experimentally	experimentally	ADV
fnp-2818	27	9	demonstrated	demonstrate	VERB
fnp-2818	27	10	in	in	ADP
fnp-2818	27	11	coronavirus	coronavirus	NOUN
fnp-2818	27	12	,	,	PUNCT
fnp-2818	27	13	herpesvirus	herpesvirus	NOUN
fnp-2818	27	14	,	,	PUNCT
fnp-2818	27	15	theiler	theiler	NOUN
fnp-2818	27	16	’s	’s	PART
fnp-2818	27	17	virus	virus	NOUN
fnp-2818	27	18	and	and	CCONJ
fnp-2818	27	19	vesicular	vesicular	ADJ
fnp-2818	27	20	stomatitis	stomatitis	NOUN
fnp-2818	27	21	virus	virus	NOUN
fnp-2818	27	22	infection	infection	NOUN
fnp-2818	27	23	among	among	ADP
fnp-2818	27	24	others20	others20	NOUN
fnp-2818	27	25	-	-	PUNCT
fnp-2818	27	26	24	24	NUM
fnp-2818	27	27	.	.	PUNCT
fnp-2818	28	1	importantly	importantly	ADV
fnp-2818	28	2	,	,	PUNCT
fnp-2818	28	3	lack	lack	NOUN
fnp-2818	28	4	of	of	ADP
fnp-2818	28	5	normal	normal	ADJ
fnp-2818	28	6	microglial	microglial	ADJ
fnp-2818	28	7	function	function	NOUN
fnp-2818	28	8	not	not	PART
fnp-2818	28	9	only	only	ADV
fnp-2818	28	10	increases	increase	VERB
fnp-2818	28	11	viral	viral	ADJ
fnp-2818	28	12	spread	spread	NOUN
fnp-2818	28	13	in	in	ADP
fnp-2818	28	14	the	the	DET
fnp-2818	28	15	brain	brain	NOUN
fnp-2818	28	16	,	,	PUNCT
fnp-2818	28	17	but	but	CCONJ
fnp-2818	28	18	is	be	AUX
fnp-2818	28	19	also	also	ADV
fnp-2818	28	20	associated	associate	VERB
fnp-2818	28	21	with	with	ADP
fnp-2818	28	22	markedly	markedly	ADV
fnp-2818	28	23	worsened	worsen	VERB
fnp-2818	28	24	neurological	neurological	ADJ
fnp-2818	28	25	symptoms	symptom	NOUN
fnp-2818	28	26	(	(	PUNCT
fnp-2818	28	27	motor	motor	NOUN
fnp-2818	28	28	function	function	NOUN
fnp-2818	28	29	deficits	deficit	NOUN
fnp-2818	28	30	,	,	PUNCT
fnp-2818	28	31	neuronal	neuronal	ADJ
fnp-2818	28	32	injury	injury	NOUN
fnp-2818	28	33	,	,	PUNCT
fnp-2818	28	34	brain	brain	NOUN
fnp-2818	28	35	oedema	oedema	NOUN
fnp-2818	28	36	,	,	PUNCT
fnp-2818	28	37	seizures	seizure	NOUN
fnp-2818	28	38	,	,	PUNCT
fnp-2818	28	39	etc	etc	X
fnp-2818	28	40	.	.	X
fnp-2818	28	41	)	)	PUNCT
fnp-2818	28	42	and	and	CCONJ
fnp-2818	28	43	increased	increase	VERB
fnp-2818	28	44	mortality	mortality	NOUN
fnp-2818	28	45	in	in	ADP
fnp-2818	28	46	animal	animal	NOUN
fnp-2818	28	47	models20	models20	NOUN
fnp-2818	28	48	-	-	PUNCT
fnp-2818	28	49	24	24	NUM
fnp-2818	28	50	.	.	PUNCT
fnp-2818	29	1	microglial	microglial	ADJ
fnp-2818	29	2	phenotype	phenotype	NOUN
fnp-2818	29	3	is	be	AUX
fnp-2818	29	4	heavily	heavily	ADV
fnp-2818	29	5	influenced	influence	VERB
fnp-2818	29	6	by	by	ADP
fnp-2818	29	7	age	age	NOUN
fnp-2818	29	8	,	,	PUNCT
fnp-2818	29	9	comorbidities	comorbiditie	NOUN
fnp-2818	29	10	and	and	CCONJ
fnp-2818	29	11	systemic	systemic	ADJ
fnp-2818	29	12	inflammation25	inflammation25	NOUN
fnp-2818	29	13	.	.	PUNCT
fnp-2818	30	1	therefore	therefore	ADV
fnp-2818	30	2	,	,	PUNCT
fnp-2818	30	3	it	it	PRON
fnp-2818	30	4	is	be	AUX
fnp-2818	30	5	likely	likely	ADJ
fnp-2818	30	6	that	that	SCONJ
fnp-2818	30	7	compromised	compromise	VERB
fnp-2818	30	8	microglial	microglial	ADJ
fnp-2818	30	9	function	function	NOUN
fnp-2818	30	10	is	be	AUX
fnp-2818	30	11	an	an	DET
fnp-2818	30	12	important	important	ADJ
fnp-2818	30	13	contributor	contributor	NOUN
fnp-2818	30	14	to	to	ADP
fnp-2818	30	15	poor	poor	ADJ
fnp-2818	30	16	outcome	outcome	NOUN
fnp-2818	30	17	in	in	ADP
fnp-2818	30	18	neuro	neuro	NOUN
fnp-2818	30	19	-	-	PUNCT
fnp-2818	30	20	covid	covid	PROPN
fnp-2818	30	21	,	,	PUNCT
fnp-2818	30	22	especially	especially	ADV
fnp-2818	30	23	if	if	SCONJ
fnp-2818	30	24	brain	brain	NOUN
fnp-2818	30	25	areas	area	NOUN
fnp-2818	30	26	involved	involve	VERB
fnp-2818	30	27	in	in	ADP
fnp-2818	30	28	respiratory	respiratory	ADJ
fnp-2818	30	29	,	,	PUNCT
fnp-2818	30	30	cardiovascular	cardiovascular	ADJ
fnp-2818	30	31	and	and	CCONJ
fnp-2818	30	32	neuroendocrine	neuroendocrine	ADJ
fnp-2818	30	33	control	control	NOUN
fnp-2818	30	34	are	be	AUX
fnp-2818	30	35	affected	affect	VERB
fnp-2818	30	36	by	by	ADP
fnp-2818	30	37	sars	sar	NOUN
fnp-2818	30	38	-	-	PUNCT
fnp-2818	30	39	cov-2	cov-2	NOUN
fnp-2818	30	40	.	.	PUNCT
fnp-2818	30	41	effective	effective	ADJ
fnp-2818	30	42	antiviral	antiviral	ADJ
fnp-2818	30	43	drug	drug	NOUN
fnp-2818	30	44	delivery	delivery	NOUN
fnp-2818	30	45	through	through	ADP
fnp-2818	30	46	the	the	DET
fnp-2818	30	47	bbb	bbb	NOUN
fnp-2818	30	48	may	may	AUX
fnp-2818	30	49	therefore	therefore	ADV
fnp-2818	30	50	be	be	AUX
fnp-2818	30	51	important	important	ADJ
fnp-2818	30	52	in	in	ADP
fnp-2818	30	53	the	the	DET
fnp-2818	30	54	management	management	NOUN
fnp-2818	30	55	of	of	ADP
fnp-2818	30	56	neurological	neurological	ADJ
fnp-2818	30	57	complications	complication	NOUN
fnp-2818	30	58	.	.	PUNCT
fnp-2818	31	1	irrespective	irrespective	ADV
fnp-2818	31	2	of	of	ADP
fnp-2818	31	3	whether	whether	SCONJ
fnp-2818	31	4	cns	cns	PROPN
fnp-2818	31	5	sars	sar	NOUN
fnp-2818	31	6	-	-	PUNCT
fnp-2818	31	7	cov-2	cov-2	PART
fnp-2818	31	8	infection	infection	NOUN
fnp-2818	31	9	occurs	occur	VERB
fnp-2818	31	10	,	,	PUNCT
fnp-2818	31	11	the	the	DET
fnp-2818	31	12	cerebral	cerebral	ADJ
fnp-2818	31	13	effects	effect	NOUN
fnp-2818	31	14	of	of	ADP
fnp-2818	31	15	systemic	systemic	ADJ
fnp-2818	31	16	inflammation	inflammation	NOUN
fnp-2818	31	17	associated	associate	VERB
fnp-2818	31	18	with	with	ADP
fnp-2818	31	19	“	"	PUNCT
fnp-2818	31	20	cytokine	cytokine	ADJ
fnp-2818	31	21	storm	storm	NOUN
fnp-2818	31	22	”	"	PUNCT
fnp-2818	31	23	and	and	CCONJ
fnp-2818	31	24	prothrombotic	prothrombotic	ADJ
fnp-2818	31	25	state	state	NOUN
fnp-2818	31	26	have	have	VERB
fnp-2818	31	27	profound	profound	ADJ
fnp-2818	31	28	impact	impact	NOUN
fnp-2818	31	29	on	on	ADP
fnp-2818	31	30	outcome	outcome	NOUN
fnp-2818	31	31	in	in	ADP
fnp-2818	31	32	severe	severe	ADJ
fnp-2818	31	33	covid-19	covid-19	PROPN
fnp-2818	31	34	cases	case	NOUN
fnp-2818	31	35	.	.	PUNCT
fnp-2818	32	1	high	high	ADJ
fnp-2818	32	2	serum	serum	NOUN
fnp-2818	32	3	levels	level	NOUN
fnp-2818	32	4	of	of	ADP
fnp-2818	32	5	inflammatory	inflammatory	ADJ
fnp-2818	32	6	cytokines	cytokine	NOUN
fnp-2818	32	7	,	,	PUNCT
fnp-2818	32	8	such	such	ADJ
fnp-2818	32	9	as	as	ADP
fnp-2818	32	10	il-6	il-6	NUM
fnp-2818	32	11	,	,	PUNCT
fnp-2818	32	12	predict	predict	VERB
fnp-2818	32	13	poor	poor	ADJ
fnp-2818	32	14	outcome26	outcome26	NOUN
fnp-2818	32	15	and	and	CCONJ
fnp-2818	32	16	may	may	AUX
fnp-2818	32	17	contribute	contribute	VERB
fnp-2818	32	18	to	to	ADP
fnp-2818	32	19	cardiacand	cardiacand	ADJ
fnp-2818	32	20	respiratory	respiratory	ADJ
fnp-2818	32	21	arrest	arrest	NOUN
fnp-2818	32	22	,	,	PUNCT
fnp-2818	32	23	coma	coma	NOUN
fnp-2818	32	24	and	and	CCONJ
fnp-2818	32	25	multiorgan	multiorgan	NOUN
fnp-2818	32	26	failure	failure	NOUN
fnp-2818	32	27	through	through	ADP
fnp-2818	32	28	complex	complex	ADJ
fnp-2818	32	29	mechanisms	mechanism	NOUN
fnp-2818	32	30	that	that	PRON
fnp-2818	32	31	include	include	VERB
fnp-2818	32	32	microcirculatory	microcirculatory	ADJ
fnp-2818	32	33	deficits	deficit	NOUN
fnp-2818	32	34	,	,	PUNCT
fnp-2818	32	35	hypotension	hypotension	NOUN
fnp-2818	32	36	,	,	PUNCT
fnp-2818	32	37	oedema	oedema	NOUN
fnp-2818	32	38	and	and	CCONJ
fnp-2818	32	39	thrombosis	thrombosis	NOUN
fnp-2818	32	40	.	.	PUNCT
fnp-2818	33	1	circulating	circulate	VERB
fnp-2818	33	2	inflammatory	inflammatory	ADJ
fnp-2818	33	3	cytokines	cytokine	NOUN
fnp-2818	33	4	stimulate	stimulate	VERB
fnp-2818	33	5	the	the	DET
fnp-2818	33	6	autonomic	autonomic	ADJ
fnp-2818	33	7	nervous	nervous	ADJ
fnp-2818	33	8	system	system	NOUN
fnp-2818	33	9	and	and	CCONJ
fnp-2818	33	10	the	the	DET
fnp-2818	33	11	hypothalamic	hypothalamic	ADJ
fnp-2818	33	12	-	-	PUNCT
fnp-2818	33	13	pituitary	pituitary	ADJ
fnp-2818	33	14	-	-	PUNCT
fnp-2818	33	15	adrenal	adrenal	ADJ
fnp-2818	33	16	(	(	PUNCT
fnp-2818	33	17	hpa	hpa	NOUN
fnp-2818	33	18	)	)	PUNCT
fnp-2818	33	19	axis	axis	NOUN
fnp-2818	33	20	with	with	ADP
fnp-2818	33	21	major	major	ADJ
fnp-2818	33	22	impact	impact	NOUN
fnp-2818	33	23	on	on	ADP
fnp-2818	33	24	blood	blood	NOUN
fnp-2818	33	25	pressure	pressure	NOUN
fnp-2818	33	26	and	and	CCONJ
fnp-2818	33	27	flow	flow	NOUN
fnp-2818	33	28	,	,	PUNCT
fnp-2818	33	29	respiration	respiration	NOUN
fnp-2818	33	30	and	and	CCONJ
fnp-2818	33	31	neuroendocrine	neuroendocrine	NOUN
fnp-2818	33	32	function	function	NOUN
fnp-2818	33	33	.	.	PUNCT
fnp-2818	34	1	the	the	DET
fnp-2818	34	2	autonomic	autonomic	ADJ
fnp-2818	34	3	nervous	nervous	ADJ
fnp-2818	34	4	system	system	NOUN
fnp-2818	34	5	and	and	CCONJ
fnp-2818	34	6	hpa	hpa	NOUN
fnp-2818	34	7	axis	axis	NOUN
fnp-2818	34	8	also	also	ADV
fnp-2818	34	9	play	play	VERB
fnp-2818	34	10	an	an	DET
fnp-2818	34	11	important	important	ADJ
fnp-2818	34	12	role	role	NOUN
fnp-2818	34	13	in	in	ADP
fnp-2818	34	14	the	the	DET
fnp-2818	34	15	regulation	regulation	NOUN
fnp-2818	34	16	of	of	ADP
fnp-2818	34	17	immune	immune	ADJ
fnp-2818	34	18	cell	cell	NOUN
fnp-2818	34	19	responses	response	NOUN
fnp-2818	34	20	,	,	PUNCT
fnp-2818	34	21	cytokine	cytokine	ADJ
fnp-2818	34	22	production	production	NOUN
fnp-2818	34	23	,	,	PUNCT
fnp-2818	34	24	cell	cell	NOUN
fnp-2818	34	25	trafficking	trafficking	NOUN
fnp-2818	34	26	and	and	CCONJ
fnp-2818	34	27	cell	cell	NOUN
fnp-2818	34	28	death	death	NOUN
fnp-2818	34	29	via	via	ADP
fnp-2818	34	30	both	both	CCONJ
fnp-2818	34	31	humoral	humoral	ADJ
fnp-2818	34	32	and	and	CCONJ
fnp-2818	34	33	neural	neural	ADJ
fnp-2818	34	34	mechanisms	mechanism	NOUN
fnp-2818	34	35	.	.	PUNCT
fnp-2818	35	1	the	the	DET
fnp-2818	35	2	sustained	sustained	ADJ
fnp-2818	35	3	increase	increase	NOUN
fnp-2818	35	4	in	in	ADP
fnp-2818	35	5	serum	serum	NOUN
fnp-2818	35	6	adrenaline	adrenaline	PROPN
fnp-2818	35	7	,	,	PUNCT
fnp-2818	35	8	noradrenaline	noradrenaline	ADJ
fnp-2818	35	9	and	and	CCONJ
fnp-2818	35	10	cortisol	cortisol	ADJ
fnp-2818	35	11	levels	level	NOUN
fnp-2818	35	12	due	due	ADJ
fnp-2818	35	13	to	to	ADP
fnp-2818	35	14	prolonged	prolong	VERB
fnp-2818	35	15	autonomic	autonomic	ADJ
fnp-2818	35	16	and	and	CCONJ
fnp-2818	35	17	hpa	hpa	NOUN
fnp-2818	35	18	axis	axis	ADJ
fnp-2818	35	19	activation	activation	NOUN
fnp-2818	35	20	eventually	eventually	ADV
fnp-2818	35	21	lead	lead	VERB
fnp-2818	35	22	to	to	ADP
fnp-2818	35	23	dysregulation	dysregulation	NOUN
fnp-2818	35	24	of	of	ADP
fnp-2818	35	25	inflammatory	inflammatory	ADJ
fnp-2818	35	26	responses	response	NOUN
fnp-2818	35	27	.	.	PUNCT
fnp-2818	36	1	this	this	PRON
fnp-2818	36	2	,	,	PUNCT
fnp-2818	36	3	in	in	ADP
fnp-2818	36	4	line	line	NOUN
fnp-2818	36	5	with	with	ADP
fnp-2818	36	6	excessive	excessive	ADJ
fnp-2818	36	7	cytokine	cytokine	NOUN
fnp-2818	36	8	production	production	NOUN
fnp-2818	36	9	,	,	PUNCT
fnp-2818	36	10	results	result	NOUN
fnp-2818	36	11	in	in	ADP
fnp-2818	36	12	insufficient	insufficient	ADJ
fnp-2818	36	13	elimination	elimination	NOUN
fnp-2818	36	14	of	of	ADP
fnp-2818	36	15	infectious	infectious	ADJ
fnp-2818	36	16	agents	agent	NOUN
fnp-2818	36	17	.	.	PUNCT
fnp-2818	37	1	the	the	DET
fnp-2818	37	2	lymphopenia	lymphopenia	NOUN
fnp-2818	37	3	due	due	ADP
fnp-2818	37	4	to	to	ADP
fnp-2818	37	5	apoptosis	apoptosis	NOUN
fnp-2818	37	6	and	and	CCONJ
fnp-2818	37	7	impaired	impaired	ADJ
fnp-2818	37	8	lymphopoiesis	lymphopoiesis	NOUN
fnp-2818	37	9	shifts	shift	NOUN
fnp-2818	37	10	immune	immune	ADJ
fnp-2818	37	11	cell	cell	NOUN
fnp-2818	37	12	balance	balance	NOUN
fnp-2818	37	13	towards	towards	ADP
fnp-2818	37	14	excessive	excessive	ADJ
fnp-2818	37	15	monocyte	monocyte	NOUN
fnp-2818	37	16	and	and	CCONJ
fnp-2818	37	17	granulocyte	granulocyte	ADJ
fnp-2818	37	18	load	load	NOUN
fnp-2818	37	19	,	,	PUNCT
fnp-2818	37	20	further	far	ADV
fnp-2818	37	21	increasing	increase	VERB
fnp-2818	37	22	the	the	DET
fnp-2818	37	23	production	production	NOUN
fnp-2818	37	24	myeloid	myeloid	ADJ
fnp-2818	37	25	cell	cell	NOUN
fnp-2818	37	26	-	-	PUNCT
fnp-2818	37	27	derived	derive	VERB
fnp-2818	37	28	proinflammatory	proinflammatory	ADJ
fnp-2818	37	29	cytokines	cytokine	NOUN
fnp-2818	37	30	.	.	PUNCT
fnp-2818	38	1	the	the	DET
fnp-2818	38	2	excessive	excessive	ADJ
fnp-2818	38	3	systemic	systemic	ADJ
fnp-2818	38	4	inflammatory	inflammatory	ADJ
fnp-2818	38	5	response	response	NOUN
fnp-2818	38	6	also	also	ADV
fnp-2818	38	7	contributes	contribute	VERB
fnp-2818	38	8	to	to	ADP
fnp-2818	38	9	the	the	DET
fnp-2818	38	10	neurological	neurological	ADJ
fnp-2818	38	11	complications	complication	NOUN
fnp-2818	38	12	via	via	ADP
fnp-2818	38	13	direct	direct	ADJ
fnp-2818	38	14	and	and	CCONJ
fnp-2818	38	15	indirect	indirect	ADJ
fnp-2818	38	16	actions	action	NOUN
fnp-2818	38	17	.	.	PUNCT
fnp-2818	39	1	findings	finding	NOUN
fnp-2818	39	2	from	from	ADP
fnp-2818	39	3	clinical	clinical	ADJ
fnp-2818	39	4	and	and	CCONJ
fnp-2818	39	5	experimental	experimental	ADJ
fnp-2818	39	6	stroke	stroke	NOUN
fnp-2818	39	7	studies	study	NOUN
fnp-2818	39	8	with	with	ADP
fnp-2818	39	9	preceding	precede	VERB
fnp-2818	39	10	or	or	CCONJ
fnp-2818	39	11	post	post	ADJ
fnp-2818	39	12	-	-	ADJ
fnp-2818	39	13	stroke	stroke	ADJ
fnp-2818	39	14	infection	infection	NOUN
fnp-2818	39	15	may	may	AUX
fnp-2818	39	16	help	help	VERB
fnp-2818	39	17	to	to	PART
fnp-2818	39	18	shed	shed	VERB
fnp-2818	39	19	light	light	NOUN
fnp-2818	39	20	on	on	ADP
fnp-2818	39	21	the	the	DET
fnp-2818	39	22	mechanisms	mechanism	NOUN
fnp-2818	39	23	of	of	ADP
fnp-2818	39	24	covid-19	covid-19	PROPN
fnp-2818	39	25	-	-	PUNCT
fnp-2818	39	26	related	relate	VERB
fnp-2818	39	27	neurological	neurological	ADJ
fnp-2818	39	28	impairment	impairment	NOUN
fnp-2818	39	29	.	.	PUNCT
fnp-2818	40	1	stroke	stroke	NOUN
fnp-2818	40	2	in	in	ADP
fnp-2818	40	3	apparently	apparently	ADV
fnp-2818	40	4	healthy	healthy	ADJ
fnp-2818	40	5	youngand	youngand	NOUN
fnp-2818	40	6	middle	middle	NOUN
fnp-2818	40	7	-	-	PUNCT
fnp-2818	40	8	aged	aged	ADJ
fnp-2818	40	9	people	people	NOUN
fnp-2818	40	10	with	with	ADP
fnp-2818	40	11	rapid	rapid	ADJ
fnp-2818	40	12	formation	formation	NOUN
fnp-2818	40	13	of	of	ADP
fnp-2818	40	14	thrombi	thrombi	NOUN
fnp-2818	40	15	in	in	ADP
fnp-2818	40	16	the	the	DET
fnp-2818	40	17	cerebral	cerebral	ADJ
fnp-2818	40	18	circulation	circulation	NOUN
fnp-2818	40	19	and	and	CCONJ
fnp-2818	40	20	high	high	ADJ
fnp-2818	40	21	mortality	mortality	NOUN
fnp-2818	40	22	of	of	ADP
fnp-2818	40	23	older	old	ADJ
fnp-2818	40	24	patients	patient	NOUN
fnp-2818	40	25	with	with	ADP
fnp-2818	40	26	chronic	chronic	ADJ
fnp-2818	40	27	inflammatory	inflammatory	ADJ
fnp-2818	40	28	disease	disease	NOUN
fnp-2818	40	29	collectively	collectively	ADV
fnp-2818	40	30	suggest	suggest	VERB
fnp-2818	40	31	a	a	DET
fnp-2818	40	32	high	high	ADJ
fnp-2818	40	33	impact	impact	NOUN
fnp-2818	40	34	of	of	ADP
fnp-2818	40	35	altered	altered	ADJ
fnp-2818	40	36	coagulation	coagulation	NOUN
fnp-2818	40	37	in	in	ADP
fnp-2818	40	38	patients	patient	NOUN
fnp-2818	40	39	with	with	ADP
fnp-2818	40	40	covid-1927,28	covid-1927,28	PROPN
fnp-2818	40	41	.	.	PROPN
fnp-2818	40	42	infections	infection	NOUN
fnp-2818	40	43	in	in	ADP
fnp-2818	40	44	general	general	ADJ
fnp-2818	40	45	(	(	PUNCT
fnp-2818	40	46	e.g.	e.g.	ADV
fnp-2818	40	47	seasonal	seasonal	ADJ
fnp-2818	40	48	flu	flu	NOUN
fnp-2818	40	49	)	)	PUNCT
fnp-2818	40	50	increase	increase	VERB
fnp-2818	40	51	stroke	stroke	NOUN
fnp-2818	40	52	incidence29	incidence29	NOUN
fnp-2818	40	53	.	.	PUNCT
fnp-2818	41	1	as	as	SCONJ
fnp-2818	41	2	known	know	VERB
fnp-2818	41	3	from	from	ADP
fnp-2818	41	4	studies	study	NOUN
fnp-2818	41	5	of	of	ADP
fnp-2818	41	6	viral	viral	ADJ
fnp-2818	41	7	and	and	CCONJ
fnp-2818	41	8	bacterial	bacterial	ADJ
fnp-2818	41	9	sepsis	sepsis	NOUN
fnp-2818	41	10	and	and	CCONJ
fnp-2818	41	11	from	from	ADP
fnp-2818	41	12	comorbid	comorbid	NOUN
fnp-2818	41	13	models	model	NOUN
fnp-2818	41	14	of	of	ADP
fnp-2818	41	15	stroke	stroke	NOUN
fnp-2818	41	16	,	,	PUNCT
fnp-2818	41	17	increased	increase	VERB
fnp-2818	41	18	systemic	systemic	ADJ
fnp-2818	41	19	inflammatory	inflammatory	ADJ
fnp-2818	41	20	burden	burden	NOUN
fnp-2818	41	21	promotes	promote	VERB
fnp-2818	41	22	vascular	vascular	ADJ
fnp-2818	41	23	inflammation	inflammation	NOUN
fnp-2818	41	24	,	,	PUNCT
fnp-2818	41	25	platelet	platelet	NOUN
fnp-2818	41	26	activation	activation	NOUN
fnp-2818	41	27	and	and	CCONJ
fnp-2818	41	28	alters	alter	VERB
fnp-2818	41	29	coagulation	coagulation	NOUN
fnp-2818	41	30	cascades	cascade	NOUN
fnp-2818	41	31	,	,	PUNCT
fnp-2818	41	32	leading	lead	VERB
fnp-2818	41	33	to	to	ADP
fnp-2818	41	34	a	a	DET
fnp-2818	41	35	procoagulant	procoagulant	NOUN
fnp-2818	41	36	state	state	NOUN
fnp-2818	41	37	leading	lead	VERB
fnp-2818	41	38	to	to	ADP
fnp-2818	41	39	thrombosis	thrombosis	NOUN
fnp-2818	41	40	and	and	CCONJ
fnp-2818	41	41	disseminated	disseminate	VERB
fnp-2818	41	42	intravascular	intravascular	ADJ
fnp-2818	41	43	coagulation	coagulation	NOUN
fnp-2818	41	44	.	.	PUNCT
fnp-2818	42	1	such	such	ADJ
fnp-2818	42	2	coagulopathy	coagulopathy	ADJ
fnp-2818	42	3	,	,	PUNCT
fnp-2818	42	4	predictive	predictive	ADJ
fnp-2818	42	5	of	of	ADP
fnp-2818	42	6	worse	bad	ADJ
fnp-2818	42	7	clinical	clinical	ADJ
fnp-2818	42	8	outcome	outcome	NOUN
fnp-2818	42	9	,	,	PUNCT
fnp-2818	42	10	has	have	AUX
fnp-2818	42	11	been	be	AUX
fnp-2818	42	12	reported	report	VERB
fnp-2818	42	13	in	in	ADP
fnp-2818	42	14	covid-1930,31	covid-1930,31	PROPN
fnp-2818	42	15	.	.	PUNCT
fnp-2818	43	1	this	this	PRON
fnp-2818	43	2	promotes	promote	VERB
fnp-2818	43	3	thrombus	thrombus	ADJ
fnp-2818	43	4	formation	formation	NOUN
fnp-2818	43	5	in	in	ADP
fnp-2818	43	6	both	both	DET
fnp-2818	43	7	veins	vein	NOUN
fnp-2818	43	8	and	and	CCONJ
fnp-2818	43	9	arteries	artery	NOUN
fnp-2818	43	10	–	–	PUNCT
fnp-2818	43	11	a	a	DET
fnp-2818	43	12	known	know	VERB
fnp-2818	43	13	feature	feature	NOUN
fnp-2818	43	14	of	of	ADP
fnp-2818	43	15	severe	severe	ADJ
fnp-2818	43	16	covid-19	covid-19	PROPN
fnp-2818	43	17	with	with	ADP
fnp-2818	43	18	thromboembolic	thromboembolic	ADJ
fnp-2818	43	19	complications	complication	NOUN
fnp-2818	43	20	reported	report	VERB
fnp-2818	43	21	in	in	ADP
fnp-2818	43	22	around	around	ADP
fnp-2818	43	23	one	one	NUM
fnp-2818	43	24	third	third	NOUN
fnp-2818	43	25	of	of	ADP
fnp-2818	43	26	infected	infected	ADJ
fnp-2818	43	27	patients32	patients32	NOUN
fnp-2818	43	28	.	.	PUNCT
fnp-2818	44	1	the	the	DET
fnp-2818	44	2	cerebrovascular	cerebrovascular	ADJ
fnp-2818	44	3	endothelial	endothelial	NOUN
fnp-2818	44	4	cells	cell	NOUN
fnp-2818	44	5	have	have	VERB
fnp-2818	44	6	particularly	particularly	ADV
fnp-2818	44	7	high	high	ADJ
fnp-2818	44	8	sensitivity	sensitivity	NOUN
fnp-2818	44	9	to	to	ADP
fnp-2818	44	10	proinflammatory	proinflammatory	ADJ
fnp-2818	44	11	cytokines	cytokine	NOUN
fnp-2818	44	12	and	and	CCONJ
fnp-2818	44	13	sars	sar	NOUN
fnp-2818	44	14	-	-	PUNCT
fnp-2818	44	15	cov-2	cov-2	PART
fnp-2818	44	16	infection	infection	NOUN
fnp-2818	44	17	could	could	AUX
fnp-2818	44	18	further	far	ADV
fnp-2818	44	19	boost	boost	VERB
fnp-2818	44	20	the	the	DET
fnp-2818	44	21	expression	expression	NOUN
fnp-2818	44	22	of	of	ADP
fnp-2818	44	23	adhesion	adhesion	NOUN
fnp-2818	44	24	molecules	molecule	NOUN
fnp-2818	44	25	and	and	CCONJ
fnp-2818	44	26	increase	increase	VERB
fnp-2818	44	27	vascular	vascular	ADJ
fnp-2818	44	28	permeability	permeability	NOUN
fnp-2818	44	29	.	.	PUNCT
fnp-2818	45	1	brain	brain	NOUN
fnp-2818	45	2	injury	injury	NOUN
fnp-2818	45	3	and	and	CCONJ
fnp-2818	45	4	mortality	mortality	NOUN
fnp-2818	45	5	are	be	AUX
fnp-2818	45	6	generally	generally	ADV
fnp-2818	45	7	far	far	ADV
fnp-2818	45	8	more	more	ADV
fnp-2818	45	9	severe	severe	ADJ
fnp-2818	45	10	in	in	ADP
fnp-2818	45	11	patients	patient	NOUN
fnp-2818	45	12	with	with	ADP
fnp-2818	45	13	additional	additional	ADJ
fnp-2818	45	14	stroke	stroke	NOUN
fnp-2818	45	15	risk	risk	NOUN
fnp-2818	45	16	factors	factor	NOUN
fnp-2818	45	17	(	(	PUNCT
fnp-2818	45	18	e.g.	e.g.	ADV
fnp-2818	45	19	in	in	ADP
fnp-2818	45	20	obese	obese	ADJ
fnp-2818	45	21	,	,	PUNCT
fnp-2818	45	22	diabetic	diabetic	ADJ
fnp-2818	45	23	,	,	PUNCT
fnp-2818	45	24	hypertensive	hypertensive	ADJ
fnp-2818	45	25	patients	patient	NOUN
fnp-2818	45	26	or	or	CCONJ
fnp-2818	45	27	after	after	ADP
fnp-2818	45	28	infection	infection	NOUN
fnp-2818	45	29	)	)	PUNCT
fnp-2818	45	30	,	,	PUNCT
fnp-2818	45	31	similarly	similarly	ADV
fnp-2818	45	32	to	to	ADP
fnp-2818	45	33	that	that	PRON
fnp-2818	45	34	seen	see	VERB
fnp-2818	45	35	in	in	ADP
fnp-2818	45	36	experimental	experimental	ADJ
fnp-2818	45	37	stroke	stroke	NOUN
fnp-2818	45	38	models	model	NOUN
fnp-2818	45	39	.	.	PUNCT
fnp-2818	46	1	as	as	ADP
fnp-2818	46	2	an	an	DET
fnp-2818	46	3	example	example	NOUN
fnp-2818	46	4	,	,	PUNCT
fnp-2818	46	5	localized	localized	ADJ
fnp-2818	46	6	infection	infection	NOUN
fnp-2818	46	7	of	of	ADP
fnp-2818	46	8	the	the	DET
fnp-2818	46	9	lungs	lung	NOUN
fnp-2818	46	10	by	by	ADP
fnp-2818	46	11	influenza	influenza	NOUN
fnp-2818	46	12	virus	virus	NOUN
fnp-2818	46	13	or	or	CCONJ
fnp-2818	46	14	streptococcus	streptococcus	VERB
fnp-2818	46	15	pneumoniae	pneumoniae	ADJ
fnp-2818	46	16	leads	lead	VERB
fnp-2818	46	17	to	to	ADP
fnp-2818	46	18	marked	mark	VERB
fnp-2818	46	19	increases	increase	NOUN
fnp-2818	46	20	in	in	ADP
fnp-2818	46	21	circulating	circulate	VERB
fnp-2818	46	22	proinflammatory	proinflammatory	ADJ
fnp-2818	46	23	cytokines	cytokine	NOUN
fnp-2818	46	24	,	,	PUNCT
fnp-2818	46	25	endothelial	endothelial	ADJ
fnp-2818	46	26	activation	activation	NOUN
fnp-2818	46	27	(	(	PUNCT
fnp-2818	46	28	indicated	indicate	VERB
fnp-2818	46	29	by	by	ADP
fnp-2818	46	30	increased	increase	VERB
fnp-2818	46	31	levels	level	NOUN
fnp-2818	46	32	of	of	ADP
fnp-2818	46	33	adhesion	adhesion	NOUN
fnp-2818	46	34	molecules	molecule	NOUN
fnp-2818	46	35	)	)	PUNCT
fnp-2818	46	36	and	and	CCONJ
fnp-2818	46	37	platelet	platelet	NOUN
fnp-2818	46	38	aggregation	aggregation	NOUN
fnp-2818	46	39	.	.	PUNCT
fnp-2818	47	1	these	these	DET
fnp-2818	47	2	infection	infection	NOUN
fnp-2818	47	3	-	-	PUNCT
fnp-2818	47	4	driven	drive	VERB
fnp-2818	47	5	changes	change	NOUN
fnp-2818	47	6	are	be	AUX
fnp-2818	47	7	associated	associate	VERB
fnp-2818	47	8	with	with	ADP
fnp-2818	47	9	augmented	augment	VERB
fnp-2818	47	10	brain	brain	NOUN
fnp-2818	47	11	inflammation	inflammation	NOUN
fnp-2818	47	12	and	and	CCONJ
fnp-2818	47	13	leukocyte	leukocyte	NOUN
fnp-2818	47	14	recruitment	recruitment	NOUN
fnp-2818	47	15	,	,	PUNCT
fnp-2818	47	16	leading	lead	VERB
fnp-2818	47	17	to	to	ADP
fnp-2818	47	18	increased	increase	VERB
fnp-2818	47	19	neuronal	neuronal	ADJ
fnp-2818	47	20	injury	injury	NOUN
fnp-2818	47	21	and	and	CCONJ
fnp-2818	47	22	worse	bad	ADJ
fnp-2818	47	23	neurological	neurological	ADJ
fnp-2818	47	24	outcome33	outcome33	NOUN
fnp-2818	47	25	-	-	PUNCT
fnp-2818	47	26	35	35	NUM
fnp-2818	47	27	.	.	PUNCT
fnp-2818	48	1	targeted	target	VERB
fnp-2818	48	2	blockade	blockade	NOUN
fnp-2818	48	3	of	of	ADP
fnp-2818	48	4	proinflammatory	proinflammatory	ADJ
fnp-2818	48	5	cytokines	cytokine	NOUN
fnp-2818	48	6	(	(	PUNCT
fnp-2818	48	7	e.g.	e.g.	ADV
fnp-2818	48	8	il-6	il-6	NUM
fnp-2818	48	9	,	,	PUNCT
fnp-2818	48	10	il-1	il-1	PUNCT
fnp-2818	48	11	or	or	CCONJ
fnp-2818	48	12	tnf	tnf	PROPN
fnp-2818	48	13	)	)	PUNCT
fnp-2818	48	14	or	or	CCONJ
fnp-2818	48	15	platelet	platelet	ADJ
fnp-2818	48	16	-	-	PUNCT
fnp-2818	48	17	endothelial	endothelial	ADJ
fnp-2818	48	18	interactions	interaction	NOUN
fnp-2818	48	19	attenuated	attenuate	VERB
fnp-2818	48	20	infection	infection	NOUN
fnp-2818	48	21	-	-	PUNCT
fnp-2818	48	22	induced	induce	VERB
fnp-2818	48	23	brain	brain	NOUN
fnp-2818	48	24	injury	injury	NOUN
fnp-2818	48	25	in	in	ADP
fnp-2818	48	26	experimental	experimental	ADJ
fnp-2818	48	27	models33,34,36	models33,34,36	PROPN
fnp-2818	48	28	-	-	PUNCT
fnp-2818	48	29	38	38	NUM
fnp-2818	48	30	,	,	PUNCT
fnp-2818	48	31	while	while	SCONJ
fnp-2818	48	32	the	the	DET
fnp-2818	48	33	potential	potential	ADJ
fnp-2818	48	34	efficacy	efficacy	NOUN
fnp-2818	48	35	of	of	ADP
fnp-2818	48	36	il-6	il-6	NOUN
fnp-2818	48	37	receptor	receptor	NOUN
fnp-2818	48	38	antagonist	antagonist	NOUN
fnp-2818	48	39	tocilizumab	tocilizumab	NOUN
fnp-2818	48	40	to	to	PART
fnp-2818	48	41	reduce	reduce	VERB
fnp-2818	48	42	mortality	mortality	NOUN
fnp-2818	48	43	in	in	ADP
fnp-2818	48	44	severe	severe	ADJ
fnp-2818	48	45	covid-19	covid-19	PROPN
fnp-2818	48	46	cases	case	NOUN
fnp-2818	48	47	has	have	AUX
fnp-2818	48	48	been	be	AUX
fnp-2818	48	49	suggested39	suggested39	NOUN
fnp-2818	48	50	.	.	PUNCT
fnp-2818	49	1	recent	recent	ADJ
fnp-2818	49	2	reports	report	NOUN
fnp-2818	49	3	have	have	AUX
fnp-2818	49	4	described	describe	VERB
fnp-2818	49	5	patients	patient	NOUN
fnp-2818	49	6	with	with	ADP
fnp-2818	49	7	ischaemic	ischaemic	ADJ
fnp-2818	49	8	stroke	stroke	NOUN
fnp-2818	49	9	complicating	complicate	VERB
fnp-2818	49	10	covid-19	covid-19	PROPN
fnp-2818	49	11	infection	infection	NOUN
fnp-2818	49	12	,	,	PUNCT
fnp-2818	49	13	often	often	ADV
fnp-2818	49	14	manifesting	manifest	VERB
fnp-2818	49	15	as	as	ADP
fnp-2818	49	16	large	large	ADJ
fnp-2818	49	17	-	-	PUNCT
fnp-2818	49	18	vessel	vessel	NOUN
fnp-2818	49	19	infarcts	infarct	NOUN
fnp-2818	49	20	occurring	occur	VERB
fnp-2818	49	21	in	in	ADP
fnp-2818	49	22	multiple	multiple	ADJ
fnp-2818	49	23	territories	territory	NOUN
fnp-2818	49	24	and	and	CCONJ
fnp-2818	49	25	associated	associate	VERB
fnp-2818	49	26	with	with	ADP
fnp-2818	49	27	features	feature	NOUN
fnp-2818	49	28	of	of	ADP
fnp-2818	49	29	prothrombotic	prothrombotic	ADJ
fnp-2818	49	30	coagulopathy3,40,41	coagulopathy3,40,41	NOUN
fnp-2818	49	31	.	.	PUNCT
fnp-2818	50	1	however	however	ADV
fnp-2818	50	2	,	,	PUNCT
fnp-2818	50	3	these	these	DET
fnp-2818	50	4	small	small	ADJ
fnp-2818	50	5	case	case	NOUN
fnp-2818	50	6	series	series	NOUN
fnp-2818	50	7	may	may	AUX
fnp-2818	50	8	not	not	PART
fnp-2818	50	9	be	be	AUX
fnp-2818	50	10	representative	representative	ADJ
fnp-2818	50	11	of	of	ADP
fnp-2818	50	12	wider	wide	ADJ
fnp-2818	50	13	clinical	clinical	ADJ
fnp-2818	50	14	practice	practice	NOUN
fnp-2818	50	15	,	,	PUNCT
fnp-2818	50	16	and	and	CCONJ
fnp-2818	50	17	no	no	DET
fnp-2818	50	18	causal	causal	ADJ
fnp-2818	50	19	relationship	relationship	NOUN
fnp-2818	50	20	has	have	AUX
fnp-2818	50	21	yet	yet	ADV
fnp-2818	50	22	been	be	AUX
fnp-2818	50	23	established	establish	VERB
fnp-2818	50	24	between	between	ADP
fnp-2818	50	25	covid-19	covid-19	PROPN
fnp-2818	50	26	infection	infection	NOUN
fnp-2818	50	27	and	and	CCONJ
fnp-2818	50	28	stroke	stroke	NOUN
fnp-2818	50	29	.	.	PUNCT
fnp-2818	51	1	other	other	ADJ
fnp-2818	51	2	mechanisms	mechanism	NOUN
fnp-2818	51	3	may	may	AUX
fnp-2818	51	4	also	also	ADV
fnp-2818	51	5	be	be	AUX
fnp-2818	51	6	relevant	relevant	ADJ
fnp-2818	51	7	,	,	PUNCT
fnp-2818	51	8	such	such	ADJ
fnp-2818	51	9	as	as	ADP
fnp-2818	51	10	destabilisation	destabilisation	NOUN
fnp-2818	51	11	of	of	ADP
fnp-2818	51	12	atheromatous	atheromatous	ADJ
fnp-2818	51	13	plaques	plaque	NOUN
fnp-2818	51	14	resulting	result	VERB
fnp-2818	51	15	in	in	ADP
fnp-2818	51	16	thrombosis	thrombosis	NOUN
fnp-2818	51	17	and	and	CCONJ
fnp-2818	51	18	cerebral	cerebral	ADJ
fnp-2818	51	19	atheroembolism	atheroembolism	NOUN
fnp-2818	51	20	,	,	PUNCT
fnp-2818	51	21	atrial	atrial	ADJ
fnp-2818	51	22	fibrillation	fibrillation	NOUN
fnp-2818	51	23	in	in	ADP
fnp-2818	51	24	critically	critically	ADV
fnp-2818	51	25	ill	ill	ADJ
fnp-2818	51	26	patients	patient	NOUN
fnp-2818	51	27	causing	cause	VERB
fnp-2818	51	28	thromboembolism	thromboembolism	NOUN
fnp-2818	51	29	of	of	ADP
fnp-2818	51	30	cardiac	cardiac	ADJ
fnp-2818	51	31	origin	origin	NOUN
fnp-2818	51	32	,	,	PUNCT
fnp-2818	51	33	or	or	CCONJ
fnp-2818	51	34	haemorrhage	haemorrhage	NOUN
fnp-2818	51	35	secondary	secondary	ADJ
fnp-2818	51	36	to	to	ADP
fnp-2818	51	37	microangiopathy	microangiopathy	ADJ
fnp-2818	51	38	and	and	CCONJ
fnp-2818	51	39	cerebral	cerebral	ADJ
fnp-2818	51	40	vasculitis	vasculitis	PROPN
fnp-2818	51	41	.	.	PUNCT
fnp-2818	52	1	importantly	importantly	ADV
fnp-2818	52	2	,	,	PUNCT
fnp-2818	52	3	patients	patient	NOUN
fnp-2818	52	4	may	may	AUX
fnp-2818	52	5	also	also	ADV
fnp-2818	52	6	acquire	acquire	VERB
fnp-2818	52	7	sars	sar	NOUN
fnp-2818	52	8	-	-	PUNCT
fnp-2818	52	9	cov-2	cov-2	PART
fnp-2818	52	10	infection	infection	NOUN
fnp-2818	52	11	following	follow	VERB
fnp-2818	52	12	stroke	stroke	NOUN
fnp-2818	52	13	.	.	PUNCT
fnp-2818	53	1	suppression	suppression	NOUN
fnp-2818	53	2	of	of	ADP
fnp-2818	53	3	both	both	CCONJ
fnp-2818	53	4	innate	innate	ADJ
fnp-2818	53	5	and	and	CCONJ
fnp-2818	53	6	adaptive	adaptive	ADJ
fnp-2818	53	7	immune	immune	ADJ
fnp-2818	53	8	response	response	NOUN
fnp-2818	53	9	is	be	AUX
fnp-2818	53	10	well	well	ADV
fnp-2818	53	11	-	-	PUNCT
fnp-2818	53	12	documented	document	VERB
fnp-2818	53	13	after	after	ADP
fnp-2818	53	14	stroke	stroke	NOUN
fnp-2818	53	15	,	,	PUNCT
fnp-2818	53	16	driven	drive	VERB
fnp-2818	53	17	by	by	ADP
fnp-2818	53	18	autonomic	autonomic	ADJ
fnp-2818	53	19	nervous	nervous	ADJ
fnp-2818	53	20	system	system	NOUN
fnp-2818	53	21	failure	failure	NOUN
fnp-2818	53	22	and	and	CCONJ
fnp-2818	53	23	activation	activation	NOUN
fnp-2818	53	24	of	of	ADP
fnp-2818	53	25	the	the	DET
fnp-2818	53	26	hpa	hpa	NOUN
fnp-2818	53	27	axis	axis	NOUN
fnp-2818	53	28	,	,	PUNCT
fnp-2818	53	29	which	which	PRON
fnp-2818	53	30	could	could	AUX
fnp-2818	53	31	exacerbate	exacerbate	VERB
fnp-2818	53	32	subclinical	subclinical	ADJ
fnp-2818	53	33	infection	infection	NOUN
fnp-2818	53	34	,	,	PUNCT
fnp-2818	53	35	or	or	CCONJ
fnp-2818	53	36	increase	increase	VERB
fnp-2818	53	37	susceptibility	susceptibility	NOUN
fnp-2818	53	38	to	to	ADP
fnp-2818	53	39	nosocomial	nosocomial	ADJ
fnp-2818	53	40	infection	infection	NOUN
fnp-2818	53	41	.	.	PUNCT
fnp-2818	54	1	an	an	DET
fnp-2818	54	2	important	important	ADJ
fnp-2818	54	3	issue	issue	NOUN
fnp-2818	54	4	to	to	PART
fnp-2818	54	5	address	address	VERB
fnp-2818	54	6	is	be	AUX
fnp-2818	54	7	whether	whether	SCONJ
fnp-2818	54	8	neurological	neurological	ADJ
fnp-2818	54	9	manifestations	manifestation	NOUN
fnp-2818	54	10	(	(	PUNCT
fnp-2818	54	11	reported	report	VERB
fnp-2818	54	12	in	in	ADP
fnp-2818	54	13	up	up	ADP
fnp-2818	54	14	to	to	PART
fnp-2818	54	15	one	one	NUM
fnp-2818	54	16	third	third	NOUN
fnp-2818	54	17	of	of	ADP
fnp-2818	54	18	cases	case	NOUN
fnp-2818	54	19	with	with	ADP
fnp-2818	54	20	different	different	ADJ
fnp-2818	54	21	severity	severity	NOUN
fnp-2818	54	22	of	of	ADP
fnp-2818	54	23	infection1,42	infection1,42	NOUN
fnp-2818	54	24	)	)	PUNCT
fnp-2818	54	25	result	result	VERB
fnp-2818	54	26	from	from	ADP
fnp-2818	54	27	systemic	systemic	ADJ
fnp-2818	54	28	effects	effect	NOUN
fnp-2818	54	29	on	on	ADP
fnp-2818	54	30	the	the	DET
fnp-2818	54	31	brain	brain	NOUN
fnp-2818	54	32	,	,	PUNCT
fnp-2818	54	33	direct	direct	ADJ
fnp-2818	54	34	cns	cns	NOUN
fnp-2818	54	35	infection	infection	NOUN
fnp-2818	54	36	by	by	ADP
fnp-2818	54	37	sars	sar	NOUN
fnp-2818	54	38	-	-	PUNCT
fnp-2818	54	39	cov-2	cov-2	NOUN
fnp-2818	54	40	,	,	PUNCT
fnp-2818	54	41	or	or	CCONJ
fnp-2818	54	42	both	both	PRON
fnp-2818	54	43	,	,	PUNCT
fnp-2818	54	44	and	and	CCONJ
fnp-2818	54	45	if	if	SCONJ
fnp-2818	54	46	the	the	DET
fnp-2818	54	47	latter	latter	NOUN
fnp-2818	54	48	is	be	AUX
fnp-2818	54	49	a	a	DET
fnp-2818	54	50	major	major	ADJ
fnp-2818	54	51	contributor	contributor	NOUN
fnp-2818	54	52	to	to	ADP
fnp-2818	54	53	covid-19	covid-19	PROPN
fnp-2818	54	54	-	-	PUNCT
fnp-2818	54	55	related	relate	VERB
fnp-2818	54	56	severe	severe	ADJ
fnp-2818	54	57	illness	illness	NOUN
fnp-2818	54	58	and	and	CCONJ
fnp-2818	54	59	mortality	mortality	NOUN
fnp-2818	54	60	.	.	PUNCT
fnp-2818	55	1	firm	firm	ADJ
fnp-2818	55	2	conclusions	conclusion	NOUN
fnp-2818	55	3	can	can	AUX
fnp-2818	55	4	not	not	PART
fnp-2818	55	5	be	be	AUX
fnp-2818	55	6	drawn	draw	VERB
fnp-2818	55	7	at	at	ADP
fnp-2818	55	8	this	this	DET
fnp-2818	55	9	stage	stage	NOUN
fnp-2818	55	10	due	due	ADP
fnp-2818	55	11	to	to	ADP
fnp-2818	55	12	limited	limited	ADJ
fnp-2818	55	13	data	data	NOUN
fnp-2818	55	14	availability	availability	NOUN
fnp-2818	55	15	,	,	PUNCT
fnp-2818	55	16	but	but	CCONJ
fnp-2818	55	17	it	it	PRON
fnp-2818	55	18	is	be	AUX
fnp-2818	55	19	likely	likely	ADJ
fnp-2818	55	20	that	that	SCONJ
fnp-2818	55	21	the	the	DET
fnp-2818	55	22	impact	impact	NOUN
fnp-2818	55	23	of	of	ADP
fnp-2818	55	24	cns	cns	NOUN
fnp-2818	55	25	-	-	PUNCT
fnp-2818	55	26	related	relate	VERB
fnp-2818	55	27	effects	effect	NOUN
fnp-2818	55	28	on	on	ADP
fnp-2818	55	29	disease	disease	NOUN
fnp-2818	55	30	outcome	outcome	NOUN
fnp-2818	55	31	is	be	AUX
fnp-2818	55	32	considerable	considerable	ADJ
fnp-2818	55	33	.	.	PUNCT
fnp-2818	56	1	most	most	ADJ
fnp-2818	56	2	neurological	neurological	ADJ
fnp-2818	56	3	manifestations	manifestation	NOUN
fnp-2818	56	4	appear	appear	VERB
fnp-2818	56	5	to	to	PART
fnp-2818	56	6	occur	occur	VERB
fnp-2818	56	7	early	early	ADV
fnp-2818	56	8	in	in	ADP
fnp-2818	56	9	the	the	DET
fnp-2818	56	10	illness	illness	NOUN
fnp-2818	56	11	,	,	PUNCT
fnp-2818	56	12	preceding	precede	VERB
fnp-2818	56	13	severe	severe	ADJ
fnp-2818	56	14	respiratory	respiratory	ADJ
fnp-2818	56	15	distress	distress	NOUN
fnp-2818	56	16	and	and	CCONJ
fnp-2818	56	17	the	the	DET
fnp-2818	56	18	need	need	NOUN
fnp-2818	56	19	for	for	ADP
fnp-2818	56	20	mechanical	mechanical	ADJ
fnp-2818	56	21	ventilation	ventilation	NOUN
fnp-2818	56	22	,	,	PUNCT
fnp-2818	56	23	while	while	SCONJ
fnp-2818	56	24	several	several	ADJ
fnp-2818	56	25	patients	patient	NOUN
fnp-2818	56	26	are	be	AUX
fnp-2818	56	27	admitted	admit	VERB
fnp-2818	56	28	to	to	ADP
fnp-2818	56	29	the	the	DET
fnp-2818	56	30	hospital	hospital	NOUN
fnp-2818	56	31	merely	merely	ADV
fnp-2818	56	32	based	base	VERB
fnp-2818	56	33	on	on	ADP
fnp-2818	56	34	neurologic	neurologic	ADJ
fnp-2818	56	35	manifestation	manifestation	NOUN
fnp-2818	56	36	with	with	ADP
fnp-2818	56	37	no	no	DET
fnp-2818	56	38	respiratory	respiratory	ADJ
fnp-2818	56	39	symptoms1	symptoms1	NOUN
fnp-2818	56	40	.	.	PUNCT
fnp-2818	57	1	at	at	ADP
fnp-2818	57	2	this	this	DET
fnp-2818	57	3	time	time	NOUN
fnp-2818	57	4	,	,	PUNCT
fnp-2818	57	5	data	datum	NOUN
fnp-2818	57	6	are	be	AUX
fnp-2818	57	7	largely	largely	ADV
fnp-2818	57	8	from	from	ADP
fnp-2818	57	9	single	single	ADJ
fnp-2818	57	10	case	case	NOUN
fnp-2818	57	11	reports	report	VERB
fnp-2818	57	12	.	.	PUNCT
fnp-2818	58	1	for	for	ADP
fnp-2818	58	2	example	example	NOUN
fnp-2818	58	3	,	,	PUNCT
fnp-2818	58	4	occurrence	occurrence	NOUN
fnp-2818	58	5	of	of	ADP
fnp-2818	58	6	neurological	neurological	ADJ
fnp-2818	58	7	symptoms	symptom	NOUN
fnp-2818	58	8	such	such	ADJ
fnp-2818	58	9	as	as	ADP
fnp-2818	58	10	fever	fever	NOUN
fnp-2818	58	11	,	,	PUNCT
fnp-2818	58	12	anosmia	anosmia	NOUN
fnp-2818	58	13	,	,	PUNCT
fnp-2818	58	14	dysgeusia	dysgeusia	PROPN
fnp-2818	58	15	,	,	PUNCT
fnp-2818	58	16	headache	headache	NOUN
fnp-2818	58	17	and	and	CCONJ
fnp-2818	58	18	possible	possible	ADJ
fnp-2818	58	19	seizure	seizure	NOUN
fnp-2818	58	20	in	in	ADP
fnp-2818	58	21	line	line	NOUN
fnp-2818	58	22	with	with	ADP
fnp-2818	58	23	respiratory	respiratory	ADJ
fnp-2818	58	24	distress	distress	NOUN
fnp-2818	58	25	and	and	CCONJ
fnp-2818	58	26	severe	severe	ADJ
fnp-2818	58	27	ventilator	ventilator	NOUN
fnp-2818	58	28	asynchronies	asynchrony	NOUN
fnp-2818	58	29	were	be	AUX
fnp-2818	58	30	found	find	VERB
fnp-2818	58	31	in	in	ADP
fnp-2818	58	32	a	a	DET
fnp-2818	58	33	patient	patient	NOUN
fnp-2818	58	34	where	where	SCONJ
fnp-2818	58	35	autopsy	autopsy	ADJ
fnp-2818	58	36	later	later	ADV
fnp-2818	58	37	confirmed	confirm	VERB
fnp-2818	58	38	the	the	DET
fnp-2818	58	39	presence	presence	NOUN
fnp-2818	58	40	of	of	ADP
fnp-2818	58	41	sars	sar	NOUN
fnp-2818	58	42	-	-	PUNCT
fnp-2818	58	43	cov-2	cov-2	PART
fnp-2818	58	44	infection	infection	NOUN
fnp-2818	58	45	in	in	ADP
fnp-2818	58	46	the	the	DET
fnp-2818	58	47	brain	brain	NOUN
fnp-2818	58	48	.	.	PUNCT
fnp-2818	59	1	findings	finding	NOUN
fnp-2818	59	2	included	include	VERB
fnp-2818	59	3	widespread	widespread	ADJ
fnp-2818	59	4	tissue	tissue	NOUN
fnp-2818	59	5	damage	damage	NOUN
fnp-2818	59	6	involving	involve	VERB
fnp-2818	59	7	the	the	DET
fnp-2818	59	8	neurons	neuron	NOUN
fnp-2818	59	9	,	,	PUNCT
fnp-2818	59	10	glia	glia	PROPN
fnp-2818	59	11	,	,	PUNCT
fnp-2818	59	12	nerve	nerve	NOUN
fnp-2818	59	13	axons	axon	NOUN
fnp-2818	59	14	,	,	PUNCT
fnp-2818	59	15	and	and	CCONJ
fnp-2818	59	16	myelin	myelin	ADJ
fnp-2818	59	17	sheath	sheath	NOUN
fnp-2818	59	18	,	,	PUNCT
fnp-2818	59	19	progressively	progressively	ADV
fnp-2818	59	20	more	more	ADV
fnp-2818	59	21	severe	severe	ADJ
fnp-2818	59	22	from	from	ADP
fnp-2818	59	23	the	the	DET
fnp-2818	59	24	olfactory	olfactory	NOUN
fnp-2818	59	25	nerve	nerve	NOUN
fnp-2818	59	26	to	to	ADP
fnp-2818	59	27	the	the	DET
fnp-2818	59	28	gyrus	gyrus	NOUN
fnp-2818	59	29	rectus	rectus	NOUN
fnp-2818	59	30	and	and	CCONJ
fnp-2818	59	31	to	to	ADP
fnp-2818	59	32	the	the	DET
fnp-2818	59	33	brainstem43	brainstem43	NOUN
fnp-2818	59	34	.	.	PUNCT
fnp-2818	60	1	a	a	DET
fnp-2818	60	2	recent	recent	ADJ
fnp-2818	60	3	report	report	NOUN
fnp-2818	60	4	showed	show	VERB
fnp-2818	60	5	that	that	SCONJ
fnp-2818	60	6	after	after	ADP
fnp-2818	60	7	positive	positive	ADJ
fnp-2818	60	8	diagnosis	diagnosis	NOUN
fnp-2818	60	9	for	for	ADP
fnp-2818	60	10	sars	sar	NOUN
fnp-2818	60	11	-	-	PUNCT
fnp-2818	60	12	cov-2	cov-2	NOUN
fnp-2818	60	13	,	,	PUNCT
fnp-2818	60	14	a	a	DET
fnp-2818	60	15	patient	patient	NOUN
fnp-2818	60	16	developed	develop	VERB
fnp-2818	60	17	complete	complete	ADJ
fnp-2818	60	18	anosmia	anosmia	NOUN
fnp-2818	60	19	and	and	CCONJ
fnp-2818	60	20	dysgeusia	dysgeusia	NOUN
fnp-2818	60	21	,	,	PUNCT
fnp-2818	60	22	with	with	ADP
fnp-2818	60	23	mri	mri	NOUN
fnp-2818	60	24	showing	show	VERB
fnp-2818	60	25	signs	sign	NOUN
fnp-2818	60	26	of	of	ADP
fnp-2818	60	27	bilateral	bilateral	ADJ
fnp-2818	60	28	olfactory	olfactory	ADJ
fnp-2818	60	29	bulb	bulb	NOUN
fnp-2818	60	30	oedema	oedema	NOUN
fnp-2818	60	31	,	,	PUNCT
fnp-2818	60	32	followed	follow	VERB
fnp-2818	60	33	by	by	ADP
fnp-2818	60	34	normalization	normalization	NOUN
fnp-2818	60	35	of	of	ADP
fnp-2818	60	36	both	both	CCONJ
fnp-2818	60	37	sensory	sensory	ADJ
fnp-2818	60	38	symptoms	symptom	NOUN
fnp-2818	60	39	and	and	CCONJ
fnp-2818	60	40	mri	mri	NOUN
fnp-2818	60	41	signal	signal	NOUN
fnp-2818	60	42	by	by	ADP
fnp-2818	60	43	day	day	NOUN
fnp-2818	60	44	1444	1444	NUM
fnp-2818	60	45	.	.	PUNCT
fnp-2818	61	1	another	another	DET
fnp-2818	61	2	report	report	NOUN
fnp-2818	61	3	found	find	VERB
fnp-2818	61	4	that	that	SCONJ
fnp-2818	61	5	44	44	NUM
fnp-2818	61	6	%	%	NOUN
fnp-2818	61	7	of	of	ADP
fnp-2818	61	8	patients	patient	NOUN
fnp-2818	61	9	admitted	admit	VERB
fnp-2818	61	10	to	to	ADP
fnp-2818	61	11	the	the	DET
fnp-2818	61	12	intensive	intensive	ADJ
fnp-2818	61	13	care	care	NOUN
fnp-2818	61	14	unit	unit	NOUN
fnp-2818	61	15	with	with	ADP
fnp-2818	61	16	covid-19	covid-19	PROPN
fnp-2818	61	17	and	and	CCONJ
fnp-2818	61	18	neurological	neurological	ADJ
fnp-2818	61	19	symptoms	symptom	NOUN
fnp-2818	61	20	showed	show	VERB
fnp-2818	61	21	cns	cns	NOUN
fnp-2818	61	22	abnormalities	abnormality	NOUN
fnp-2818	61	23	on	on	ADP
fnp-2818	61	24	mri	mri	NOUN
fnp-2818	61	25	,	,	PUNCT
fnp-2818	61	26	which	which	PRON
fnp-2818	61	27	included	include	VERB
fnp-2818	61	28	cortical	cortical	ADJ
fnp-2818	61	29	(	(	PUNCT
fnp-2818	61	30	frontal	frontal	ADJ
fnp-2818	61	31	,	,	PUNCT
fnp-2818	61	32	parietal	parietal	ADJ
fnp-2818	61	33	,	,	PUNCT
fnp-2818	61	34	occipital	occipital	ADJ
fnp-2818	61	35	,	,	PUNCT
fnp-2818	61	36	temporal	temporal	ADJ
fnp-2818	61	37	,	,	PUNCT
fnp-2818	61	38	insular	insular	ADJ
fnp-2818	61	39	)	)	PUNCT
fnp-2818	61	40	and	and	CCONJ
fnp-2818	61	41	deep	deep	ADJ
fnp-2818	61	42	white	white	ADJ
fnp-2818	61	43	matter	matter	NOUN
fnp-2818	61	44	flair	flair	NOUN
fnp-2818	61	45	signal	signal	NOUN
fnp-2818	61	46	abnormalities	abnormality	NOUN
fnp-2818	61	47	,	,	PUNCT
fnp-2818	61	48	in	in	ADP
fnp-2818	61	49	the	the	DET
fnp-2818	61	50	absence	absence	NOUN
fnp-2818	61	51	of	of	ADP
fnp-2818	61	52	sars	sar	NOUN
fnp-2818	61	53	-	-	PUNCT
fnp-2818	61	54	cov-2	cov-2	NOUN
fnp-2818	61	55	in	in	ADP
fnp-2818	61	56	the	the	DET
fnp-2818	61	57	csf	csf	NOUN
fnp-2818	61	58	(	(	PUNCT
fnp-2818	61	59	50	50	NUM
fnp-2818	61	60	%	%	NOUN
fnp-2818	61	61	of	of	ADP
fnp-2818	61	62	cases	case	NOUN
fnp-2818	61	63	tested	test	VERB
fnp-2818	61	64	)	)	PUNCT
fnp-2818	61	65	.	.	PUNCT
fnp-2818	62	1	thus	thus	ADV
fnp-2818	62	2	,	,	PUNCT
fnp-2818	62	3	while	while	SCONJ
fnp-2818	62	4	focal	focal	ADJ
fnp-2818	62	5	neuropathologies	neuropathologie	NOUN
fnp-2818	62	6	appear	appear	VERB
fnp-2818	62	7	to	to	PART
fnp-2818	62	8	be	be	AUX
fnp-2818	62	9	frequent	frequent	ADJ
fnp-2818	62	10	in	in	ADP
fnp-2818	62	11	severe	severe	ADJ
fnp-2818	62	12	cases	case	NOUN
fnp-2818	62	13	,	,	PUNCT
fnp-2818	62	14	the	the	DET
fnp-2818	62	15	extent	extent	NOUN
fnp-2818	62	16	of	of	ADP
fnp-2818	62	17	associated	associated	ADJ
fnp-2818	62	18	brain	brain	NOUN
fnp-2818	62	19	infection	infection	NOUN
fnp-2818	62	20	remains	remain	VERB
fnp-2818	62	21	unclear	unclear	ADJ
fnp-2818	62	22	presently	presently	ADV
fnp-2818	62	23	.	.	PUNCT
fnp-2818	63	1	of	of	ADP
fnp-2818	63	2	note	note	NOUN
fnp-2818	63	3	,	,	PUNCT
fnp-2818	63	4	the	the	DET
fnp-2818	63	5	incidence	incidence	NOUN
fnp-2818	63	6	of	of	ADP
fnp-2818	63	7	epileptiform	epileptiform	NOUN
fnp-2818	63	8	discharges	discharge	NOUN
fnp-2818	63	9	,	,	PUNCT
fnp-2818	63	10	seizure	seizure	NOUN
fnp-2818	63	11	-	-	PUNCT
fnp-2818	63	12	like	like	ADJ
fnp-2818	63	13	events	event	NOUN
fnp-2818	63	14	and	and	CCONJ
fnp-2818	63	15	new	new	ADJ
fnp-2818	63	16	onset	onset	NOUN
fnp-2818	63	17	encephalopathy	encephalopathy	NOUN
fnp-2818	63	18	is	be	AUX
fnp-2818	63	19	more	more	ADJ
fnp-2818	63	20	than	than	ADP
fnp-2818	63	21	two	two	NUM
fnp-2818	63	22	-	-	PUNCT
fnp-2818	63	23	fold	fold	VERB
fnp-2818	63	24	higher	higher	ADV
fnp-2818	63	25	in	in	ADP
fnp-2818	63	26	acutely	acutely	ADV
fnp-2818	63	27	ill	ill	ADJ
fnp-2818	63	28	covid-19	covid-19	PROPN
fnp-2818	63	29	patients	patient	NOUN
fnp-2818	63	30	with	with	ADP
fnp-2818	63	31	neurological	neurological	ADJ
fnp-2818	63	32	symptoms	symptom	NOUN
fnp-2818	63	33	compared	compare	VERB
fnp-2818	63	34	to	to	ADP
fnp-2818	63	35	non	non	ADJ
fnp-2818	63	36	-	-	ADJ
fnp-2818	63	37	infected	infected	ADJ
fnp-2818	63	38	patients	patient	NOUN
fnp-2818	63	39	,	,	PUNCT
fnp-2818	63	40	but	but	CCONJ
fnp-2818	63	41	it	it	PRON
fnp-2818	63	42	is	be	AUX
fnp-2818	63	43	not	not	PART
fnp-2818	63	44	known	know	VERB
fnp-2818	63	45	if	if	SCONJ
fnp-2818	63	46	this	this	PRON
fnp-2818	63	47	is	be	AUX
fnp-2818	63	48	through	through	ADP
fnp-2818	63	49	direct	direct	ADJ
fnp-2818	63	50	or	or	CCONJ
fnp-2818	63	51	indirect	indirect	ADJ
fnp-2818	63	52	actions	action	NOUN
fnp-2818	63	53	on	on	ADP
fnp-2818	63	54	the	the	DET
fnp-2818	63	55	cns45	cns45	NOUN
fnp-2818	63	56	.	.	PUNCT
fnp-2818	64	1	while	while	SCONJ
fnp-2818	64	2	sars	sar	NOUN
fnp-2818	64	3	-	-	PUNCT
fnp-2818	64	4	cov-2	cov-2	PART
fnp-2818	64	5	infection	infection	NOUN
fnp-2818	64	6	shares	share	VERB
fnp-2818	64	7	many	many	ADJ
fnp-2818	64	8	similarities	similarity	NOUN
fnp-2818	64	9	with	with	ADP
fnp-2818	64	10	bacterial	bacterial	ADJ
fnp-2818	64	11	sepsis	sepsis	NOUN
fnp-2818	64	12	,	,	PUNCT
fnp-2818	64	13	the	the	DET
fnp-2818	64	14	inflammatory	inflammatory	ADJ
fnp-2818	64	15	response	response	NOUN
fnp-2818	64	16	was	be	AUX
fnp-2818	64	17	considered	consider	VERB
fnp-2818	64	18	more	more	ADV
fnp-2818	64	19	modest	modest	ADJ
fnp-2818	64	20	(	(	PUNCT
fnp-2818	64	21	e.g.	e.g.	ADV
fnp-2818	64	22	lower	low	ADJ
fnp-2818	64	23	il-6	il-6	NOUN
fnp-2818	64	24	levels	level	NOUN
fnp-2818	64	25	)	)	PUNCT
fnp-2818	64	26	,	,	PUNCT
fnp-2818	64	27	and	and	CCONJ
fnp-2818	64	28	progressive	progressive	ADJ
fnp-2818	64	29	and	and	CCONJ
fnp-2818	64	30	profound	profound	ADJ
fnp-2818	64	31	suppression	suppression	NOUN
fnp-2818	64	32	of	of	ADP
fnp-2818	64	33	adaptive	adaptive	ADJ
fnp-2818	64	34	immunity	immunity	NOUN
fnp-2818	64	35	was	be	AUX
fnp-2818	64	36	noted	note	VERB
fnp-2818	64	37	in	in	ADP
fnp-2818	64	38	covid-19	covid-19	PROPN
fnp-2818	64	39	relative	relative	NOUN
fnp-2818	64	40	to	to	ADP
fnp-2818	64	41	sepsis46	sepsis46	PROPN
fnp-2818	64	42	.	.	PUNCT
fnp-2818	65	1	therefore	therefore	ADV
fnp-2818	65	2	,	,	PUNCT
fnp-2818	65	3	further	further	ADJ
fnp-2818	65	4	studies	study	NOUN
fnp-2818	65	5	are	be	AUX
fnp-2818	65	6	required	require	VERB
fnp-2818	65	7	to	to	PART
fnp-2818	65	8	assess	assess	VERB
fnp-2818	65	9	the	the	DET
fnp-2818	65	10	nature	nature	NOUN
fnp-2818	65	11	of	of	ADP
fnp-2818	65	12	systemic	systemic	ADJ
fnp-2818	65	13	inflammatory	inflammatory	ADJ
fnp-2818	65	14	changes	change	NOUN
fnp-2818	65	15	and	and	CCONJ
fnp-2818	65	16	their	their	PRON
fnp-2818	65	17	impact	impact	NOUN
fnp-2818	65	18	on	on	ADP
fnp-2818	65	19	neurological	neurological	ADJ
fnp-2818	65	20	symptoms	symptom	NOUN
fnp-2818	65	21	and	and	CCONJ
fnp-2818	65	22	disease	disease	NOUN
fnp-2818	65	23	outcome	outcome	NOUN
fnp-2818	65	24	.	.	PUNCT
fnp-2818	66	1	in	in	ADP
fnp-2818	66	2	conclusion	conclusion	NOUN
fnp-2818	66	3	,	,	PUNCT
fnp-2818	66	4	the	the	DET
fnp-2818	66	5	available	available	ADJ
fnp-2818	66	6	evidence	evidence	NOUN
fnp-2818	66	7	strongly	strongly	ADV
fnp-2818	66	8	indicates	indicate	VERB
fnp-2818	66	9	that	that	SCONJ
fnp-2818	66	10	the	the	DET
fnp-2818	66	11	brain	brain	NOUN
fnp-2818	66	12	is	be	AUX
fnp-2818	66	13	an	an	DET
fnp-2818	66	14	important	important	ADJ
fnp-2818	66	15	target	target	NOUN
fnp-2818	66	16	of	of	ADP
fnp-2818	66	17	sars	sar	NOUN
fnp-2818	66	18	-	-	PUNCT
fnp-2818	66	19	cov-2	cov-2	NOUN
fnp-2818	66	20	and	and	CCONJ
fnp-2818	66	21	the	the	DET
fnp-2818	66	22	impact	impact	NOUN
fnp-2818	66	23	of	of	ADP
fnp-2818	66	24	its	its	PRON
fnp-2818	66	25	brain	brain	NOUN
fnp-2818	66	26	-	-	PUNCT
fnp-2818	66	27	related	relate	VERB
fnp-2818	66	28	pathophysiology	pathophysiology	NOUN
fnp-2818	66	29	on	on	ADP
fnp-2818	66	30	survival	survival	NOUN
fnp-2818	66	31	and	and	CCONJ
fnp-2818	66	32	outcome	outcome	NOUN
fnp-2818	66	33	in	in	ADP
fnp-2818	66	34	covid-19	covid-19	PROPN
fnp-2818	66	35	is	be	AUX
fnp-2818	66	36	substantial	substantial	ADJ
fnp-2818	66	37	.	.	PUNCT
fnp-2818	67	1	while	while	SCONJ
fnp-2818	67	2	diagnostic	diagnostic	ADJ
fnp-2818	67	3	efforts	effort	NOUN
fnp-2818	67	4	and	and	CCONJ
fnp-2818	67	5	research	research	NOUN
fnp-2818	67	6	studies	study	NOUN
fnp-2818	67	7	to	to	PART
fnp-2818	67	8	investigate	investigate	VERB
fnp-2818	67	9	the	the	DET
fnp-2818	67	10	presence	presence	NOUN
fnp-2818	67	11	of	of	ADP
fnp-2818	67	12	infection	infection	NOUN
fnp-2818	67	13	in	in	ADP
fnp-2818	67	14	the	the	DET
fnp-2818	67	15	brain	brain	NOUN
fnp-2818	67	16	and	and	CCONJ
fnp-2818	67	17	to	to	PART
fnp-2818	67	18	reveal	reveal	VERB
fnp-2818	67	19	the	the	DET
fnp-2818	67	20	mechanisms	mechanism	NOUN
fnp-2818	67	21	of	of	ADP
fnp-2818	67	22	both	both	CCONJ
fnp-2818	67	23	central	central	ADJ
fnp-2818	67	24	and	and	CCONJ
fnp-2818	67	25	systemic	systemic	ADJ
fnp-2818	67	26	inflammation	inflammation	NOUN
fnp-2818	67	27	in	in	ADP
fnp-2818	67	28	covid-19	covid-19	PROPN
fnp-2818	67	29	are	be	AUX
fnp-2818	67	30	necessary	necessary	ADJ
fnp-2818	67	31	,	,	PUNCT
fnp-2818	67	32	lessons	lesson	NOUN
fnp-2818	67	33	from	from	ADP
fnp-2818	67	34	previous	previous	ADJ
fnp-2818	67	35	work	work	NOUN
fnp-2818	67	36	on	on	ADP
fnp-2818	67	37	infection	infection	NOUN
fnp-2818	67	38	,	,	PUNCT
fnp-2818	67	39	stroke	stroke	NOUN
fnp-2818	67	40	and	and	CCONJ
fnp-2818	67	41	systemic	systemic	ADJ
fnp-2818	67	42	inflammation	inflammation	NOUN
fnp-2818	67	43	should	should	AUX
fnp-2818	67	44	be	be	AUX
fnp-2818	67	45	considered	consider	VERB
fnp-2818	67	46	.	.	PUNCT
fnp-2818	68	1	regarding	regard	VERB
fnp-2818	68	2	the	the	DET
fnp-2818	68	3	clinical	clinical	ADJ
fnp-2818	68	4	management	management	NOUN
fnp-2818	68	5	of	of	ADP
fnp-2818	68	6	covid-19	covid-19	PROPN
fnp-2818	68	7	patients	patient	NOUN
fnp-2818	68	8	,	,	PUNCT
fnp-2818	68	9	immune	immune	ADJ
fnp-2818	68	10	modulatory	modulatory	ADJ
fnp-2818	68	11	therapies	therapy	NOUN
fnp-2818	68	12	are	be	AUX
fnp-2818	68	13	attractive	attractive	ADJ
fnp-2818	68	14	candidates	candidate	NOUN
fnp-2818	68	15	.	.	PUNCT
fnp-2818	69	1	in	in	ADP
fnp-2818	69	2	this	this	DET
fnp-2818	69	3	respect	respect	NOUN
fnp-2818	69	4	it	it	PRON
fnp-2818	69	5	will	will	AUX
fnp-2818	69	6	be	be	AUX
fnp-2818	69	7	intriguing	intriguing	ADJ
fnp-2818	69	8	to	to	PART
fnp-2818	69	9	learn	learn	VERB
fnp-2818	69	10	the	the	DET
fnp-2818	69	11	outcomes	outcome	NOUN
fnp-2818	69	12	of	of	ADP
fnp-2818	69	13	ongoing	ongoing	ADJ
fnp-2818	69	14	clinical	clinical	ADJ
fnp-2818	69	15	trials	trial	NOUN
fnp-2818	69	16	of	of	ADP
fnp-2818	69	17	anti	anti	ADJ
fnp-2818	69	18	-	-	ADJ
fnp-2818	69	19	cytokine	cytokine	ADJ
fnp-2818	69	20	therapies	therapy	NOUN
fnp-2818	69	21	,	,	PUNCT
fnp-2818	69	22	including	include	VERB
fnp-2818	69	23	anakinra	anakinra	NOUN
fnp-2818	69	24	(	(	PUNCT
fnp-2818	69	25	il-1	il-1	ADP
fnp-2818	69	26	receptor	receptor	NOUN
fnp-2818	69	27	antagonist	antagonist	NOUN
fnp-2818	69	28	)	)	PUNCT
fnp-2818	69	29	and	and	CCONJ
fnp-2818	69	30	tocilizumab	tocilizumab	NOUN
fnp-2818	69	31	(	(	PUNCT
fnp-2818	69	32	il-6	il-6	NOUN
fnp-2818	69	33	receptor	receptor	NOUN
fnp-2818	69	34	antibody	antibody	NOUN
fnp-2818	69	35	)	)	PUNCT
fnp-2818	69	36	.	.	PUNCT
fnp-2818	70	1	references	reference	NOUN
fnp-2818	70	2	1	1	NUM
fnp-2818	70	3	.	.	PUNCT
fnp-2818	70	4	mao	mao	PROPN
fnp-2818	71	1	l	l	NOUN
fnp-2818	71	2	,	,	PUNCT
fnp-2818	71	3	jin	jin	PROPN
fnp-2818	71	4	h	h	PROPN
fnp-2818	71	5	,	,	PUNCT
fnp-2818	71	6	wang	wang	PROPN
fnp-2818	71	7	m	m	PROPN
fnp-2818	71	8	,	,	PUNCT
fnp-2818	71	9	hu	hu	PROPN
fnp-2818	71	10	y	y	PROPN
fnp-2818	71	11	,	,	PUNCT
fnp-2818	71	12	chen	chen	PROPN
fnp-2818	71	13	s	s	PROPN
fnp-2818	71	14	,	,	PUNCT
fnp-2818	71	15	he	he	PRON
fnp-2818	71	16	q	q	PROPN
fnp-2818	71	17	,	,	PUNCT
fnp-2818	71	18	chang	chang	PROPN
fnp-2818	71	19	j	j	PROPN
fnp-2818	71	20	,	,	PUNCT
fnp-2818	71	21	hong	hong	PROPN
fnp-2818	71	22	c	c	PROPN
fnp-2818	71	23	,	,	PUNCT
fnp-2818	71	24	zhou	zhou	PROPN
fnp-2818	71	25	y	y	PROPN
fnp-2818	71	26	,	,	PUNCT
fnp-2818	71	27	wang	wang	PROPN
fnp-2818	71	28	d	d	PROPN
fnp-2818	71	29	,	,	PUNCT
fnp-2818	71	30	miao	miao	PROPN
fnp-2818	71	31	x	x	PROPN
fnp-2818	71	32	,	,	PUNCT
fnp-2818	71	33	li	li	PROPN
fnp-2818	71	34	y	y	PROPN
fnp-2818	71	35	,	,	PUNCT
fnp-2818	71	36	hu	hu	PROPN
fnp-2818	71	37	b.	b.	PROPN
fnp-2818	71	38	neurologic	neurologic	ADJ
fnp-2818	71	39	manifestations	manifestation	NOUN
fnp-2818	71	40	of	of	ADP
fnp-2818	71	41	hospitalized	hospitalize	VERB
fnp-2818	71	42	patients	patient	NOUN
fnp-2818	71	43	with	with	ADP
fnp-2818	71	44	coronavirus	coronavirus	NOUN
fnp-2818	71	45	disease	disease	NOUN
fnp-2818	71	46	2019	2019	NUM
fnp-2818	71	47	in	in	ADP
fnp-2818	71	48	wuhan	wuhan	PROPN
fnp-2818	71	49	,	,	PUNCT
fnp-2818	71	50	china	china	PROPN
fnp-2818	71	51	.	.	PROPN
fnp-2818	72	1	jama	jama	PROPN
fnp-2818	72	2	neurology	neurology	PROPN
fnp-2818	72	3	.	.	PUNCT
fnp-2818	73	1	2020;e201127	2020;e201127	NUM
fnp-2818	73	2	.	.	PUNCT
fnp-2818	74	1	doi:10.1001	doi:10.1001	PROPN
fnp-2818	74	2	/	/	SYM
fnp-2818	74	3	jamaneurol.2020.1127	jamaneurol.2020.1127	PROPN
fnp-2818	74	4	2	2	NUM
fnp-2818	74	5	.	.	PUNCT
fnp-2818	75	1	wu	wu	PROPN
fnp-2818	75	2	y	y	PROPN
fnp-2818	75	3	,	,	PUNCT
fnp-2818	75	4	xu	xu	PROPN
fnp-2818	76	1	x	x	PROPN
fnp-2818	76	2	,	,	PUNCT
fnp-2818	76	3	chen	chen	PROPN
fnp-2818	76	4	z	z	PROPN
fnp-2818	76	5	,	,	PUNCT
fnp-2818	76	6	duan	duan	PROPN
fnp-2818	76	7	j	j	PROPN
fnp-2818	76	8	,	,	PUNCT
fnp-2818	76	9	hashimoto	hashimoto	PROPN
fnp-2818	76	10	k	k	PROPN
fnp-2818	76	11	,	,	PUNCT
fnp-2818	76	12	yang	yang	PROPN
fnp-2818	76	13	l	l	PROPN
fnp-2818	76	14	,	,	PUNCT
fnp-2818	76	15	liu	liu	PROPN
fnp-2818	76	16	c	c	PROPN
fnp-2818	76	17	,	,	PUNCT
fnp-2818	76	18	yang	yang	PROPN
fnp-2818	76	19	c.	c.	PROPN
fnp-2818	76	20	nervous	nervous	ADJ
fnp-2818	76	21	system	system	NOUN
fnp-2818	76	22	involvement	involvement	NOUN
fnp-2818	76	23	after	after	ADP
fnp-2818	76	24	infection	infection	NOUN
fnp-2818	76	25	with	with	ADP
fnp-2818	76	26	covid-19	covid-19	PROPN
fnp-2818	76	27	and	and	CCONJ
fnp-2818	76	28	other	other	ADJ
fnp-2818	76	29	coronaviruses	coronaviruse	NOUN
fnp-2818	76	30	.	.	PUNCT
fnp-2818	77	1	brain	brain	NOUN
fnp-2818	77	2	,	,	PUNCT
fnp-2818	77	3	behavior	behavior	NOUN
fnp-2818	77	4	,	,	PUNCT
fnp-2818	77	5	and	and	CCONJ
fnp-2818	77	6	immunity	immunity	NOUN
fnp-2818	77	7	.	.	PUNCT
fnp-2818	78	1	2020	2020	NUM
fnp-2818	78	2	;	;	PUNCT
fnp-2818	79	1	s0889	s0889	PROPN
fnp-2818	79	2	-	-	PUNCT
fnp-2818	79	3	1591(20)30357	1591(20)30357	NUM
fnp-2818	79	4	-	-	PUNCT
fnp-2818	79	5	3	3	NUM
fnp-2818	79	6	.	.	PUNCT
fnp-2818	79	7	doi:10.1016	doi:10.1016	PROPN
fnp-2818	79	8	/	/	SYM
fnp-2818	79	9	j.bbi.2020.03.031	j.bbi.2020.03.031	PROPN
fnp-2818	79	10	3	3	X
fnp-2818	79	11	.	.	X
fnp-2818	79	12	oxley	oxley	PROPN
fnp-2818	79	13	tj	tj	PROPN
fnp-2818	79	14	,	,	PUNCT
fnp-2818	79	15	mocco	mocco	PROPN
fnp-2818	79	16	j	j	PROPN
fnp-2818	79	17	,	,	PUNCT
fnp-2818	79	18	majidi	majidi	PROPN
fnp-2818	79	19	s	s	PROPN
fnp-2818	79	20	,	,	PUNCT
fnp-2818	79	21	kellner	kellner	PROPN
fnp-2818	79	22	cp	cp	PROPN
fnp-2818	79	23	,	,	PUNCT
fnp-2818	79	24	shoirah	shoirah	PROPN
fnp-2818	79	25	h	h	PROPN
fnp-2818	79	26	,	,	PUNCT
fnp-2818	79	27	singh	singh	PROPN
fnp-2818	79	28	ip	ip	NOUN
fnp-2818	79	29	,	,	PUNCT
fnp-2818	79	30	de	de	X
fnp-2818	79	31	leacy	leacy	PROPN
fnp-2818	79	32	ra	ra	PROPN
fnp-2818	79	33	,	,	PUNCT
fnp-2818	79	34	shigematsu	shigematsu	PROPN
fnp-2818	79	35	t	t	PROPN
fnp-2818	79	36	,	,	PUNCT
fnp-2818	79	37	ladner	ladner	PROPN
fnp-2818	79	38	tr	tr	PROPN
fnp-2818	79	39	,	,	PUNCT
fnp-2818	79	40	yaeger	yaeger	PROPN
fnp-2818	79	41	ka	ka	PROPN
fnp-2818	79	42	,	,	PUNCT
fnp-2818	79	43	skliut	skliut	VERB
fnp-2818	79	44	m	m	PROPN
fnp-2818	79	45	,	,	PUNCT
fnp-2818	79	46	weinberger	weinberger	PROPN
fnp-2818	79	47	j	j	PROPN
fnp-2818	79	48	,	,	PUNCT
fnp-2818	79	49	dangayach	dangayach	NOUN
fnp-2818	79	50	ns	ns	NUM
fnp-2818	79	51	,	,	PUNCT
fnp-2818	79	52	bederson	bederson	PROPN
fnp-2818	79	53	jb	jb	PROPN
fnp-2818	79	54	,	,	PUNCT
fnp-2818	79	55	tuhrim	tuhrim	VERB
fnp-2818	79	56	s	s	PROPN
fnp-2818	79	57	,	,	PUNCT
fnp-2818	79	58	fifi	fifi	PROPN
fnp-2818	79	59	jt	jt	PROPN
fnp-2818	79	60	.	.	PUNCT
fnp-2818	80	1	large	large	ADJ
fnp-2818	80	2	-	-	PUNCT
fnp-2818	80	3	vessel	vessel	NOUN
fnp-2818	80	4	stroke	stroke	NOUN
fnp-2818	80	5	as	as	ADP
fnp-2818	80	6	a	a	DET
fnp-2818	80	7	presenting	present	VERB
fnp-2818	80	8	feature	feature	NOUN
fnp-2818	80	9	of	of	ADP
fnp-2818	80	10	covid-19	covid-19	PROPN
fnp-2818	80	11	in	in	ADP
fnp-2818	80	12	the	the	DET
fnp-2818	80	13	young	young	NOUN
fnp-2818	80	14	.	.	PUNCT
fnp-2818	81	1	the	the	DET
fnp-2818	81	2	new	new	PROPN
fnp-2818	81	3	england	england	PROPN
fnp-2818	81	4	journal	journal	PROPN
fnp-2818	81	5	of	of	ADP
fnp-2818	81	6	medicine	medicine	NOUN
fnp-2818	81	7	.	.	PUNCT
fnp-2818	82	1	2020;382	2020;382	NUM
fnp-2818	82	2	:	:	PUNCT
fnp-2818	82	3	e60	e60	PROPN
fnp-2818	82	4	.	.	PUNCT
fnp-2818	83	1	doi:10.1056	doi:10.1056	PROPN
fnp-2818	83	2	/	/	SYM
fnp-2818	83	3	nejmc2009787	nejmc2009787	PROPN
fnp-2818	83	4	4	4	NUM
fnp-2818	83	5	.	.	PUNCT
fnp-2818	84	1	aggarwal	aggarwal	NOUN
fnp-2818	84	2	g	g	PROPN
fnp-2818	84	3	,	,	PUNCT
fnp-2818	84	4	lippi	lippi	PROPN
fnp-2818	84	5	g	g	PROPN
fnp-2818	84	6	,	,	PUNCT
fnp-2818	84	7	michael	michael	PROPN
fnp-2818	84	8	henry	henry	PROPN
fnp-2818	84	9	b.	b.	PROPN
fnp-2818	84	10	cerebrovascular	cerebrovascular	ADJ
fnp-2818	84	11	disease	disease	NOUN
fnp-2818	84	12	is	be	AUX
fnp-2818	84	13	associated	associate	VERB
fnp-2818	84	14	with	with	ADP
fnp-2818	84	15	an	an	DET
fnp-2818	84	16	increased	increase	VERB
fnp-2818	84	17	disease	disease	NOUN
fnp-2818	84	18	severity	severity	NOUN
fnp-2818	84	19	in	in	ADP
fnp-2818	84	20	patients	patient	NOUN
fnp-2818	84	21	with	with	ADP
fnp-2818	84	22	coronavirus	coronavirus	NOUN
fnp-2818	84	23	disease	disease	NOUN
fnp-2818	84	24	2019	2019	NUM
fnp-2818	84	25	(	(	PUNCT
fnp-2818	84	26	covid-19	covid-19	PROPN
fnp-2818	84	27	):	):	PUNCT
fnp-2818	84	28	a	a	DET
fnp-2818	84	29	pooled	pooled	ADJ
fnp-2818	84	30	analysis	analysis	NOUN
fnp-2818	84	31	of	of	ADP
fnp-2818	84	32	published	publish	VERB
fnp-2818	84	33	literature	literature	NOUN
fnp-2818	84	34	.	.	PUNCT
fnp-2818	85	1	international	international	ADJ
fnp-2818	85	2	journal	journal	PROPN
fnp-2818	85	3	of	of	ADP
fnp-2818	85	4	stroke	stroke	PROPN
fnp-2818	85	5	.	.	PUNCT
fnp-2818	86	1	2020;1747493020921664	2020;1747493020921664	NUM
fnp-2818	86	2	.	.	PUNCT
fnp-2818	87	1	doi:10.1177/1747493020921664	doi:10.1177/1747493020921664	NOUN
fnp-2818	87	2	5	5	NUM
fnp-2818	87	3	.	.	PUNCT
fnp-2818	87	4	panciani	panciani	PROPN
fnp-2818	87	5	pp	pp	PROPN
fnp-2818	87	6	,	,	PUNCT
fnp-2818	87	7	saraceno	saraceno	PROPN
fnp-2818	87	8	g	g	PROPN
fnp-2818	87	9	,	,	PUNCT
fnp-2818	87	10	zanin	zanin	PROPN
fnp-2818	87	11	l	l	NOUN
fnp-2818	87	12	,	,	PUNCT
fnp-2818	87	13	renisi	renisi	ADJ
fnp-2818	87	14	g	g	PROPN
fnp-2818	87	15	,	,	PUNCT
fnp-2818	87	16	signorini	signorini	PROPN
fnp-2818	87	17	l	l	PROPN
fnp-2818	87	18	,	,	PUNCT
fnp-2818	87	19	battaglia	battaglia	PROPN
fnp-2818	87	20	l	l	PROPN
fnp-2818	87	21	,	,	PUNCT
fnp-2818	87	22	fontanella	fontanella	PROPN
fnp-2818	87	23	mm	mm	PROPN
fnp-2818	87	24	.	.	PUNCT
fnp-2818	88	1	sars	sars	PROPN
fnp-2818	88	2	-	-	PUNCT
fnp-2818	88	3	cov-2	cov-2	NUM
fnp-2818	88	4	:	:	PUNCT
fnp-2818	88	5	"	"	PUNCT
fnp-2818	88	6	three	three	NUM
fnp-2818	88	7	-	-	PUNCT
fnp-2818	88	8	steps	step	NOUN
fnp-2818	88	9	"	"	PUNCT
fnp-2818	88	10	infection	infection	NOUN
fnp-2818	88	11	model	model	NOUN
fnp-2818	88	12	and	and	CCONJ
fnp-2818	88	13	csf	csf	ADJ
fnp-2818	88	14	diagnostic	diagnostic	ADJ
fnp-2818	88	15	implication	implication	NOUN
fnp-2818	88	16	.	.	PUNCT
fnp-2818	89	1	brain	brain	NOUN
fnp-2818	89	2	,	,	PUNCT
fnp-2818	89	3	behavior	behavior	NOUN
fnp-2818	89	4	,	,	PUNCT
fnp-2818	89	5	and	and	CCONJ
fnp-2818	89	6	immunity	immunity	NOUN
fnp-2818	89	7	.	.	PUNCT
fnp-2818	90	1	2020	2020	NUM
fnp-2818	90	2	may	may	AUX
fnp-2818	90	3	5	5	NUM
fnp-2818	90	4	,	,	PUNCT
fnp-2818	90	5	doi	doi	NOUN
fnp-2818	90	6	:	:	PUNCT
fnp-2818	90	7	10.1016	10.1016	NUM
fnp-2818	90	8	/	/	SYM
fnp-2818	90	9	j.bbi.2020.05.002	j.bbi.2020.05.002	PROPN
fnp-2818	90	10	6	6	NUM
fnp-2818	90	11	.	.	PUNCT
fnp-2818	90	12	zanin	zanin	NOUN
fnp-2818	91	1	l	l	NOUN
fnp-2818	91	2	,	,	PUNCT
fnp-2818	91	3	saraceno	saraceno	PROPN
fnp-2818	91	4	g	g	PROPN
fnp-2818	91	5	,	,	PUNCT
fnp-2818	91	6	panciani	panciani	PROPN
fnp-2818	91	7	pp	pp	ADV
fnp-2818	91	8	,	,	PUNCT
fnp-2818	91	9	renisi	renisi	ADJ
fnp-2818	91	10	g	g	PROPN
fnp-2818	91	11	,	,	PUNCT
fnp-2818	91	12	signorini	signorini	PROPN
fnp-2818	91	13	l	l	PROPN
fnp-2818	91	14	,	,	PUNCT
fnp-2818	91	15	migliorati	migliorati	PROPN
fnp-2818	91	16	k	k	NOUN
fnp-2818	91	17	,	,	PUNCT
fnp-2818	91	18	fontanella	fontanella	PROPN
fnp-2818	91	19	mm	mm	PROPN
fnp-2818	91	20	.	.	PUNCT
fnp-2818	92	1	sars	sars	PROPN
fnp-2818	92	2	-	-	PUNCT
fnp-2818	92	3	cov-2	cov-2	NUM
fnp-2818	92	4	can	can	AUX
fnp-2818	92	5	induce	induce	VERB
fnp-2818	92	6	brain	brain	NOUN
fnp-2818	92	7	and	and	CCONJ
fnp-2818	92	8	spine	spine	ADJ
fnp-2818	92	9	demyelinating	demyelinate	VERB
fnp-2818	92	10	lesions	lesion	NOUN
fnp-2818	92	11	.	.	PUNCT
fnp-2818	93	1	acta	acta	PROPN
fnp-2818	93	2	neurochirurgica	neurochirurgica	PROPN
fnp-2818	93	3	.	.	PUNCT
fnp-2818	94	1	2020	2020	NUM
fnp-2818	94	2	may	may	AUX
fnp-2818	94	3	4;1	4;1	NOUN
fnp-2818	94	4	-	-	PUNCT
fnp-2818	94	5	4	4	NUM
fnp-2818	94	6	.	.	PUNCT
fnp-2818	95	1	doi	doi	NOUN
fnp-2818	95	2	:	:	PUNCT
fnp-2818	95	3	10.1007	10.1007	NUM
fnp-2818	95	4	/	/	SYM
fnp-2818	95	5	s00701	s00701	NOUN
fnp-2818	95	6	-	-	PUNCT
fnp-2818	95	7	020	020	NUM
fnp-2818	95	8	-	-	PUNCT
fnp-2818	95	9	04374	04374	NUM
fnp-2818	95	10	-	-	PUNCT
fnp-2818	95	11	x	x	SYM
fnp-2818	95	12	7	7	PROPN
fnp-2818	95	13	.	.	PUNCT
fnp-2818	95	14	recasens	recasen	NOUN
fnp-2818	95	15	bb	bb	PROPN
fnp-2818	95	16	,	,	PUNCT
fnp-2818	95	17	llorens	llorens	PROPN
fnp-2818	95	18	jmm	jmm	PROPN
fnp-2818	95	19	,	,	PUNCT
fnp-2818	95	20	sevilla	sevilla	PROPN
fnp-2818	95	21	jjr	jjr	PROPN
fnp-2818	95	22	,	,	PUNCT
fnp-2818	95	23	rubio	rubio	PROPN
fnp-2818	95	24	ma	ma	PROPN
fnp-2818	95	25	.	.	PROPN
fnp-2818	95	26	lack	lack	NOUN
fnp-2818	95	27	of	of	ADP
fnp-2818	95	28	dyspnea	dyspnea	NOUN
fnp-2818	95	29	in	in	ADP
fnp-2818	95	30	patients	patient	NOUN
fnp-2818	95	31	with	with	ADP
fnp-2818	95	32	covid-19	covid-19	PROPN
fnp-2818	95	33	:	:	PUNCT
fnp-2818	95	34	another	another	DET
fnp-2818	95	35	neurological	neurological	ADJ
fnp-2818	95	36	conundrum	conundrum	NOUN
fnp-2818	95	37	?	?	PUNCT
fnp-2818	96	1	european	european	ADJ
fnp-2818	96	2	journal	journal	PROPN
fnp-2818	96	3	of	of	ADP
fnp-2818	96	4	neurology	neurology	NOUN
fnp-2818	96	5	.	.	PUNCT
fnp-2818	97	1	2020	2020	NUM
fnp-2818	97	2	apr	apr	VERB
fnp-2818	97	3	17	17	NUM
fnp-2818	97	4	,	,	PUNCT
fnp-2818	97	5	doi	doi	NOUN
fnp-2818	97	6	:	:	PUNCT
fnp-2818	97	7	10.1111	10.1111	NUM
fnp-2818	97	8	/	/	SYM
fnp-2818	97	9	ene.14265	ene.14265	NUM
fnp-2818	97	10	8	8	NUM
fnp-2818	97	11	.	.	PUNCT
fnp-2818	97	12	schaller	schaller	PROPN
fnp-2818	97	13	t	t	PROPN
fnp-2818	97	14	,	,	PUNCT
fnp-2818	97	15	hirschbuhl	hirschbuhl	PROPN
fnp-2818	97	16	k	k	NOUN
fnp-2818	97	17	,	,	PUNCT
fnp-2818	97	18	burkhardt	burkhardt	PROPN
fnp-2818	97	19	k	k	PROPN
fnp-2818	97	20	,	,	PUNCT
fnp-2818	97	21	braun	braun	NOUN
fnp-2818	97	22	g	g	PROPN
fnp-2818	97	23	,	,	PUNCT
fnp-2818	97	24	trepel	trepel	NOUN
fnp-2818	97	25	m	m	PROPN
fnp-2818	97	26	,	,	PUNCT
fnp-2818	97	27	markl	markl	PROPN
fnp-2818	97	28	b	b	PROPN
fnp-2818	97	29	,	,	PUNCT
fnp-2818	97	30	claus	claus	PROPN
fnp-2818	97	31	r.	r.	PROPN
fnp-2818	97	32	postmortem	postmortem	PROPN
fnp-2818	97	33	examination	examination	NOUN
fnp-2818	97	34	of	of	ADP
fnp-2818	97	35	patients	patient	NOUN
fnp-2818	97	36	with	with	ADP
fnp-2818	97	37	covid-19	covid-19	PROPN
fnp-2818	97	38	.	.	PROPN
fnp-2818	97	39	jama	jama	PROPN
fnp-2818	97	40	.	.	PUNCT
fnp-2818	98	1	may	may	AUX
fnp-2818	98	2	21	21	NUM
fnp-2818	98	3	,	,	PUNCT
fnp-2818	98	4	2020	2020	NUM
fnp-2818	98	5	.	.	PUNCT
fnp-2818	99	1	doi:10.1001	doi:10.1001	PROPN
fnp-2818	99	2	/	/	SYM
fnp-2818	99	3	jama.2020.8907	jama.2020.8907	PROPN
fnp-2818	99	4	9	9	NUM
fnp-2818	99	5	.	.	PUNCT
fnp-2818	100	1	turtle	turtle	NOUN
fnp-2818	100	2	l.	l.	NOUN
fnp-2818	100	3	respiratory	respiratory	ADJ
fnp-2818	100	4	failure	failure	NOUN
fnp-2818	100	5	alone	alone	ADV
fnp-2818	100	6	does	do	AUX
fnp-2818	100	7	not	not	PART
fnp-2818	100	8	suggest	suggest	VERB
fnp-2818	100	9	central	central	ADJ
fnp-2818	100	10	nervous	nervous	ADJ
fnp-2818	100	11	system	system	NOUN
fnp-2818	100	12	invasion	invasion	NOUN
fnp-2818	100	13	by	by	ADP
fnp-2818	100	14	sars	sar	NOUN
fnp-2818	100	15	-	-	PUNCT
fnp-2818	100	16	cov-2	cov-2	NOUN
fnp-2818	100	17	.	.	NOUN
fnp-2818	100	18	journal	journal	PROPN
fnp-2818	100	19	of	of	ADP
fnp-2818	100	20	medical	medical	ADJ
fnp-2818	100	21	virology	virology	NOUN
fnp-2818	100	22	.	.	PUNCT
fnp-2818	101	1	04	04	NUM
fnp-2818	101	2	,	,	PUNCT
fnp-2818	101	3	april	april	PROPN
fnp-2818	101	4	2020	2020	NUM
fnp-2818	101	5	.	.	PUNCT
fnp-2818	102	1	https://doi.org/10.1002/jmv.25828	https://doi.org/10.1002/jmv.25828	NOUN
fnp-2818	102	2	10	10	NUM
fnp-2818	102	3	.	.	PUNCT
fnp-2818	103	1	desforges	desforge	NOUN
fnp-2818	103	2	m	m	PROPN
fnp-2818	103	3	,	,	PUNCT
fnp-2818	103	4	le	le	X
fnp-2818	103	5	coupanec	coupanec	PROPN
fnp-2818	103	6	a	a	X
fnp-2818	103	7	,	,	PUNCT
fnp-2818	103	8	brison	brison	PROPN
fnp-2818	103	9	e	e	PROPN
fnp-2818	103	10	,	,	PUNCT
fnp-2818	103	11	meessen	meessen	ADJ
fnp-2818	103	12	-	-	PUNCT
fnp-2818	103	13	pinard	pinard	NOUN
fnp-2818	103	14	m	m	PROPN
fnp-2818	103	15	,	,	PUNCT
fnp-2818	103	16	talbot	talbot	PROPN
fnp-2818	103	17	pj	pj	PROPN
fnp-2818	103	18	.	.	PROPN
fnp-2818	103	19	neuroinvasive	neuroinvasive	PROPN
fnp-2818	103	20	and	and	CCONJ
fnp-2818	103	21	neurotropic	neurotropic	ADJ
fnp-2818	103	22	human	human	ADJ
fnp-2818	103	23	respiratory	respiratory	ADJ
fnp-2818	103	24	coronaviruses	coronaviruse	NOUN
fnp-2818	103	25	:	:	PUNCT
fnp-2818	103	26	potential	potential	ADJ
fnp-2818	103	27	neurovirulent	neurovirulent	ADJ
fnp-2818	103	28	agents	agent	NOUN
fnp-2818	103	29	in	in	ADP
fnp-2818	103	30	humans	human	NOUN
fnp-2818	103	31	.	.	PUNCT
fnp-2818	104	1	advances	advance	NOUN
fnp-2818	104	2	in	in	ADP
fnp-2818	104	3	experimental	experimental	ADJ
fnp-2818	104	4	medicine	medicine	NOUN
fnp-2818	104	5	and	and	CCONJ
fnp-2818	104	6	biology	biology	NOUN
fnp-2818	104	7	.	.	PUNCT
fnp-2818	105	1	2014;807:75	2014;807:75	NUM
fnp-2818	105	2	-	-	SYM
fnp-2818	105	3	96	96	NUM
fnp-2818	105	4	11	11	NUM
fnp-2818	105	5	.	.	PUNCT
fnp-2818	106	1	li	li	PROPN
fnp-2818	106	2	yc	yc	PROPN
fnp-2818	106	3	,	,	PUNCT
fnp-2818	106	4	bai	bai	PROPN
fnp-2818	106	5	wz	wz	PROPN
fnp-2818	106	6	,	,	PUNCT
fnp-2818	106	7	hashikawa	hashikawa	PROPN
fnp-2818	106	8	t.	t.	PROPN
fnp-2818	106	9	the	the	DET
fnp-2818	106	10	neuroinvasive	neuroinvasive	ADJ
fnp-2818	106	11	potential	potential	NOUN
fnp-2818	106	12	of	of	ADP
fnp-2818	106	13	sars	sar	NOUN
fnp-2818	106	14	-	-	PUNCT
fnp-2818	106	15	cov2	cov2	PROPN
fnp-2818	106	16	may	may	AUX
fnp-2818	106	17	play	play	VERB
fnp-2818	106	18	a	a	DET
fnp-2818	106	19	role	role	NOUN
fnp-2818	106	20	in	in	ADP
fnp-2818	106	21	the	the	DET
fnp-2818	106	22	respiratory	respiratory	ADJ
fnp-2818	106	23	failure	failure	NOUN
fnp-2818	106	24	of	of	ADP
fnp-2818	106	25	covid-19	covid-19	PROPN
fnp-2818	106	26	patients	patient	NOUN
fnp-2818	106	27	.	.	PUNCT
fnp-2818	107	1	journal	journal	PROPN
fnp-2818	107	2	of	of	ADP
fnp-2818	107	3	medical	medical	ADJ
fnp-2818	107	4	virology	virology	NOUN
fnp-2818	107	5	.	.	PUNCT
fnp-2818	108	1	2020;10.1002	2020;10.1002	NUM
fnp-2818	108	2	/	/	SYM
fnp-2818	108	3	jmv.25728	jmv.25728	NUM
fnp-2818	108	4	.	.	PUNCT
fnp-2818	109	1	doi:10.1002	doi:10.1002	NOUN
fnp-2818	109	2	/	/	SYM
fnp-2818	109	3	jmv.25728	jmv.25728	PROPN
fnp-2818	109	4	12	12	NUM
fnp-2818	109	5	.	.	PUNCT
fnp-2818	110	1	natoli	natoli	PROPN
fnp-2818	110	2	s	s	PROPN
fnp-2818	110	3	,	,	PUNCT
fnp-2818	110	4	oliveira	oliveira	PROPN
fnp-2818	110	5	v	v	PROPN
fnp-2818	110	6	,	,	PUNCT
fnp-2818	110	7	calabresi	calabresi	NOUN
fnp-2818	110	8	p	p	X
fnp-2818	110	9	,	,	PUNCT
fnp-2818	110	10	maia	maia	PROPN
fnp-2818	110	11	lf	lf	PROPN
fnp-2818	110	12	,	,	PUNCT
fnp-2818	110	13	pisani	pisani	PROPN
fnp-2818	110	14	a.	a.	PROPN
fnp-2818	110	15	does	do	AUX
fnp-2818	110	16	sars	sar	NOUN
fnp-2818	110	17	-	-	PUNCT
fnp-2818	110	18	cov-2	cov-2	PART
fnp-2818	110	19	invade	invade	VERB
fnp-2818	110	20	the	the	DET
fnp-2818	110	21	brain	brain	NOUN
fnp-2818	110	22	?	?	PUNCT
fnp-2818	111	1	translational	translational	ADJ
fnp-2818	111	2	lessons	lesson	NOUN
fnp-2818	111	3	from	from	ADP
fnp-2818	111	4	animal	animal	NOUN
fnp-2818	111	5	models	model	NOUN
fnp-2818	111	6	.	.	PUNCT
fnp-2818	112	1	european	european	ADJ
fnp-2818	112	2	journal	journal	PROPN
fnp-2818	112	3	of	of	ADP
fnp-2818	112	4	neurology	neurology	NOUN
fnp-2818	112	5	.	.	PUNCT
fnp-2818	113	1	2020;10.1111	2020;10.1111	X
fnp-2818	113	2	/	/	SYM
fnp-2818	113	3	ene.14277	ene.14277	PROPN
fnp-2818	113	4	.	.	PUNCT
fnp-2818	114	1	doi:10.1111	doi:10.1111	NOUN
fnp-2818	114	2	/	/	SYM
fnp-2818	114	3	ene.14277	ene.14277	PROPN
fnp-2818	114	4	13	13	NUM
fnp-2818	114	5	.	.	PUNCT
fnp-2818	115	1	paniz	paniz	NOUN
fnp-2818	115	2	-	-	PUNCT
fnp-2818	115	3	mondolfi	mondolfi	NOUN
fnp-2818	115	4	a	a	NOUN
fnp-2818	115	5	,	,	PUNCT
fnp-2818	115	6	bryce	bryce	PROPN
fnp-2818	115	7	c	c	PROPN
fnp-2818	115	8	,	,	PUNCT
fnp-2818	115	9	grimes	grimes	PROPN
fnp-2818	115	10	z	z	PROPN
fnp-2818	115	11	,	,	PUNCT
fnp-2818	115	12	gordon	gordon	PROPN
fnp-2818	115	13	re	re	PROPN
fnp-2818	115	14	,	,	PUNCT
fnp-2818	115	15	reidy	reidy	PROPN
fnp-2818	115	16	j	j	PROPN
fnp-2818	115	17	,	,	PUNCT
fnp-2818	115	18	lednicky	lednicky	PROPN
fnp-2818	115	19	j	j	PROPN
fnp-2818	115	20	,	,	PUNCT
fnp-2818	115	21	sordillo	sordillo	VERB
fnp-2818	115	22	em	em	PRON
fnp-2818	115	23	,	,	PUNCT
fnp-2818	115	24	fowkes	fowke	VERB
fnp-2818	115	25	m.	m.	NOUN
fnp-2818	115	26	central	central	ADJ
fnp-2818	115	27	nervous	nervous	ADJ
fnp-2818	115	28	system	system	NOUN
fnp-2818	115	29	involvement	involvement	NOUN
fnp-2818	115	30	by	by	ADP
fnp-2818	115	31	severe	severe	ADJ
fnp-2818	115	32	acute	acute	ADJ
fnp-2818	115	33	respiratory	respiratory	ADJ
fnp-2818	115	34	syndrome	syndrome	NOUN
fnp-2818	115	35	coronavirus	coronavirus	NOUN
fnp-2818	116	1	-2	-2	INTJ
fnp-2818	116	2	(	(	PUNCT
fnp-2818	116	3	sars	sar	NOUN
fnp-2818	116	4	-	-	PUNCT
fnp-2818	116	5	cov-2	cov-2	NOUN
fnp-2818	116	6	)	)	PUNCT
fnp-2818	116	7	.	.	PUNCT
fnp-2818	117	1	journal	journal	PROPN
fnp-2818	117	2	of	of	ADP
fnp-2818	117	3	medical	medical	ADJ
fnp-2818	117	4	virology	virology	NOUN
fnp-2818	117	5	.	.	PUNCT
fnp-2818	118	1	2020;10.1002	2020;10.1002	NUM
fnp-2818	118	2	/	/	SYM
fnp-2818	118	3	jmv.25915	jmv.25915	NOUN
fnp-2818	118	4	.	.	PUNCT
fnp-2818	118	5	doi:10.1002	doi:10.1002	NOUN
fnp-2818	118	6	/	/	SYM
fnp-2818	118	7	jmv.25915	jmv.25915	PROPN
fnp-2818	118	8	14	14	NUM
fnp-2818	118	9	.	.	PUNCT
fnp-2818	119	1	varga	varga	PROPN
fnp-2818	119	2	z	z	PROPN
fnp-2818	119	3	,	,	PUNCT
fnp-2818	119	4	flammer	flammer	PROPN
fnp-2818	119	5	aj	aj	PROPN
fnp-2818	119	6	,	,	PUNCT
fnp-2818	119	7	steiger	steiger	PROPN
fnp-2818	119	8	p	p	PROPN
fnp-2818	119	9	,	,	PUNCT
fnp-2818	119	10	haberecker	haberecker	PROPN
fnp-2818	119	11	m	m	PROPN
fnp-2818	119	12	,	,	PUNCT
fnp-2818	119	13	andermatt	andermatt	PROPN
fnp-2818	119	14	r	r	NOUN
fnp-2818	119	15	,	,	PUNCT
fnp-2818	119	16	zinkernagel	zinkernagel	X
fnp-2818	119	17	as	as	ADP
fnp-2818	119	18	,	,	PUNCT
fnp-2818	119	19	mehra	mehra	PROPN
fnp-2818	119	20	mr	mr	PROPN
fnp-2818	119	21	,	,	PUNCT
fnp-2818	119	22	schuepbach	schuepbach	PROPN
fnp-2818	119	23	ra	ra	PROPN
fnp-2818	119	24	,	,	PUNCT
fnp-2818	119	25	ruschitzka	ruschitzka	PROPN
fnp-2818	119	26	f	f	PROPN
fnp-2818	119	27	,	,	PUNCT
fnp-2818	119	28	moch	moch	PROPN
fnp-2818	119	29	h.	h.	PROPN
fnp-2818	119	30	endothelial	endothelial	PROPN
fnp-2818	119	31	cell	cell	NOUN
fnp-2818	119	32	infection	infection	NOUN
fnp-2818	119	33	and	and	CCONJ
fnp-2818	119	34	endotheliitis	endotheliitis	PRON
fnp-2818	119	35	in	in	ADP
fnp-2818	119	36	covid-19	covid-19	PROPN
fnp-2818	119	37	.	.	PUNCT
fnp-2818	120	1	lancet	lancet	PROPN
fnp-2818	120	2	.	.	PUNCT
fnp-2818	121	1	2020;395:1417	2020;395:1417	NUM
fnp-2818	121	2	-	-	SYM
fnp-2818	121	3	1418	1418	NUM
fnp-2818	121	4	15	15	NUM
fnp-2818	121	5	.	.	PUNCT
fnp-2818	121	6	bostanciklioglu	bostanciklioglu	NOUN
fnp-2818	121	7	m.	m.	NOUN
fnp-2818	121	8	sars	sars	PROPN
fnp-2818	121	9	-	-	PUNCT
fnp-2818	121	10	cov-2	cov-2	PART
fnp-2818	121	11	entry	entry	NOUN
fnp-2818	121	12	and	and	CCONJ
fnp-2818	121	13	spread	spread	VERB
fnp-2818	121	14	in	in	ADP
fnp-2818	121	15	the	the	DET
fnp-2818	121	16	lymphatic	lymphatic	ADJ
fnp-2818	121	17	drainage	drainage	NOUN
fnp-2818	121	18	system	system	NOUN
fnp-2818	121	19	of	of	ADP
fnp-2818	121	20	the	the	DET
fnp-2818	121	21	brain	brain	NOUN
fnp-2818	121	22	.	.	PUNCT
fnp-2818	122	1	brain	brain	NOUN
fnp-2818	122	2	,	,	PUNCT
fnp-2818	122	3	behavior	behavior	NOUN
fnp-2818	122	4	,	,	PUNCT
fnp-2818	122	5	and	and	CCONJ
fnp-2818	122	6	immunity	immunity	NOUN
fnp-2818	122	7	.	.	PUNCT
fnp-2818	123	1	2020	2020	NUM
fnp-2818	123	2	;	;	PUNCT
fnp-2818	124	1	doi	doi	NOUN
fnp-2818	124	2	:	:	PUNCT
fnp-2818	124	3	10.1016	10.1016	NUM
fnp-2818	124	4	/	/	SYM
fnp-2818	124	5	j.bbi.2020.04.080	j.bbi.2020.04.080	PROPN
fnp-2818	124	6	16	16	NUM
fnp-2818	124	7	.	.	PUNCT
fnp-2818	125	1	leon	leon	PROPN
fnp-2818	125	2	fodoulian	fodoulian	PROPN
fnp-2818	125	3	jt	jt	PROPN
fnp-2818	125	4	,	,	PUNCT
fnp-2818	125	5	daniel	daniel	PROPN
fnp-2818	125	6	rossier	rossier	PROPN
fnp-2818	125	7	,	,	PUNCT
fnp-2818	125	8	basile	basile	PROPN
fnp-2818	125	9	n.	n.	PROPN
fnp-2818	125	10	landis	landis	PROPN
fnp-2818	125	11	,	,	PUNCT
fnp-2818	125	12	alan	alan	PROPN
fnp-2818	125	13	carleton	carleton	PROPN
fnp-2818	125	14	,	,	PUNCT
fnp-2818	125	15	ivan	ivan	PROPN
fnp-2818	125	16	rodriguez	rodriguez	PROPN
fnp-2818	125	17	.	.	PUNCT
fnp-2818	126	1	sars	sars	PROPN
fnp-2818	126	2	-	-	PUNCT
fnp-2818	126	3	cov-2	cov-2	NOUN
fnp-2818	126	4	receptor	receptor	NOUN
fnp-2818	126	5	and	and	CCONJ
fnp-2818	126	6	entry	entry	NOUN
fnp-2818	126	7	genes	gene	NOUN
fnp-2818	126	8	are	be	AUX
fnp-2818	126	9	expressed	express	VERB
fnp-2818	126	10	by	by	ADP
fnp-2818	126	11	sustentacular	sustentacular	ADJ
fnp-2818	126	12	cells	cell	NOUN
fnp-2818	126	13	in	in	ADP
fnp-2818	126	14	the	the	DET
fnp-2818	126	15	human	human	ADJ
fnp-2818	126	16	olfactory	olfactory	NOUN
fnp-2818	126	17	neuroepithelium.biorxiv2020.03.31.013268;doi	neuroepithelium.biorxiv2020.03.31.013268;doi	NOUN
fnp-2818	126	18	:	:	PUNCT
fnp-2818	126	19	https://doi.org/10.1101/2020.03.31.013268	https://doi.org/10.1101/2020.03.31.013268	NOUN
fnp-2818	126	20	17	17	NUM
fnp-2818	126	21	.	.	PUNCT
fnp-2818	127	1	desforges	desforge	NOUN
fnp-2818	127	2	m	m	PROPN
fnp-2818	127	3	,	,	PUNCT
fnp-2818	127	4	le	le	X
fnp-2818	127	5	coupanec	coupanec	PROPN
fnp-2818	127	6	a	a	PRON
fnp-2818	127	7	,	,	PUNCT
fnp-2818	127	8	dubeau	dubeau	NOUN
fnp-2818	127	9	p	p	NOUN
fnp-2818	127	10	,	,	PUNCT
fnp-2818	127	11	bourgouin	bourgouin	NOUN
fnp-2818	127	12	a	a	NOUN
fnp-2818	127	13	,	,	PUNCT
fnp-2818	127	14	lajoie	lajoie	PROPN
fnp-2818	127	15	l	l	PROPN
fnp-2818	127	16	,	,	PUNCT
fnp-2818	127	17	dube	dube	PROPN
fnp-2818	127	18	m	m	PROPN
fnp-2818	127	19	,	,	PUNCT
fnp-2818	127	20	talbot	talbot	PROPN
fnp-2818	127	21	pj	pj	PROPN
fnp-2818	127	22	.	.	PUNCT
fnp-2818	128	1	human	human	ADJ
fnp-2818	128	2	coronaviruses	coronaviruse	NOUN
fnp-2818	128	3	and	and	CCONJ
fnp-2818	128	4	other	other	ADJ
fnp-2818	128	5	respiratory	respiratory	ADJ
fnp-2818	128	6	viruses	virus	NOUN
fnp-2818	128	7	:	:	PUNCT
fnp-2818	128	8	underestimated	underestimate	VERB
fnp-2818	128	9	opportunistic	opportunistic	ADJ
fnp-2818	128	10	pathogens	pathogen	NOUN
fnp-2818	128	11	of	of	ADP
fnp-2818	128	12	the	the	DET
fnp-2818	128	13	central	central	ADJ
fnp-2818	128	14	nervous	nervous	ADJ
fnp-2818	128	15	system	system	NOUN
fnp-2818	128	16	?	?	PUNCT
fnp-2818	129	1	viruses	virus	NOUN
fnp-2818	129	2	.	.	PUNCT
fnp-2818	130	1	2019;12	2019;12	NUM
fnp-2818	130	2	18	18	NUM
fnp-2818	130	3	.	.	PUNCT
fnp-2818	131	1	matsuda	matsuda	PROPN
fnp-2818	131	2	k	k	PROPN
fnp-2818	131	3	,	,	PUNCT
fnp-2818	131	4	shibata	shibata	PROPN
fnp-2818	131	5	t	t	PROPN
fnp-2818	131	6	,	,	PUNCT
fnp-2818	131	7	sakoda	sakoda	PROPN
fnp-2818	131	8	y	y	PROPN
fnp-2818	131	9	,	,	PUNCT
fnp-2818	131	10	kida	kida	PROPN
fnp-2818	131	11	h	h	PROPN
fnp-2818	131	12	,	,	PUNCT
fnp-2818	131	13	kimura	kimura	PROPN
fnp-2818	131	14	t	t	PROPN
fnp-2818	131	15	,	,	PUNCT
fnp-2818	131	16	ochiai	ochiai	PROPN
fnp-2818	131	17	k	k	PROPN
fnp-2818	131	18	,	,	PUNCT
fnp-2818	131	19	umemura	umemura	PROPN
fnp-2818	131	20	t.	t.	PROPN
fnp-2818	131	21	in	in	ADP
fnp-2818	131	22	vitro	vitro	X
fnp-2818	131	23	demonstration	demonstration	NOUN
fnp-2818	131	24	of	of	ADP
fnp-2818	131	25	neural	neural	ADJ
fnp-2818	131	26	transmission	transmission	NOUN
fnp-2818	131	27	of	of	ADP
fnp-2818	131	28	avian	avian	ADJ
fnp-2818	131	29	influenza	influenza	NOUN
fnp-2818	131	30	a	a	DET
fnp-2818	131	31	virus	virus	NOUN
fnp-2818	131	32	.	.	PUNCT
fnp-2818	132	1	the	the	DET
fnp-2818	132	2	journal	journal	NOUN
fnp-2818	132	3	of	of	ADP
fnp-2818	132	4	general	general	ADJ
fnp-2818	132	5	virology	virology	NOUN
fnp-2818	132	6	.	.	PUNCT
fnp-2818	133	1	2005;86:1131	2005;86:1131	NUM
fnp-2818	133	2	-	-	SYM
fnp-2818	133	3	1139	1139	NUM
fnp-2818	133	4	19	19	NUM
fnp-2818	133	5	.	.	PUNCT
fnp-2818	134	1	csonka	csonka	PROPN
fnp-2818	134	2	t	t	PROPN
fnp-2818	134	3	,	,	PUNCT
fnp-2818	134	4	szepesi	szepesi	PROPN
fnp-2818	134	5	r	r	NOUN
fnp-2818	134	6	,	,	PUNCT
fnp-2818	134	7	bidiga	bidiga	ADJ
fnp-2818	134	8	l	l	NOUN
fnp-2818	134	9	,	,	PUNCT
fnp-2818	134	10	peter	peter	PROPN
fnp-2818	134	11	m	m	PROPN
fnp-2818	134	12	,	,	PUNCT
fnp-2818	134	13	klekner	klekner	X
fnp-2818	134	14	a	a	PRON
fnp-2818	134	15	,	,	PUNCT
fnp-2818	134	16	hutoczky	hutoczky	ADJ
fnp-2818	134	17	g	g	NOUN
fnp-2818	134	18	,	,	PUNCT
fnp-2818	134	19	csiba	csiba	PROPN
fnp-2818	134	20	l	l	PROPN
fnp-2818	134	21	,	,	PUNCT
fnp-2818	134	22	mehes	mehe	VERB
fnp-2818	134	23	g	g	PROPN
fnp-2818	134	24	,	,	PUNCT
fnp-2818	134	25	hortobagyi	hortobagyi	PROPN
fnp-2818	135	1	t.	t.	NOUN
fnp-2818	136	1	[	[	X
fnp-2818	136	2	the	the	DET
fnp-2818	136	3	diagnosis	diagnosis	NOUN
fnp-2818	136	4	of	of	ADP
fnp-2818	136	5	herpes	herpe	NOUN
fnp-2818	136	6	encephalitis	encephalitis	NOUN
fnp-2818	136	7	--	--	PUNCT
fnp-2818	136	8	a	a	DET
fnp-2818	136	9	case	case	NOUN
fnp-2818	136	10	-	-	PUNCT
fnp-2818	136	11	based	base	VERB
fnp-2818	136	12	update	update	NOUN
fnp-2818	136	13	]	]	X
fnp-2818	136	14	.	.	PUNCT
fnp-2818	137	1	ideggyogyaszati	ideggyogyaszati	PROPN
fnp-2818	137	2	szemle	szemle	NOUN
fnp-2818	137	3	.	.	PUNCT
fnp-2818	138	1	2013;66:337	2013;66:337	PROPN
fnp-2818	138	2	-	-	PUNCT
fnp-2818	138	3	342	342	NUM
fnp-2818	138	4	20	20	NUM
fnp-2818	138	5	.	.	PUNCT
fnp-2818	139	1	reinert	reinert	PROPN
fnp-2818	139	2	ls	ls	PROPN
fnp-2818	139	3	,	,	PUNCT
fnp-2818	139	4	lopusna	lopusna	PROPN
fnp-2818	139	5	k	k	PROPN
fnp-2818	139	6	,	,	PUNCT
fnp-2818	139	7	winther	winther	PROPN
fnp-2818	139	8	h	h	PROPN
fnp-2818	139	9	,	,	PUNCT
fnp-2818	139	10	sun	sun	PROPN
fnp-2818	139	11	c	c	PROPN
fnp-2818	139	12	,	,	PUNCT
fnp-2818	139	13	thomsen	thomsen	PROPN
fnp-2818	139	14	mk	mk	PROPN
fnp-2818	139	15	,	,	PUNCT
fnp-2818	139	16	nandakumar	nandakumar	PROPN
fnp-2818	139	17	r	r	PROPN
fnp-2818	139	18	,	,	PUNCT
fnp-2818	139	19	mogensen	mogensen	PROPN
fnp-2818	139	20	th	th	NOUN
fnp-2818	139	21	,	,	PUNCT
fnp-2818	139	22	meyer	meyer	PROPN
fnp-2818	139	23	m	m	PROPN
fnp-2818	139	24	,	,	PUNCT
fnp-2818	139	25	vaegter	vaegter	NOUN
fnp-2818	139	26	c	c	NOUN
fnp-2818	139	27	,	,	PUNCT
fnp-2818	139	28	nyengaard	nyengaard	PROPN
fnp-2818	139	29	jr	jr	PROPN
fnp-2818	139	30	,	,	PUNCT
fnp-2818	139	31	fitzgerald	fitzgerald	PROPN
fnp-2818	139	32	ka	ka	PROPN
fnp-2818	139	33	,	,	PUNCT
fnp-2818	139	34	paludan	paludan	PROPN
fnp-2818	139	35	sr	sr	PROPN
fnp-2818	139	36	.	.	PUNCT
fnp-2818	140	1	sensing	sense	VERB
fnp-2818	140	2	of	of	ADP
fnp-2818	140	3	hsv-1	hsv-1	X
fnp-2818	140	4	by	by	ADP
fnp-2818	140	5	the	the	DET
fnp-2818	140	6	cgas	cgas	ADV
fnp-2818	140	7	-	-	PUNCT
fnp-2818	140	8	sting	ste	VERB
fnp-2818	140	9	pathway	pathway	NOUN
fnp-2818	140	10	in	in	ADP
fnp-2818	140	11	microglia	microglia	NOUN
fnp-2818	140	12	orchestrates	orchestrates	AUX
fnp-2818	140	13	antiviral	antiviral	ADJ
fnp-2818	140	14	defence	defence	NOUN
fnp-2818	140	15	in	in	ADP
fnp-2818	140	16	the	the	DET
fnp-2818	140	17	cns	cns	PROPN
fnp-2818	140	18	.	.	PUNCT
fnp-2818	141	1	nature	nature	PROPN
fnp-2818	141	2	communications	communication	NOUN
fnp-2818	141	3	.	.	PUNCT
fnp-2818	142	1	2016;7:13348	2016;7:13348	PROPN
fnp-2818	142	2	21	21	NUM
fnp-2818	142	3	.	.	PUNCT
fnp-2818	143	1	fekete	fekete	PROPN
fnp-2818	143	2	r	r	PROPN
fnp-2818	143	3	,	,	PUNCT
fnp-2818	143	4	cserep	cserep	NOUN
fnp-2818	143	5	c	c	PROPN
fnp-2818	143	6	,	,	PUNCT
fnp-2818	143	7	lenart	lenart	ADJ
fnp-2818	143	8	n	n	CCONJ
fnp-2818	143	9	,	,	PUNCT
fnp-2818	143	10	toth	toth	PROPN
fnp-2818	143	11	k	k	PROPN
fnp-2818	143	12	,	,	PUNCT
fnp-2818	143	13	orsolits	orsolits	PROPN
fnp-2818	143	14	b	b	NOUN
fnp-2818	143	15	,	,	PUNCT
fnp-2818	143	16	martinecz	martinecz	ADJ
fnp-2818	143	17	b	b	NOUN
fnp-2818	143	18	,	,	PUNCT
fnp-2818	143	19	mehes	mehes	ADP
fnp-2818	143	20	e	e	NOUN
fnp-2818	143	21	,	,	PUNCT
fnp-2818	143	22	szabo	szabo	PROPN
fnp-2818	143	23	b	b	PROPN
fnp-2818	143	24	,	,	PUNCT
fnp-2818	143	25	nemeth	nemeth	PROPN
fnp-2818	143	26	v	v	PROPN
fnp-2818	143	27	,	,	PUNCT
fnp-2818	143	28	gonci	gonci	PROPN
fnp-2818	143	29	b	b	PROPN
fnp-2818	143	30	,	,	PUNCT
fnp-2818	143	31	sperlagh	sperlagh	PROPN
fnp-2818	143	32	b	b	NUM
fnp-2818	143	33	,	,	PUNCT
fnp-2818	143	34	boldogkoi	boldogkoi	PROPN
fnp-2818	143	35	z	z	PROPN
fnp-2818	143	36	,	,	PUNCT
fnp-2818	143	37	kittel	kittel	PROPN
fnp-2818	143	38	a	a	PROPN
fnp-2818	143	39	,	,	PUNCT
fnp-2818	143	40	baranyi	baranyi	PROPN
fnp-2818	143	41	m	m	PROPN
fnp-2818	143	42	,	,	PUNCT
fnp-2818	143	43	ferenczi	ferenczi	PROPN
fnp-2818	143	44	s	s	PROPN
fnp-2818	143	45	,	,	PUNCT
fnp-2818	143	46	kovacs	kovacs	PROPN
fnp-2818	143	47	k	k	PROPN
fnp-2818	143	48	,	,	PUNCT
fnp-2818	143	49	szalay	szalay	NOUN
fnp-2818	143	50	g	g	NOUN
fnp-2818	143	51	,	,	PUNCT
fnp-2818	143	52	rozsa	rozsa	NOUN
fnp-2818	143	53	b	b	PROPN
fnp-2818	143	54	,	,	PUNCT
fnp-2818	143	55	webb	webb	PROPN
fnp-2818	143	56	c	c	PROPN
fnp-2818	143	57	,	,	PUNCT
fnp-2818	143	58	kovacs	kovacs	PROPN
fnp-2818	143	59	gg	gg	PROPN
fnp-2818	143	60	,	,	PUNCT
fnp-2818	143	61	hortobagyi	hortobagyi	PROPN
fnp-2818	143	62	t	t	PROPN
fnp-2818	143	63	,	,	PUNCT
fnp-2818	143	64	west	west	PROPN
fnp-2818	143	65	bl	bl	PROPN
fnp-2818	143	66	,	,	PUNCT
fnp-2818	143	67	kornyei	kornyei	PROPN
fnp-2818	143	68	z	z	PROPN
fnp-2818	143	69	,	,	PUNCT
fnp-2818	143	70	denes	dene	VERB
fnp-2818	143	71	a.	a.	NOUN
fnp-2818	143	72	microglia	microglia	PROPN
fnp-2818	143	73	control	control	VERB
fnp-2818	143	74	the	the	DET
fnp-2818	143	75	spread	spread	NOUN
fnp-2818	143	76	of	of	ADP
fnp-2818	143	77	neurotropic	neurotropic	ADJ
fnp-2818	143	78	virus	virus	NOUN
fnp-2818	143	79	infection	infection	NOUN
fnp-2818	143	80	via	via	ADP
fnp-2818	143	81	p2y12	p2y12	NOUN
fnp-2818	143	82	signalling	signalling	NOUN
fnp-2818	143	83	and	and	CCONJ
fnp-2818	143	84	recruit	recruit	NOUN
fnp-2818	143	85	monocytes	monocyte	VERB
fnp-2818	143	86	through	through	ADP
fnp-2818	143	87	p2y12	p2y12	ADJ
fnp-2818	143	88	-	-	PUNCT
fnp-2818	143	89	independent	independent	ADJ
fnp-2818	143	90	mechanisms	mechanism	NOUN
fnp-2818	143	91	.	.	PUNCT
fnp-2818	144	1	acta	acta	PROPN
fnp-2818	144	2	neuropathologica	neuropathologica	PROPN
fnp-2818	144	3	.	.	PUNCT
fnp-2818	145	1	2018;136:461	2018;136:461	PROPN
fnp-2818	145	2	-	-	SYM
fnp-2818	145	3	482	482	NUM
fnp-2818	145	4	22	22	NUM
fnp-2818	145	5	.	.	PUNCT
fnp-2818	146	1	drokhlyansky	drokhlyansky	PROPN
fnp-2818	146	2	e	e	PROPN
fnp-2818	146	3	,	,	PUNCT
fnp-2818	146	4	goz	goz	PROPN
fnp-2818	146	5	ayturk	ayturk	PROPN
fnp-2818	146	6	d	d	PROPN
fnp-2818	146	7	,	,	PUNCT
fnp-2818	146	8	soh	soh	PROPN
fnp-2818	146	9	tk	tk	PROPN
fnp-2818	146	10	,	,	PUNCT
fnp-2818	146	11	chrenek	chrenek	NOUN
fnp-2818	146	12	r	r	NOUN
fnp-2818	146	13	,	,	PUNCT
fnp-2818	146	14	o'loughlin	o'loughlin	PROPN
fnp-2818	146	15	e	e	PROPN
fnp-2818	146	16	,	,	PUNCT
fnp-2818	146	17	madore	madore	VERB
fnp-2818	146	18	c	c	NOUN
fnp-2818	146	19	,	,	PUNCT
fnp-2818	146	20	butovsky	butovsky	ADJ
fnp-2818	146	21	o	o	NOUN
fnp-2818	146	22	,	,	PUNCT
fnp-2818	146	23	cepko	cepko	VERB
fnp-2818	146	24	cl	cl	NOUN
fnp-2818	146	25	.	.	PUNCT
fnp-2818	147	1	the	the	DET
fnp-2818	147	2	brain	brain	NOUN
fnp-2818	147	3	parenchyma	parenchyma	NOUN
fnp-2818	147	4	has	have	VERB
fnp-2818	147	5	a	a	DET
fnp-2818	147	6	type	type	NOUN
fnp-2818	147	7	i	i	PRON
fnp-2818	147	8	interferon	interferon	ADJ
fnp-2818	147	9	response	response	NOUN
fnp-2818	147	10	that	that	PRON
fnp-2818	147	11	can	can	AUX
fnp-2818	147	12	limit	limit	VERB
fnp-2818	147	13	virus	virus	NOUN
fnp-2818	147	14	spread	spread	VERB
fnp-2818	147	15	.	.	PUNCT
fnp-2818	148	1	proceedings	proceeding	NOUN
fnp-2818	148	2	of	of	ADP
fnp-2818	148	3	the	the	DET
fnp-2818	148	4	national	national	PROPN
fnp-2818	148	5	academy	academy	PROPN
fnp-2818	148	6	of	of	ADP
fnp-2818	148	7	sciences	sciences	PROPN
fnp-2818	148	8	of	of	ADP
fnp-2818	148	9	the	the	DET
fnp-2818	148	10	united	united	PROPN
fnp-2818	148	11	states	states	PROPN
fnp-2818	148	12	of	of	ADP
fnp-2818	148	13	america	america	PROPN
fnp-2818	148	14	.	.	PUNCT
fnp-2818	149	1	2017;114	2017;114	NUM
fnp-2818	149	2	:	:	PUNCT
fnp-2818	149	3	e95	e95	PROPN
fnp-2818	149	4	-	-	PUNCT
fnp-2818	149	5	e104	e104	PROPN
fnp-2818	149	6	23	23	NUM
fnp-2818	149	7	.	.	PUNCT
fnp-2818	150	1	wheeler	wheeler	PROPN
fnp-2818	150	2	dl	dl	PROPN
fnp-2818	150	3	,	,	PUNCT
fnp-2818	150	4	sariol	sariol	VERB
fnp-2818	150	5	a	a	PRON
fnp-2818	150	6	,	,	PUNCT
fnp-2818	150	7	meyerholz	meyerholz	PROPN
fnp-2818	150	8	dk	dk	PROPN
fnp-2818	150	9	,	,	PUNCT
fnp-2818	150	10	perlman	perlman	PROPN
fnp-2818	150	11	s.	s.	PROPN
fnp-2818	150	12	microglia	microglia	PROPN
fnp-2818	150	13	are	be	AUX
fnp-2818	150	14	required	require	VERB
fnp-2818	150	15	for	for	ADP
fnp-2818	150	16	protection	protection	NOUN
fnp-2818	150	17	against	against	ADP
fnp-2818	150	18	lethal	lethal	ADJ
fnp-2818	150	19	coronavirus	coronavirus	NOUN
fnp-2818	150	20	encephalitis	encephalitis	NOUN
fnp-2818	150	21	in	in	ADP
fnp-2818	150	22	mice	mouse	NOUN
fnp-2818	150	23	.	.	PUNCT
fnp-2818	151	1	the	the	DET
fnp-2818	151	2	journal	journal	NOUN
fnp-2818	151	3	of	of	ADP
fnp-2818	151	4	clinical	clinical	ADJ
fnp-2818	151	5	investigation	investigation	NOUN
fnp-2818	151	6	.	.	PUNCT
fnp-2818	152	1	2018;128:931	2018;128:931	X
fnp-2818	152	2	-	-	SYM
fnp-2818	152	3	943	943	NUM
fnp-2818	152	4	24	24	NUM
fnp-2818	152	5	.	.	PUNCT
fnp-2818	153	1	waltl	waltl	PROPN
fnp-2818	153	2	i	i	PROPN
fnp-2818	153	3	,	,	PUNCT
fnp-2818	153	4	kaufer	kaufer	PROPN
fnp-2818	153	5	c	c	PROPN
fnp-2818	153	6	,	,	PUNCT
fnp-2818	153	7	gerhauser	gerhauser	NOUN
fnp-2818	153	8	i	i	NOUN
fnp-2818	153	9	,	,	PUNCT
fnp-2818	153	10	chhatbar	chhatbar	PROPN
fnp-2818	153	11	c	c	PROPN
fnp-2818	153	12	,	,	PUNCT
fnp-2818	153	13	ghita	ghita	PROPN
fnp-2818	153	14	l	l	PROPN
fnp-2818	153	15	,	,	PUNCT
fnp-2818	153	16	kalinke	kalinke	PROPN
fnp-2818	153	17	u	u	NOUN
fnp-2818	153	18	,	,	PUNCT
fnp-2818	153	19	loscher	loscher	PROPN
fnp-2818	153	20	w.	w.	PROPN
fnp-2818	153	21	microglia	microglia	PROPN
fnp-2818	153	22	have	have	VERB
fnp-2818	153	23	a	a	DET
fnp-2818	153	24	protective	protective	ADJ
fnp-2818	153	25	role	role	NOUN
fnp-2818	153	26	in	in	ADP
fnp-2818	153	27	viral	viral	ADJ
fnp-2818	153	28	encephalitis	encephalitis	NOUN
fnp-2818	153	29	-	-	PUNCT
fnp-2818	153	30	induced	induce	VERB
fnp-2818	153	31	seizure	seizure	NOUN
fnp-2818	153	32	development	development	NOUN
fnp-2818	153	33	and	and	CCONJ
fnp-2818	153	34	hippocampal	hippocampal	ADJ
fnp-2818	153	35	damage	damage	NOUN
fnp-2818	153	36	.	.	PUNCT
fnp-2818	154	1	brain	brain	NOUN
fnp-2818	154	2	,	,	PUNCT
fnp-2818	154	3	behavior	behavior	NOUN
fnp-2818	154	4	,	,	PUNCT
fnp-2818	154	5	and	and	CCONJ
fnp-2818	154	6	immunity	immunity	NOUN
fnp-2818	154	7	.	.	PUNCT
fnp-2818	155	1	2018;74:186	2018;74:186	NOUN
fnp-2818	155	2	-	-	SYM
fnp-2818	155	3	204	204	NUM
fnp-2818	155	4	25	25	NUM
fnp-2818	155	5	.	.	PUNCT
fnp-2818	156	1	dubbelaar	dubbelaar	PROPN
fnp-2818	156	2	ml	ml	NOUN
fnp-2818	156	3	,	,	PUNCT
fnp-2818	156	4	kracht	kracht	PROPN
fnp-2818	156	5	l	l	PROPN
fnp-2818	156	6	,	,	PUNCT
fnp-2818	156	7	eggen	eggen	NOUN
fnp-2818	156	8	bjl	bjl	NOUN
fnp-2818	156	9	,	,	PUNCT
fnp-2818	156	10	boddeke	boddeke	PROPN
fnp-2818	156	11	e.	e.	PROPN
fnp-2818	156	12	the	the	DET
fnp-2818	156	13	kaleidoscope	kaleidoscope	NOUN
fnp-2818	156	14	of	of	ADP
fnp-2818	156	15	microglial	microglial	ADJ
fnp-2818	156	16	phenotypes	phenotype	NOUN
fnp-2818	156	17	.	.	PUNCT
fnp-2818	157	1	frontiers	frontier	NOUN
fnp-2818	157	2	in	in	ADP
fnp-2818	157	3	immunology	immunology	NOUN
fnp-2818	157	4	.	.	PUNCT
fnp-2818	158	1	2018;9:1753	2018;9:1753	NOUN
fnp-2818	158	2	26	26	NUM
fnp-2818	158	3	.	.	PUNCT
fnp-2818	159	1	moore	moore	PROPN
fnp-2818	159	2	jb	jb	PROPN
fnp-2818	159	3	,	,	PUNCT
fnp-2818	159	4	june	june	PROPN
fnp-2818	159	5	ch	ch	PROPN
fnp-2818	159	6	.	.	PROPN
fnp-2818	159	7	cytokine	cytokine	PROPN
fnp-2818	159	8	release	release	NOUN
fnp-2818	159	9	syndrome	syndrome	NOUN
fnp-2818	159	10	in	in	ADP
fnp-2818	159	11	severe	severe	ADJ
fnp-2818	159	12	covid-19	covid-19	PROPN
fnp-2818	159	13	.	.	PUNCT
fnp-2818	159	14	science	science	PROPN
fnp-2818	159	15	.	.	PUNCT
fnp-2818	160	1	2020;368:473	2020;368:473	NUM
fnp-2818	160	2	-	-	SYM
fnp-2818	160	3	474	474	NUM
fnp-2818	160	4	27	27	NUM
fnp-2818	160	5	.	.	PUNCT
fnp-2818	161	1	lippi	lippi	PROPN
fnp-2818	161	2	g	g	PROPN
fnp-2818	161	3	,	,	PUNCT
fnp-2818	161	4	wong	wong	PROPN
fnp-2818	161	5	j	j	PROPN
fnp-2818	161	6	,	,	PUNCT
fnp-2818	161	7	henry	henry	PROPN
fnp-2818	161	8	bm	bm	PROPN
fnp-2818	161	9	.	.	PUNCT
fnp-2818	161	10	hypertension	hypertension	NOUN
fnp-2818	161	11	and	and	CCONJ
fnp-2818	161	12	its	its	PRON
fnp-2818	161	13	severity	severity	NOUN
fnp-2818	161	14	or	or	CCONJ
fnp-2818	161	15	mortality	mortality	NOUN
fnp-2818	161	16	in	in	ADP
fnp-2818	161	17	coronavirus	coronavirus	NOUN
fnp-2818	161	18	disease	disease	NOUN
fnp-2818	161	19	2019	2019	NUM
fnp-2818	161	20	(	(	PUNCT
fnp-2818	161	21	covid-19	covid-19	PROPN
fnp-2818	161	22	):	):	PUNCT
fnp-2818	161	23	a	a	DET
fnp-2818	161	24	pooled	pooled	ADJ
fnp-2818	161	25	analysis	analysis	NOUN
fnp-2818	161	26	.	.	PUNCT
fnp-2818	162	1	polish	polish	ADJ
fnp-2818	162	2	archives	archive	NOUN
fnp-2818	162	3	of	of	ADP
fnp-2818	162	4	internal	internal	ADJ
fnp-2818	162	5	medicine	medicine	NOUN
fnp-2818	162	6	.	.	PUNCT
fnp-2818	163	1	2020;130:304‐309	2020;130:304‐309	NUM
fnp-2818	163	2	.	.	PUNCT
fnp-2818	164	1	doi:10.20452	doi:10.20452	NOUN
fnp-2818	164	2	/	/	SYM
fnp-2818	164	3	pamw.152722020	pamw.152722020	VERB
fnp-2818	164	4	28	28	NUM
fnp-2818	164	5	.	.	PUNCT
fnp-2818	165	1	terpos	terpos	NOUN
fnp-2818	165	2	e	e	NOUN
fnp-2818	165	3	,	,	PUNCT
fnp-2818	165	4	ntanasis	ntanasis	NOUN
fnp-2818	165	5	-	-	PUNCT
fnp-2818	165	6	stathopoulos	stathopoulo	NOUN
fnp-2818	165	7	i	i	PRON
fnp-2818	165	8	,	,	PUNCT
fnp-2818	165	9	elalamy	elalamy	VERB
fnp-2818	165	10	i	i	PRON
fnp-2818	165	11	,	,	PUNCT
fnp-2818	165	12	kastritis	kastritis	PROPN
fnp-2818	165	13	e	e	PROPN
fnp-2818	165	14	,	,	PUNCT
fnp-2818	165	15	sergentanis	sergentanis	PROPN
fnp-2818	165	16	tn	tn	PROPN
fnp-2818	165	17	,	,	PUNCT
fnp-2818	165	18	politou	politou	NOUN
fnp-2818	165	19	m	m	PROPN
fnp-2818	165	20	,	,	PUNCT
fnp-2818	165	21	psaltopoulou	psaltopoulou	PROPN
fnp-2818	165	22	t	t	PROPN
fnp-2818	165	23	,	,	PUNCT
fnp-2818	165	24	gerotziafas	gerotziafas	NOUN
fnp-2818	165	25	g	g	NOUN
fnp-2818	165	26	,	,	PUNCT
fnp-2818	165	27	dimopoulos	dimopoulos	PROPN
fnp-2818	165	28	ma	ma	PROPN
fnp-2818	165	29	.	.	PROPN
fnp-2818	165	30	hematological	hematological	ADJ
fnp-2818	165	31	findings	finding	NOUN
fnp-2818	165	32	and	and	CCONJ
fnp-2818	165	33	complications	complication	NOUN
fnp-2818	165	34	of	of	ADP
fnp-2818	165	35	covid-19	covid-19	PROPN
fnp-2818	165	36	.	.	PUNCT
fnp-2818	166	1	american	american	PROPN
fnp-2818	166	2	journal	journal	PROPN
fnp-2818	166	3	of	of	ADP
fnp-2818	166	4	hematology	hematology	NOUN
fnp-2818	166	5	.	.	PUNCT
fnp-2818	167	1	2020;10.1002	2020;10.1002	NUM
fnp-2818	167	2	/	/	SYM
fnp-2818	167	3	ajh.25829	ajh.25829	NOUN
fnp-2818	167	4	.	.	PUNCT
fnp-2818	167	5	doi:10.1002	doi:10.1002	NOUN
fnp-2818	167	6	/	/	SYM
fnp-2818	167	7	ajh.25829	ajh.25829	ADP
fnp-2818	167	8	29	29	NUM
fnp-2818	167	9	.	.	PUNCT
fnp-2818	168	1	miller	miller	PROPN
fnp-2818	168	2	ec	ec	PROPN
fnp-2818	168	3	,	,	PUNCT
fnp-2818	168	4	elkind	elkind	PROPN
fnp-2818	168	5	ms	ms	PROPN
fnp-2818	168	6	.	.	PROPN
fnp-2818	168	7	infection	infection	NOUN
fnp-2818	168	8	and	and	CCONJ
fnp-2818	168	9	stroke	stroke	NOUN
fnp-2818	168	10	:	:	PUNCT
fnp-2818	168	11	an	an	DET
fnp-2818	168	12	update	update	NOUN
fnp-2818	168	13	on	on	ADP
fnp-2818	168	14	recent	recent	ADJ
fnp-2818	168	15	progress	progress	NOUN
fnp-2818	168	16	.	.	PUNCT
fnp-2818	169	1	current	current	ADJ
fnp-2818	169	2	neurology	neurology	NOUN
fnp-2818	169	3	and	and	CCONJ
fnp-2818	169	4	neuroscience	neuroscience	NOUN
fnp-2818	169	5	reports	report	NOUN
fnp-2818	169	6	.	.	PUNCT
fnp-2818	170	1	2016;16:2	2016;16:2	NUM
fnp-2818	170	2	30	30	NUM
fnp-2818	170	3	.	.	PUNCT
fnp-2818	171	1	zhou	zhou	PROPN
fnp-2818	171	2	f	f	PROPN
fnp-2818	171	3	,	,	PUNCT
fnp-2818	171	4	yu	yu	PROPN
fnp-2818	171	5	t	t	PROPN
fnp-2818	171	6	,	,	PUNCT
fnp-2818	171	7	du	du	PROPN
fnp-2818	171	8	r	r	PROPN
fnp-2818	171	9	,	,	PUNCT
fnp-2818	171	10	fan	fan	NOUN
fnp-2818	171	11	g	g	NOUN
fnp-2818	171	12	,	,	PUNCT
fnp-2818	171	13	liu	liu	PROPN
fnp-2818	171	14	y	y	PROPN
fnp-2818	171	15	,	,	PUNCT
fnp-2818	171	16	liu	liu	PROPN
fnp-2818	171	17	z	z	PROPN
fnp-2818	171	18	,	,	PUNCT
fnp-2818	171	19	xiang	xiang	PROPN
fnp-2818	171	20	j	j	PROPN
fnp-2818	171	21	,	,	PUNCT
fnp-2818	171	22	wang	wang	PROPN
fnp-2818	171	23	y	y	PROPN
fnp-2818	171	24	,	,	PUNCT
fnp-2818	171	25	song	song	PROPN
fnp-2818	171	26	b	b	PROPN
fnp-2818	171	27	,	,	PUNCT
fnp-2818	171	28	gu	gu	NOUN
fnp-2818	171	29	x	x	PROPN
fnp-2818	171	30	,	,	PUNCT
fnp-2818	171	31	guan	guan	PROPN
fnp-2818	171	32	l	l	PROPN
fnp-2818	171	33	,	,	PUNCT
fnp-2818	171	34	wei	wei	PROPN
fnp-2818	171	35	y	y	PROPN
fnp-2818	171	36	,	,	PUNCT
fnp-2818	171	37	li	li	PROPN
fnp-2818	171	38	h	h	PROPN
fnp-2818	171	39	,	,	PUNCT
fnp-2818	171	40	wu	wu	PROPN
fnp-2818	171	41	x	x	PROPN
fnp-2818	171	42	,	,	PUNCT
fnp-2818	171	43	xu	xu	PROPN
fnp-2818	171	44	j	j	PROPN
fnp-2818	171	45	,	,	PUNCT
fnp-2818	171	46	tu	tu	PROPN
fnp-2818	171	47	s	s	PROPN
fnp-2818	171	48	,	,	PUNCT
fnp-2818	171	49	zhang	zhang	PROPN
fnp-2818	171	50	y	y	PROPN
fnp-2818	171	51	,	,	PUNCT
fnp-2818	171	52	chen	chen	PROPN
fnp-2818	171	53	h	h	PROPN
fnp-2818	171	54	,	,	PUNCT
fnp-2818	171	55	cao	cao	PROPN
fnp-2818	171	56	b.	b.	PROPN
fnp-2818	171	57	clinical	clinical	ADJ
fnp-2818	171	58	course	course	NOUN
fnp-2818	171	59	and	and	CCONJ
fnp-2818	171	60	risk	risk	NOUN
fnp-2818	171	61	factors	factor	NOUN
fnp-2818	171	62	for	for	ADP
fnp-2818	171	63	mortality	mortality	NOUN
fnp-2818	171	64	of	of	ADP
fnp-2818	171	65	adult	adult	NOUN
fnp-2818	171	66	inpatients	inpatient	NOUN
fnp-2818	171	67	with	with	ADP
fnp-2818	171	68	covid-19	covid-19	PROPN
fnp-2818	171	69	in	in	ADP
fnp-2818	171	70	wuhan	wuhan	PROPN
fnp-2818	171	71	,	,	PUNCT
fnp-2818	171	72	china	china	PROPN
fnp-2818	171	73	:	:	PUNCT
fnp-2818	171	74	a	a	DET
fnp-2818	171	75	retrospective	retrospective	ADJ
fnp-2818	171	76	cohort	cohort	NOUN
fnp-2818	171	77	study	study	NOUN
fnp-2818	171	78	.	.	PUNCT
fnp-2818	172	1	lancet	lancet	PROPN
fnp-2818	172	2	.	.	PUNCT
fnp-2818	173	1	2020;395:1054	2020;395:1054	NUM
fnp-2818	173	2	-	-	SYM
fnp-2818	173	3	1062	1062	NUM
fnp-2818	173	4	31	31	NUM
fnp-2818	173	5	.	.	PUNCT
fnp-2818	173	6	tang	tang	PROPN
fnp-2818	173	7	n	n	CCONJ
fnp-2818	173	8	,	,	PUNCT
fnp-2818	173	9	li	li	PROPN
fnp-2818	173	10	d	d	PROPN
fnp-2818	173	11	,	,	PUNCT
fnp-2818	173	12	wang	wang	PROPN
fnp-2818	173	13	x	x	PROPN
fnp-2818	173	14	,	,	PUNCT
fnp-2818	173	15	sun	sun	PROPN
fnp-2818	173	16	z.	z.	PROPN
fnp-2818	173	17	abnormal	abnormal	ADJ
fnp-2818	173	18	coagulation	coagulation	NOUN
fnp-2818	173	19	parameters	parameter	NOUN
fnp-2818	173	20	are	be	AUX
fnp-2818	173	21	associated	associate	VERB
fnp-2818	173	22	with	with	ADP
fnp-2818	173	23	poor	poor	ADJ
fnp-2818	173	24	prognosis	prognosis	NOUN
fnp-2818	173	25	in	in	ADP
fnp-2818	173	26	patients	patient	NOUN
fnp-2818	173	27	with	with	ADP
fnp-2818	173	28	novel	novel	ADJ
fnp-2818	173	29	coronavirus	coronavirus	NOUN
fnp-2818	173	30	pneumonia	pneumonia	NOUN
fnp-2818	173	31	.	.	PUNCT
fnp-2818	174	1	journal	journal	PROPN
fnp-2818	174	2	of	of	ADP
fnp-2818	174	3	thrombosis	thrombosis	NOUN
fnp-2818	174	4	and	and	CCONJ
fnp-2818	174	5	haemostasis	haemostasis	NOUN
fnp-2818	174	6	.	.	PUNCT
fnp-2818	175	1	2020;18:844	2020;18:844	NOUN
fnp-2818	175	2	-	-	SYM
fnp-2818	175	3	847	847	NUM
fnp-2818	175	4	32	32	NUM
fnp-2818	175	5	.	.	PUNCT
fnp-2818	176	1	klok	klok	PROPN
fnp-2818	176	2	fa	fa	PROPN
fnp-2818	176	3	,	,	PUNCT
fnp-2818	176	4	kruip	kruip	PROPN
fnp-2818	176	5	m	m	PROPN
fnp-2818	176	6	,	,	PUNCT
fnp-2818	176	7	van	van	PROPN
fnp-2818	176	8	der	der	PROPN
fnp-2818	176	9	meer	meer	PROPN
fnp-2818	176	10	njm	njm	PROPN
fnp-2818	176	11	,	,	PUNCT
fnp-2818	176	12	arbous	arbous	ADJ
fnp-2818	176	13	ms	ms	PROPN
fnp-2818	176	14	,	,	PUNCT
fnp-2818	176	15	gommers	gommer	NOUN
fnp-2818	176	16	d	d	PROPN
fnp-2818	176	17	,	,	PUNCT
fnp-2818	176	18	kant	kant	PROPN
fnp-2818	176	19	km	km	PROPN
fnp-2818	176	20	,	,	PUNCT
fnp-2818	176	21	kaptein	kaptein	PROPN
fnp-2818	176	22	fhj	fhj	PROPN
fnp-2818	176	23	,	,	PUNCT
fnp-2818	176	24	van	van	PROPN
fnp-2818	176	25	paassen	paassen	PROPN
fnp-2818	176	26	j	j	PROPN
fnp-2818	176	27	,	,	PUNCT
fnp-2818	176	28	stals	stals	PROPN
fnp-2818	176	29	mam	mam	PROPN
fnp-2818	176	30	,	,	PUNCT
fnp-2818	176	31	huisman	huisman	PROPN
fnp-2818	176	32	mv	mv	PROPN
fnp-2818	176	33	,	,	PUNCT
fnp-2818	176	34	endeman	endeman	PROPN
fnp-2818	176	35	h.	h.	PROPN
fnp-2818	176	36	incidence	incidence	NOUN
fnp-2818	176	37	of	of	ADP
fnp-2818	176	38	thrombotic	thrombotic	ADJ
fnp-2818	176	39	complications	complication	NOUN
fnp-2818	176	40	in	in	ADP
fnp-2818	176	41	critically	critically	ADV
fnp-2818	176	42	ill	ill	ADJ
fnp-2818	176	43	icu	icu	PROPN
fnp-2818	176	44	patients	patient	NOUN
fnp-2818	176	45	with	with	ADP
fnp-2818	176	46	covid-19	covid-19	PROPN
fnp-2818	177	1	.	.	PUNCT
fnp-2818	177	2	thrombosis	thrombosis	NOUN
fnp-2818	177	3	research	research	NOUN
fnp-2818	177	4	.	.	PUNCT
fnp-2818	178	1	2020;s0049	2020;s0049	NUM
fnp-2818	178	2	-	-	SYM
fnp-2818	178	3	3848(20)30120	3848(20)30120	NUM
fnp-2818	178	4	-	-	SYM
fnp-2818	178	5	1	1	NUM
fnp-2818	178	6	.	.	PUNCT
fnp-2818	178	7	doi:10.1016	doi:10.1016	PROPN
fnp-2818	178	8	/	/	SYM
fnp-2818	178	9	j.thromres.2020.04.013	j.thromres.2020.04.013	PROPN
fnp-2818	178	10	33	33	NUM
fnp-2818	178	11	.	.	PUNCT
fnp-2818	179	1	denes	denes	PROPN
fnp-2818	179	2	a	a	PRON
fnp-2818	179	3	,	,	PUNCT
fnp-2818	179	4	pradillo	pradillo	PROPN
fnp-2818	179	5	jm	jm	PROPN
fnp-2818	179	6	,	,	PUNCT
fnp-2818	179	7	drake	drake	PROPN
fnp-2818	179	8	c	c	X
fnp-2818	179	9	,	,	PUNCT
fnp-2818	179	10	sharp	sharp	ADV
fnp-2818	179	11	a	a	PRON
fnp-2818	179	12	,	,	PUNCT
fnp-2818	179	13	warn	warn	VERB
fnp-2818	179	14	p	p	PROPN
fnp-2818	179	15	,	,	PUNCT
fnp-2818	179	16	murray	murray	PROPN
fnp-2818	179	17	kn	kn	PROPN
fnp-2818	179	18	,	,	PUNCT
fnp-2818	179	19	rohit	rohit	PROPN
fnp-2818	179	20	b	b	NUM
fnp-2818	179	21	,	,	PUNCT
fnp-2818	179	22	dockrell	dockrell	NOUN
fnp-2818	179	23	dh	dh	NOUN
fnp-2818	179	24	,	,	PUNCT
fnp-2818	179	25	chamberlain	chamberlain	PROPN
fnp-2818	179	26	j	j	PROPN
fnp-2818	179	27	,	,	PUNCT
fnp-2818	179	28	casbolt	casbolt	NOUN
fnp-2818	179	29	h	h	NOUN
fnp-2818	179	30	,	,	PUNCT
fnp-2818	179	31	francis	francis	PROPN
fnp-2818	179	32	s	s	PROPN
fnp-2818	179	33	,	,	PUNCT
fnp-2818	179	34	martinecz	martinecz	PROPN
fnp-2818	179	35	b	b	NOUN
fnp-2818	179	36	,	,	PUNCT
fnp-2818	179	37	nieswandt	nieswandt	PROPN
fnp-2818	179	38	b	b	PROPN
fnp-2818	179	39	,	,	PUNCT
fnp-2818	179	40	rothwell	rothwell	PROPN
fnp-2818	179	41	nj	nj	PROPN
fnp-2818	179	42	,	,	PUNCT
fnp-2818	179	43	allan	allan	PROPN
fnp-2818	179	44	sm	sm	PROPN
fnp-2818	179	45	.	.	PROPN
fnp-2818	179	46	streptococcus	streptococcus	VERB
fnp-2818	179	47	pneumoniae	pneumoniae	ADJ
fnp-2818	179	48	worsens	worsens	ADJ
fnp-2818	179	49	cerebral	cerebral	ADJ
fnp-2818	179	50	ischemia	ischemia	NOUN
fnp-2818	179	51	via	via	ADP
fnp-2818	179	52	interleukin	interleukin	NOUN
fnp-2818	179	53	1	1	NUM
fnp-2818	179	54	and	and	CCONJ
fnp-2818	179	55	platelet	platelet	NOUN
fnp-2818	179	56	glycoprotein	glycoprotein	NOUN
fnp-2818	179	57	ib	ib	NOUN
fnp-2818	179	58	-	-	NOUN
fnp-2818	179	59	alpha	alpha	NOUN
fnp-2818	179	60	.	.	PUNCT
fnp-2818	180	1	annals	annal	NOUN
fnp-2818	180	2	of	of	ADP
fnp-2818	180	3	neurology	neurology	NOUN
fnp-2818	180	4	.	.	PUNCT
fnp-2818	181	1	2014;75:670	2014;75:670	NOUN
fnp-2818	181	2	-	-	SYM
fnp-2818	181	3	683	683	NUM
fnp-2818	181	4	34	34	NUM
fnp-2818	181	5	.	.	PUNCT
fnp-2818	182	1	denes	denes	PROPN
fnp-2818	182	2	a	a	PRON
fnp-2818	182	3	,	,	PUNCT
fnp-2818	182	4	humphreys	humphreys	PROPN
fnp-2818	182	5	n	n	CCONJ
fnp-2818	182	6	,	,	PUNCT
fnp-2818	182	7	lane	lane	NOUN
fnp-2818	182	8	te	te	PROPN
fnp-2818	182	9	,	,	PUNCT
fnp-2818	182	10	grencis	grencis	PROPN
fnp-2818	182	11	r	r	PROPN
fnp-2818	182	12	,	,	PUNCT
fnp-2818	182	13	rothwell	rothwell	PROPN
fnp-2818	182	14	n.	n.	PROPN
fnp-2818	182	15	chronic	chronic	PROPN
fnp-2818	182	16	systemic	systemic	ADJ
fnp-2818	182	17	infection	infection	NOUN
fnp-2818	182	18	exacerbates	exacerbate	VERB
fnp-2818	182	19	ischemic	ischemic	ADJ
fnp-2818	182	20	brain	brain	NOUN
fnp-2818	182	21	damage	damage	NOUN
fnp-2818	182	22	via	via	ADP
fnp-2818	182	23	a	a	DET
fnp-2818	182	24	ccl5	ccl5	NOUN
fnp-2818	182	25	(	(	PUNCT
fnp-2818	182	26	regulated	regulate	VERB
fnp-2818	182	27	on	on	ADP
fnp-2818	182	28	activation	activation	NOUN
fnp-2818	182	29	,	,	PUNCT
fnp-2818	182	30	normal	normal	ADJ
fnp-2818	182	31	t	t	NOUN
fnp-2818	182	32	-	-	PUNCT
fnp-2818	182	33	cell	cell	NOUN
fnp-2818	182	34	expressed	express	VERB
fnp-2818	182	35	and	and	CCONJ
fnp-2818	182	36	secreted)-mediated	secreted)-mediate	VERB
fnp-2818	182	37	proinflammatory	proinflammatory	ADJ
fnp-2818	182	38	response	response	NOUN
fnp-2818	182	39	in	in	ADP
fnp-2818	182	40	mice	mouse	NOUN
fnp-2818	182	41	.	.	PUNCT
fnp-2818	183	1	the	the	DET
fnp-2818	183	2	journal	journal	NOUN
fnp-2818	183	3	of	of	ADP
fnp-2818	183	4	neuroscience	neuroscience	NOUN
fnp-2818	183	5	.	.	PUNCT
fnp-2818	184	1	2010;30:10086	2010;30:10086	NUM
fnp-2818	184	2	-	-	SYM
fnp-2818	184	3	10095	10095	NUM
fnp-2818	184	4	35	35	NUM
fnp-2818	184	5	.	.	PUNCT
fnp-2818	185	1	muhammad	muhammad	PROPN
fnp-2818	185	2	s	s	PROPN
fnp-2818	185	3	,	,	PUNCT
fnp-2818	185	4	haasbach	haasbach	NOUN
fnp-2818	185	5	e	e	NOUN
fnp-2818	185	6	,	,	PUNCT
fnp-2818	185	7	kotchourko	kotchourko	PROPN
fnp-2818	185	8	m	m	PROPN
fnp-2818	185	9	,	,	PUNCT
fnp-2818	185	10	strigli	strigli	VERB
fnp-2818	185	11	a	a	NOUN
fnp-2818	185	12	,	,	PUNCT
fnp-2818	185	13	krenz	krenz	PROPN
fnp-2818	185	14	a	a	X
fnp-2818	185	15	,	,	PUNCT
fnp-2818	185	16	ridder	ridder	PROPN
fnp-2818	185	17	da	da	PROPN
fnp-2818	185	18	,	,	PUNCT
fnp-2818	185	19	vogel	vogel	PROPN
fnp-2818	185	20	ab	ab	PROPN
fnp-2818	185	21	,	,	PUNCT
fnp-2818	185	22	marti	marti	PROPN
fnp-2818	185	23	hh	hh	PROPN
fnp-2818	185	24	,	,	PUNCT
fnp-2818	185	25	al	al	PROPN
fnp-2818	185	26	-	-	PUNCT
fnp-2818	185	27	abed	abe	VERB
fnp-2818	185	28	y	y	PROPN
fnp-2818	185	29	,	,	PUNCT
fnp-2818	185	30	planz	planz	NOUN
fnp-2818	185	31	o	o	NOUN
fnp-2818	185	32	,	,	PUNCT
fnp-2818	185	33	schwaninger	schwaninger	NOUN
fnp-2818	185	34	m.	m.	PROPN
fnp-2818	185	35	influenza	influenza	PROPN
fnp-2818	185	36	virus	virus	PROPN
fnp-2818	185	37	infection	infection	NOUN
fnp-2818	185	38	aggravates	aggravate	VERB
fnp-2818	185	39	stroke	stroke	NOUN
fnp-2818	185	40	outcome	outcome	NOUN
fnp-2818	185	41	.	.	PUNCT
fnp-2818	186	1	stroke	stroke	NOUN
fnp-2818	186	2	.	.	PUNCT
fnp-2818	187	1	2011;42:783	2011;42:783	NUM
fnp-2818	187	2	-	-	SYM
fnp-2818	187	3	791	791	NUM
fnp-2818	187	4	36	36	NUM
fnp-2818	187	5	.	.	PUNCT
fnp-2818	188	1	mccann	mccann	PROPN
fnp-2818	188	2	sk	sk	PROPN
fnp-2818	188	3	,	,	PUNCT
fnp-2818	188	4	cramond	cramond	ADJ
fnp-2818	188	5	f	f	NOUN
fnp-2818	188	6	,	,	PUNCT
fnp-2818	188	7	macleod	macleod	PROPN
fnp-2818	188	8	mr	mr	PROPN
fnp-2818	188	9	,	,	PUNCT
fnp-2818	188	10	sena	sena	PROPN
fnp-2818	188	11	es	es	PROPN
fnp-2818	188	12	.	.	PUNCT
fnp-2818	188	13	systematic	systematic	ADJ
fnp-2818	188	14	review	review	NOUN
fnp-2818	188	15	and	and	CCONJ
fnp-2818	188	16	meta	meta	NOUN
fnp-2818	188	17	-	-	PUNCT
fnp-2818	188	18	analysis	analysis	NOUN
fnp-2818	188	19	of	of	ADP
fnp-2818	188	20	the	the	DET
fnp-2818	188	21	efficacy	efficacy	NOUN
fnp-2818	188	22	of	of	ADP
fnp-2818	188	23	interleukin-1	interleukin-1	NOUN
fnp-2818	188	24	receptor	receptor	NOUN
fnp-2818	188	25	antagonist	antagonist	NOUN
fnp-2818	188	26	in	in	ADP
fnp-2818	188	27	animal	animal	NOUN
fnp-2818	188	28	models	model	NOUN
fnp-2818	188	29	of	of	ADP
fnp-2818	188	30	stroke	stroke	NOUN
fnp-2818	188	31	:	:	PUNCT
fnp-2818	188	32	an	an	DET
fnp-2818	188	33	update	update	NOUN
fnp-2818	188	34	.	.	PUNCT
fnp-2818	189	1	translational	translational	ADJ
fnp-2818	189	2	stroke	stroke	NOUN
fnp-2818	189	3	research	research	NOUN
fnp-2818	189	4	.	.	PUNCT
fnp-2818	190	1	2016;7:395	2016;7:395	X
fnp-2818	190	2	-	-	PUNCT
fnp-2818	190	3	406	406	NUM
fnp-2818	190	4	37	37	NUM
fnp-2818	190	5	.	.	PUNCT
fnp-2818	191	1	bonetti	bonetti	PROPN
fnp-2818	191	2	nr	nr	PROPN
fnp-2818	191	3	,	,	PUNCT
fnp-2818	191	4	diaz	diaz	PROPN
fnp-2818	191	5	-	-	PUNCT
fnp-2818	191	6	canestro	canestro	PROPN
fnp-2818	191	7	c	c	PROPN
fnp-2818	191	8	,	,	PUNCT
fnp-2818	191	9	liberale	liberale	PROPN
fnp-2818	191	10	l	l	PROPN
fnp-2818	191	11	,	,	PUNCT
fnp-2818	191	12	crucet	crucet	PROPN
fnp-2818	191	13	m	m	PROPN
fnp-2818	191	14	,	,	PUNCT
fnp-2818	191	15	akhmedov	akhmedov	ADP
fnp-2818	191	16	a	a	DET
fnp-2818	191	17	,	,	PUNCT
fnp-2818	191	18	merlini	merlini	PROPN
fnp-2818	191	19	m	m	PROPN
fnp-2818	191	20	,	,	PUNCT
fnp-2818	191	21	reiner	reiner	NOUN
fnp-2818	191	22	mf	mf	PROPN
fnp-2818	191	23	,	,	PUNCT
fnp-2818	191	24	gobbato	gobbato	NOUN
fnp-2818	191	25	s	s	PROPN
fnp-2818	191	26	,	,	PUNCT
fnp-2818	191	27	stivala	stivala	PROPN
fnp-2818	191	28	s	s	PROPN
fnp-2818	191	29	,	,	PUNCT
fnp-2818	191	30	kollias	kollias	PROPN
fnp-2818	191	31	g	g	PROPN
fnp-2818	191	32	,	,	PUNCT
fnp-2818	191	33	ruschitzka	ruschitzka	PROPN
fnp-2818	191	34	f	f	PROPN
fnp-2818	191	35	,	,	PUNCT
fnp-2818	191	36	luscher	luscher	ADJ
fnp-2818	191	37	tf	tf	PROPN
fnp-2818	191	38	,	,	PUNCT
fnp-2818	191	39	beer	beer	PROPN
fnp-2818	191	40	jh	jh	PROPN
fnp-2818	191	41	,	,	PUNCT
fnp-2818	191	42	camici	camici	PROPN
fnp-2818	191	43	gg	gg	PROPN
fnp-2818	191	44	.	.	PUNCT
fnp-2818	192	1	tumour	tumour	NOUN
fnp-2818	192	2	necrosis	necrosis	NOUN
fnp-2818	192	3	factor	factor	NOUN
fnp-2818	192	4	-	-	PUNCT
fnp-2818	192	5	alpha	alpha	NOUN
fnp-2818	192	6	inhibition	inhibition	NOUN
fnp-2818	192	7	improves	improve	VERB
fnp-2818	192	8	stroke	stroke	NOUN
fnp-2818	192	9	outcome	outcome	NOUN
fnp-2818	192	10	in	in	ADP
fnp-2818	192	11	a	a	DET
fnp-2818	192	12	mouse	mouse	NOUN
fnp-2818	192	13	model	model	NOUN
fnp-2818	192	14	of	of	ADP
fnp-2818	192	15	rheumatoid	rheumatoid	NOUN
fnp-2818	192	16	arthritis	arthritis	NOUN
fnp-2818	192	17	.	.	PUNCT
fnp-2818	193	1	scientific	scientific	ADJ
fnp-2818	193	2	reports	report	NOUN
fnp-2818	193	3	.	.	PUNCT
fnp-2818	194	1	2019;9:2173	2019;9:2173	PROPN
fnp-2818	194	2	38	38	NUM
fnp-2818	194	3	.	.	PUNCT
fnp-2818	195	1	lambertsen	lambertsen	PROPN
fnp-2818	195	2	kl	kl	PROPN
fnp-2818	195	3	,	,	PUNCT
fnp-2818	195	4	finsen	finsen	NOUN
fnp-2818	195	5	b	b	NUM
fnp-2818	195	6	,	,	PUNCT
fnp-2818	195	7	clausen	clausen	PROPN
fnp-2818	195	8	bh	bh	PROPN
fnp-2818	195	9	.	.	PUNCT
fnp-2818	195	10	post	post	ADJ
fnp-2818	195	11	-	-	ADJ
fnp-2818	195	12	stroke	stroke	ADJ
fnp-2818	195	13	inflammation	inflammation	NOUN
fnp-2818	195	14	-	-	PUNCT
fnp-2818	195	15	target	target	NOUN
fnp-2818	195	16	or	or	CCONJ
fnp-2818	195	17	tool	tool	NOUN
fnp-2818	195	18	for	for	ADP
fnp-2818	195	19	therapy	therapy	NOUN
fnp-2818	195	20	?	?	PUNCT
fnp-2818	196	1	acta	acta	PROPN
fnp-2818	196	2	neuropathologica	neuropathologica	PROPN
fnp-2818	196	3	.	.	PUNCT
fnp-2818	197	1	2019;137:693	2019;137:693	NUM
fnp-2818	197	2	-	-	SYM
fnp-2818	197	3	714	714	NUM
fnp-2818	197	4	39	39	NUM
fnp-2818	197	5	.	.	PUNCT
fnp-2818	198	1	zhang	zhang	PROPN
fnp-2818	198	2	c	c	PROPN
fnp-2818	198	3	,	,	PUNCT
fnp-2818	198	4	wu	wu	PROPN
fnp-2818	198	5	z	z	PROPN
fnp-2818	198	6	,	,	PUNCT
fnp-2818	198	7	li	li	PROPN
fnp-2818	198	8	jw	jw	PROPN
fnp-2818	198	9	,	,	PUNCT
fnp-2818	198	10	zhao	zhao	PROPN
fnp-2818	198	11	h	h	PROPN
fnp-2818	198	12	,	,	PUNCT
fnp-2818	198	13	wang	wang	PROPN
fnp-2818	198	14	gq	gq	PROPN
fnp-2818	198	15	.	.	PUNCT
fnp-2818	199	1	the	the	DET
fnp-2818	199	2	cytokine	cytokine	NOUN
fnp-2818	199	3	release	release	NOUN
fnp-2818	199	4	syndrome	syndrome	NOUN
fnp-2818	199	5	(	(	PUNCT
fnp-2818	199	6	crs	crs	PROPN
fnp-2818	199	7	)	)	PUNCT
fnp-2818	199	8	of	of	ADP
fnp-2818	199	9	severe	severe	ADJ
fnp-2818	199	10	covid-19	covid-19	PROPN
fnp-2818	199	11	and	and	CCONJ
fnp-2818	199	12	interleukin-6	interleukin-6	NUM
fnp-2818	199	13	receptor	receptor	NOUN
fnp-2818	199	14	(	(	PUNCT
fnp-2818	199	15	il-6r	il-6r	ADJ
fnp-2818	199	16	)	)	PUNCT
fnp-2818	199	17	antagonist	antagonist	NOUN
fnp-2818	199	18	tocilizumab	tocilizumab	NOUN
fnp-2818	199	19	may	may	AUX
fnp-2818	199	20	be	be	AUX
fnp-2818	199	21	the	the	DET
fnp-2818	199	22	key	key	NOUN
fnp-2818	199	23	to	to	PART
fnp-2818	199	24	reduce	reduce	VERB
fnp-2818	199	25	the	the	DET
fnp-2818	199	26	mortality	mortality	NOUN
fnp-2818	199	27	.	.	PUNCT
fnp-2818	200	1	international	international	ADJ
fnp-2818	200	2	journal	journal	PROPN
fnp-2818	200	3	of	of	ADP
fnp-2818	200	4	antimicrobial	antimicrobial	ADJ
fnp-2818	200	5	agents	agent	NOUN
fnp-2818	200	6	.	.	PUNCT
fnp-2818	201	1	2020:105954	2020:105954	NUM
fnp-2818	201	2	40	40	NUM
fnp-2818	201	3	.	.	PUNCT
fnp-2818	202	1	zhang	zhang	PROPN
fnp-2818	202	2	y	y	PROPN
fnp-2818	202	3	,	,	PUNCT
fnp-2818	202	4	xiao	xiao	PROPN
fnp-2818	202	5	m	m	PROPN
fnp-2818	202	6	,	,	PUNCT
fnp-2818	202	7	zhang	zhang	PROPN
fnp-2818	202	8	s	s	PROPN
fnp-2818	202	9	,	,	PUNCT
fnp-2818	202	10	xia	xia	PROPN
fnp-2818	202	11	p	p	PROPN
fnp-2818	202	12	,	,	PUNCT
fnp-2818	202	13	cao	cao	PROPN
fnp-2818	202	14	w	w	PROPN
fnp-2818	202	15	,	,	PUNCT
fnp-2818	202	16	jiang	jiang	PROPN
fnp-2818	202	17	w	w	PROPN
fnp-2818	202	18	,	,	PUNCT
fnp-2818	202	19	chen	chen	PROPN
fnp-2818	202	20	h	h	PROPN
fnp-2818	202	21	,	,	PUNCT
fnp-2818	202	22	ding	de	VERB
fnp-2818	202	23	x	x	SYM
fnp-2818	202	24	,	,	PUNCT
fnp-2818	202	25	zhao	zhao	PROPN
fnp-2818	202	26	h	h	PROPN
fnp-2818	202	27	,	,	PUNCT
fnp-2818	202	28	zhang	zhang	PROPN
fnp-2818	202	29	h	h	PROPN
fnp-2818	202	30	,	,	PUNCT
fnp-2818	202	31	wang	wang	PROPN
fnp-2818	202	32	c	c	PROPN
fnp-2818	202	33	,	,	PUNCT
fnp-2818	202	34	zhao	zhao	PROPN
fnp-2818	202	35	j	j	PROPN
fnp-2818	202	36	,	,	PUNCT
fnp-2818	202	37	sun	sun	PROPN
fnp-2818	202	38	x	x	SYM
fnp-2818	202	39	,	,	PUNCT
fnp-2818	202	40	tian	tian	ADJ
fnp-2818	202	41	r	r	PROPN
fnp-2818	202	42	,	,	PUNCT
fnp-2818	202	43	wu	wu	PROPN
fnp-2818	202	44	w	w	PROPN
fnp-2818	202	45	,	,	PUNCT
fnp-2818	202	46	wu	wu	PROPN
fnp-2818	202	47	d	d	PROPN
fnp-2818	202	48	,	,	PUNCT
fnp-2818	202	49	ma	ma	PROPN
fnp-2818	202	50	j	j	PROPN
fnp-2818	202	51	,	,	PUNCT
fnp-2818	202	52	chen	chen	PROPN
fnp-2818	202	53	y	y	PROPN
fnp-2818	202	54	,	,	PUNCT
fnp-2818	202	55	zhang	zhang	PROPN
fnp-2818	202	56	d	d	PROPN
fnp-2818	202	57	,	,	PUNCT
fnp-2818	202	58	xie	xie	PROPN
fnp-2818	202	59	j	j	PROPN
fnp-2818	202	60	,	,	PUNCT
fnp-2818	202	61	yan	yan	PROPN
fnp-2818	202	62	x	x	X
fnp-2818	202	63	,	,	PUNCT
fnp-2818	202	64	zhou	zhou	PROPN
fnp-2818	202	65	x	x	PROPN
fnp-2818	202	66	,	,	PUNCT
fnp-2818	202	67	liu	liu	PROPN
fnp-2818	202	68	z	z	PROPN
fnp-2818	202	69	,	,	PUNCT
fnp-2818	202	70	wang	wang	PROPN
fnp-2818	202	71	j	j	PROPN
fnp-2818	202	72	,	,	PUNCT
fnp-2818	202	73	du	du	PROPN
fnp-2818	202	74	b	b	PROPN
fnp-2818	202	75	,	,	PUNCT
fnp-2818	202	76	qin	qin	PROPN
fnp-2818	202	77	y	y	PROPN
fnp-2818	202	78	,	,	PUNCT
fnp-2818	202	79	gao	gao	PROPN
fnp-2818	202	80	p	p	X
fnp-2818	202	81	,	,	PUNCT
fnp-2818	202	82	qin	qin	PROPN
fnp-2818	202	83	x	x	PROPN
fnp-2818	202	84	,	,	PUNCT
fnp-2818	202	85	xu	xu	PROPN
fnp-2818	202	86	y	y	PROPN
fnp-2818	202	87	,	,	PUNCT
fnp-2818	202	88	zhang	zhang	PROPN
fnp-2818	202	89	w	w	PROPN
fnp-2818	202	90	,	,	PUNCT
fnp-2818	202	91	li	li	PROPN
fnp-2818	202	92	t	t	PROPN
fnp-2818	202	93	,	,	PUNCT
fnp-2818	202	94	zhang	zhang	PROPN
fnp-2818	202	95	f	f	PROPN
fnp-2818	202	96	,	,	PUNCT
fnp-2818	202	97	zhao	zhao	PROPN
fnp-2818	202	98	y	y	PROPN
fnp-2818	202	99	,	,	PUNCT
fnp-2818	202	100	li	li	PROPN
fnp-2818	202	101	y.	y.	PROPN
fnp-2818	202	102	coagulopathy	coagulopathy	ADJ
fnp-2818	202	103	and	and	CCONJ
fnp-2818	202	104	antiphospholipid	antiphospholipid	NOUN
fnp-2818	202	105	antibodies	antibody	NOUN
fnp-2818	202	106	in	in	ADP
fnp-2818	202	107	patients	patient	NOUN
fnp-2818	202	108	with	with	ADP
fnp-2818	202	109	covid-19	covid-19	PROPN
fnp-2818	202	110	.	.	PUNCT
fnp-2818	203	1	the	the	DET
fnp-2818	203	2	new	new	PROPN
fnp-2818	203	3	england	england	PROPN
fnp-2818	203	4	journal	journal	PROPN
fnp-2818	203	5	of	of	ADP
fnp-2818	203	6	medicine	medicine	NOUN
fnp-2818	203	7	.	.	PUNCT
fnp-2818	204	1	2020;382	2020;382	NUM
fnp-2818	204	2	:	:	PUNCT
fnp-2818	204	3	e38	e38	PROPN
fnp-2818	204	4	41	41	NUM
fnp-2818	204	5	.	.	PUNCT
fnp-2818	205	1	beyrouti	beyrouti	PROPN
fnp-2818	205	2	r	r	PROPN
fnp-2818	205	3	,	,	PUNCT
fnp-2818	205	4	adams	adams	PROPN
fnp-2818	205	5	me	i	PRON
fnp-2818	205	6	,	,	PUNCT
fnp-2818	205	7	benjamin	benjamin	PROPN
fnp-2818	205	8	l	l	PROPN
fnp-2818	205	9	,	,	PUNCT
fnp-2818	205	10	cohen	cohen	PROPN
fnp-2818	205	11	h	h	PROPN
fnp-2818	205	12	,	,	PUNCT
fnp-2818	205	13	farmer	farmer	PROPN
fnp-2818	205	14	sf	sf	PROPN
fnp-2818	205	15	,	,	PUNCT
fnp-2818	205	16	goh	goh	PROPN
fnp-2818	205	17	yy	yy	PROPN
fnp-2818	205	18	,	,	PUNCT
fnp-2818	205	19	humphries	humphries	PROPN
fnp-2818	205	20	f	f	PROPN
fnp-2818	205	21	,	,	PUNCT
fnp-2818	205	22	jager	jager	PROPN
fnp-2818	205	23	hr	hr	PROPN
fnp-2818	205	24	,	,	PUNCT
fnp-2818	205	25	losseff	losseff	PROPN
fnp-2818	205	26	na	na	PROPN
fnp-2818	205	27	,	,	PUNCT
fnp-2818	205	28	perry	perry	PROPN
fnp-2818	205	29	rj	rj	PROPN
fnp-2818	205	30	,	,	PUNCT
fnp-2818	205	31	shah	shah	PROPN
fnp-2818	205	32	s	s	PROPN
fnp-2818	205	33	,	,	PUNCT
fnp-2818	205	34	simister	simister	PROPN
fnp-2818	205	35	rj	rj	PROPN
fnp-2818	205	36	,	,	PUNCT
fnp-2818	206	1	turner	turner	PROPN
fnp-2818	206	2	d	d	PROPN
fnp-2818	206	3	,	,	PUNCT
fnp-2818	206	4	chandratheva	chandratheva	VERB
fnp-2818	206	5	a	a	PRON
fnp-2818	206	6	,	,	PUNCT
fnp-2818	206	7	werring	werring	NOUN
fnp-2818	206	8	dj	dj	NOUN
fnp-2818	206	9	.	.	PUNCT
fnp-2818	207	1	characteristics	characteristic	NOUN
fnp-2818	207	2	of	of	ADP
fnp-2818	207	3	ischaemic	ischaemic	ADJ
fnp-2818	207	4	stroke	stroke	NOUN
fnp-2818	207	5	associated	associate	VERB
fnp-2818	207	6	with	with	ADP
fnp-2818	207	7	covid-19	covid-19	PROPN
fnp-2818	207	8	.	.	PROPN
fnp-2818	207	9	journal	journal	PROPN
fnp-2818	207	10	of	of	ADP
fnp-2818	207	11	neurology	neurology	NOUN
fnp-2818	207	12	,	,	PUNCT
fnp-2818	207	13	neurosurgery	neurosurgery	NOUN
fnp-2818	207	14	,	,	PUNCT
fnp-2818	207	15	and	and	CCONJ
fnp-2818	207	16	psychiatry	psychiatry	NOUN
fnp-2818	207	17	.	.	PUNCT
fnp-2818	208	1	2020;jnnp-2020	2020;jnnp-2020	NUM
fnp-2818	208	2	-	-	SYM
fnp-2818	208	3	323586	323586	NUM
fnp-2818	208	4	.	.	PUNCT
fnp-2818	209	1	doi:10.1136	doi:10.1136	NOUN
fnp-2818	209	2	/	/	SYM
fnp-2818	209	3	jnnp-2020	jnnp-2020	PROPN
fnp-2818	209	4	-	-	PUNCT
fnp-2818	209	5	323586	323586	NUM
fnp-2818	209	6	42	42	NUM
fnp-2818	209	7	.	.	PUNCT
fnp-2818	210	1	kandemirli	kandemirli	PROPN
fnp-2818	210	2	sg	sg	PROPN
fnp-2818	210	3	,	,	PUNCT
fnp-2818	210	4	dogan	dogan	PROPN
fnp-2818	210	5	l	l	PROPN
fnp-2818	210	6	,	,	PUNCT
fnp-2818	210	7	sarikaya	sarikaya	PROPN
fnp-2818	210	8	zt	zt	PROPN
fnp-2818	210	9	,	,	PUNCT
fnp-2818	210	10	kara	kara	PROPN
fnp-2818	210	11	s	s	PROPN
fnp-2818	210	12	,	,	PUNCT
fnp-2818	210	13	akinci	akinci	PROPN
fnp-2818	210	14	c	c	PROPN
fnp-2818	210	15	,	,	PUNCT
fnp-2818	210	16	kaya	kaya	PROPN
fnp-2818	210	17	d	d	PROPN
fnp-2818	210	18	,	,	PUNCT
fnp-2818	210	19	kaya	kaya	PROPN
fnp-2818	210	20	y	y	PROPN
fnp-2818	210	21	,	,	PUNCT
fnp-2818	210	22	yildirim	yildirim	PROPN
fnp-2818	210	23	d	d	PROPN
fnp-2818	210	24	,	,	PUNCT
fnp-2818	210	25	tuzuner	tuzuner	NOUN
fnp-2818	210	26	f	f	PROPN
fnp-2818	210	27	,	,	PUNCT
fnp-2818	210	28	yildirim	yildirim	PROPN
fnp-2818	210	29	ms	ms	PROPN
fnp-2818	210	30	,	,	PUNCT
fnp-2818	210	31	ozluk	ozluk	PROPN
fnp-2818	210	32	e	e	PROPN
fnp-2818	210	33	,	,	PUNCT
fnp-2818	210	34	gucyetmez	gucyetmez	VERB
fnp-2818	210	35	b	b	NOUN
fnp-2818	210	36	,	,	PUNCT
fnp-2818	210	37	karaarslan	karaarslan	X
fnp-2818	210	38	e	e	PROPN
fnp-2818	210	39	,	,	PUNCT
fnp-2818	210	40	koyluoglu	koyluoglu	PROPN
fnp-2818	210	41	i	i	PROPN
fnp-2818	210	42	,	,	PUNCT
fnp-2818	210	43	demirel	demirel	PROPN
fnp-2818	210	44	kaya	kaya	PROPN
fnp-2818	210	45	hs	hs	PROPN
fnp-2818	210	46	,	,	PUNCT
fnp-2818	210	47	mammadov	mammadov	PROPN
fnp-2818	210	48	o	o	NOUN
fnp-2818	210	49	,	,	PUNCT
fnp-2818	210	50	kisa	kisa	PROPN
fnp-2818	210	51	ozdemir	ozdemir	PROPN
fnp-2818	210	52	i	i	PROPN
fnp-2818	210	53	,	,	PUNCT
fnp-2818	210	54	afsar	afsar	PROPN
fnp-2818	210	55	n	n	CCONJ
fnp-2818	210	56	,	,	PUNCT
fnp-2818	210	57	citci	citci	PROPN
fnp-2818	210	58	yalcinkaya	yalcinkaya	PROPN
fnp-2818	210	59	b	b	PROPN
fnp-2818	210	60	,	,	PUNCT
fnp-2818	210	61	rasimoglu	rasimoglu	PROPN
fnp-2818	210	62	s	s	PROPN
fnp-2818	210	63	,	,	PUNCT
fnp-2818	210	64	guduk	guduk	PROPN
fnp-2818	210	65	de	de	PROPN
fnp-2818	210	66	,	,	PUNCT
fnp-2818	210	67	kedir	kedir	PROPN
fnp-2818	210	68	jima	jima	PROPN
fnp-2818	210	69	a	a	PROPN
fnp-2818	210	70	,	,	PUNCT
fnp-2818	210	71	ilksoz	ilksoz	NOUN
fnp-2818	210	72	a	a	PRON
fnp-2818	210	73	,	,	PUNCT
fnp-2818	210	74	ersoz	ersoz	NOUN
fnp-2818	210	75	v	v	NOUN
fnp-2818	210	76	,	,	PUNCT
fnp-2818	210	77	yonca	yonca	PROPN
fnp-2818	210	78	eren	eren	PROPN
fnp-2818	210	79	m	m	PROPN
fnp-2818	210	80	,	,	PUNCT
fnp-2818	210	81	celtik	celtik	NOUN
fnp-2818	210	82	n	n	CCONJ
fnp-2818	210	83	,	,	PUNCT
fnp-2818	210	84	arslan	arslan	PROPN
fnp-2818	210	85	s	s	PART
fnp-2818	210	86	,	,	PUNCT
fnp-2818	210	87	korkmazer	korkmazer	PROPN
fnp-2818	210	88	b	b	PROPN
fnp-2818	210	89	,	,	PUNCT
fnp-2818	210	90	dincer	dincer	PROPN
fnp-2818	210	91	ss	ss	PROPN
fnp-2818	210	92	,	,	PUNCT
fnp-2818	210	93	gulek	gulek	NOUN
fnp-2818	210	94	e	e	NOUN
fnp-2818	210	95	,	,	PUNCT
fnp-2818	210	96	dikmen	dikman	NOUN
fnp-2818	210	97	i	i	PRON
fnp-2818	210	98	,	,	PUNCT
fnp-2818	210	99	yazici	yazici	PROPN
fnp-2818	210	100	m	m	PROPN
fnp-2818	210	101	,	,	PUNCT
fnp-2818	210	102	unsal	unsal	PROPN
fnp-2818	210	103	s	s	PROPN
fnp-2818	210	104	,	,	PUNCT
fnp-2818	210	105	ljama	ljama	PROPN
fnp-2818	210	106	t	t	PROPN
fnp-2818	210	107	,	,	PUNCT
fnp-2818	210	108	demirel	demirel	NOUN
fnp-2818	210	109	i	i	PRON
fnp-2818	210	110	,	,	PUNCT
fnp-2818	210	111	ayyildiz	ayyildiz	PROPN
fnp-2818	210	112	a	a	PRON
fnp-2818	210	113	,	,	PUNCT
fnp-2818	210	114	kesimci	kesimci	VERB
fnp-2818	210	115	i	i	PRON
fnp-2818	210	116	,	,	PUNCT
fnp-2818	210	117	bolsoy	bolsoy	VERB
fnp-2818	210	118	deveci	deveci	PROPN
fnp-2818	210	119	s	s	PROPN
fnp-2818	210	120	,	,	PUNCT
fnp-2818	210	121	tutuncu	tutuncu	PROPN
fnp-2818	210	122	m	m	PROPN
fnp-2818	210	123	,	,	PUNCT
fnp-2818	210	124	kizilkilic	kizilkilic	ADJ
fnp-2818	210	125	o	o	NOUN
fnp-2818	210	126	,	,	PUNCT
fnp-2818	210	127	telci	telci	NOUN
fnp-2818	210	128	l	l	NOUN
fnp-2818	210	129	,	,	PUNCT
fnp-2818	210	130	zengin	zengin	VERB
fnp-2818	210	131	r	r	NOUN
fnp-2818	210	132	,	,	PUNCT
fnp-2818	210	133	dincer	dincer	NOUN
fnp-2818	210	134	a	a	NOUN
fnp-2818	210	135	,	,	PUNCT
fnp-2818	210	136	akinci	akinci	PROPN
fnp-2818	210	137	io	io	PROPN
fnp-2818	210	138	,	,	PUNCT
fnp-2818	210	139	kocer	kocer	PROPN
fnp-2818	210	140	n.	n.	PROPN
fnp-2818	210	141	brain	brain	NOUN
fnp-2818	210	142	mri	mri	NOUN
fnp-2818	210	143	findings	finding	NOUN
fnp-2818	210	144	in	in	ADP
fnp-2818	210	145	patients	patient	NOUN
fnp-2818	210	146	in	in	ADP
fnp-2818	210	147	the	the	DET
fnp-2818	210	148	intensive	intensive	ADJ
fnp-2818	210	149	care	care	NOUN
fnp-2818	210	150	unit	unit	NOUN
fnp-2818	210	151	with	with	ADP
fnp-2818	210	152	covid-19	covid-19	PROPN
fnp-2818	210	153	infection	infection	NOUN
fnp-2818	210	154	.	.	PUNCT
fnp-2818	211	1	radiology	radiology	NOUN
fnp-2818	211	2	.	.	PUNCT
fnp-2818	212	1	2020:201697	2020:201697	NUM
fnp-2818	212	2	43	43	NUM
fnp-2818	212	3	.	.	PUNCT
fnp-2818	213	1	bulfamante	bulfamante	PROPN
fnp-2818	213	2	g	g	PROPN
fnp-2818	213	3	,	,	PUNCT
fnp-2818	213	4	chiumello	chiumello	PROPN
fnp-2818	213	5	d	d	PROPN
fnp-2818	213	6	,	,	PUNCT
fnp-2818	213	7	canevini	canevini	PROPN
fnp-2818	213	8	mp	mp	PROPN
fnp-2818	213	9	,	,	PUNCT
fnp-2818	213	10	priori	priori	X
fnp-2818	213	11	a	a	PRON
fnp-2818	213	12	,	,	PUNCT
fnp-2818	213	13	mazzanti	mazzanti	PROPN
fnp-2818	213	14	m	m	PROPN
fnp-2818	213	15	,	,	PUNCT
fnp-2818	213	16	centanni	centanni	PROPN
fnp-2818	213	17	s	s	PROPN
fnp-2818	213	18	,	,	PUNCT
fnp-2818	213	19	felisati	felisati	PROPN
fnp-2818	213	20	g.	g.	PROPN
fnp-2818	213	21	first	first	PROPN
fnp-2818	213	22	ultrastructural	ultrastructural	ADJ
fnp-2818	213	23	autoptic	autoptic	ADJ
fnp-2818	213	24	findings	finding	NOUN
fnp-2818	213	25	of	of	ADP
fnp-2818	213	26	sars	sar	NOUN
fnp-2818	213	27	-	-	PUNCT
fnp-2818	213	28	cov-2	cov-2	NOUN
fnp-2818	213	29	in	in	ADP
fnp-2818	213	30	olfactory	olfactory	ADJ
fnp-2818	213	31	pathways	pathway	NOUN
fnp-2818	213	32	and	and	CCONJ
fnp-2818	213	33	brainstem	brainstem	NOUN
fnp-2818	213	34	.	.	PUNCT
fnp-2818	214	1	minerva	minerva	PROPN
fnp-2818	214	2	anestesiologica	anestesiologica	PROPN
fnp-2818	214	3	.	.	PUNCT
fnp-2818	215	1	2020;10.23736	2020;10.23736	NUM
fnp-2818	215	2	/	/	SYM
fnp-2818	215	3	s0375	s0375	VERB
fnp-2818	215	4	-	-	PUNCT
fnp-2818	215	5	9393.20.14772	9393.20.14772	NUM
fnp-2818	215	6	-	-	SYM
fnp-2818	215	7	2	2	NUM
fnp-2818	215	8	.	.	NUM
fnp-2818	215	9	44	44	NUM
fnp-2818	215	10	.	.	PUNCT
fnp-2818	216	1	laurendon	laurendon	PROPN
fnp-2818	216	2	t	t	PROPN
fnp-2818	216	3	,	,	PUNCT
fnp-2818	216	4	radulesco	radulesco	PROPN
fnp-2818	216	5	t	t	PROPN
fnp-2818	216	6	,	,	PUNCT
fnp-2818	216	7	mugnier	mugnier	PROPN
fnp-2818	216	8	j	j	PROPN
fnp-2818	216	9	,	,	PUNCT
fnp-2818	216	10	gerault	gerault	PROPN
fnp-2818	216	11	m	m	PROPN
fnp-2818	216	12	,	,	PUNCT
fnp-2818	216	13	chagnaud	chagnaud	ADJ
fnp-2818	216	14	c	c	PROPN
fnp-2818	216	15	,	,	PUNCT
fnp-2818	216	16	el	el	PROPN
fnp-2818	216	17	ahmadi	ahmadi	PROPN
fnp-2818	216	18	aa	aa	PROPN
fnp-2818	216	19	,	,	PUNCT
fnp-2818	216	20	varoquaux	varoquaux	PROPN
fnp-2818	216	21	a.	a.	PROPN
fnp-2818	216	22	bilateral	bilateral	ADJ
fnp-2818	216	23	transient	transient	ADJ
fnp-2818	216	24	olfactory	olfactory	ADJ
fnp-2818	216	25	bulbs	bulb	NOUN
fnp-2818	216	26	edema	edema	NOUN
fnp-2818	216	27	during	during	ADP
fnp-2818	216	28	covid-19	covid-19	PROPN
fnp-2818	216	29	-	-	PUNCT
fnp-2818	216	30	related	relate	VERB
fnp-2818	216	31	anosmia	anosmia	NOUN
fnp-2818	216	32	.	.	PUNCT
fnp-2818	217	1	neurology	neurology	NOUN
fnp-2818	217	2	.	.	PUNCT
fnp-2818	218	1	may	may	AUX
fnp-2818	218	2	22	22	NUM
fnp-2818	218	3	,	,	PUNCT
fnp-2818	218	4	2020	2020	NUM
fnp-2818	218	5	;	;	PUNCT
fnp-2818	218	6	10.1212	10.1212	NUM
fnp-2818	218	7	/	/	SYM
fnp-2818	218	8	wnl.0000000000009850	wnl.0000000000009850	SYM
fnp-2818	218	9	45	45	NUM
fnp-2818	218	10	.	.	PUNCT
fnp-2818	218	11	galanopoulou	galanopoulou	PROPN
fnp-2818	218	12	as	as	ADP
fnp-2818	218	13	,	,	PUNCT
fnp-2818	218	14	ferastraoaru	ferastraoaru	NOUN
fnp-2818	218	15	v	v	NOUN
fnp-2818	218	16	,	,	PUNCT
fnp-2818	218	17	correa	correa	PROPN
fnp-2818	218	18	dj	dj	PROPN
fnp-2818	218	19	,	,	PUNCT
fnp-2818	218	20	cherian	cherian	PROPN
fnp-2818	218	21	k	k	NOUN
fnp-2818	218	22	,	,	PUNCT
fnp-2818	218	23	duberstein	duberstein	NOUN
fnp-2818	218	24	s	s	PROPN
fnp-2818	218	25	,	,	PUNCT
fnp-2818	218	26	gursky	gursky	PROPN
fnp-2818	218	27	j	j	PROPN
fnp-2818	218	28	,	,	PUNCT
fnp-2818	218	29	hanumanthu	hanumanthu	ADJ
fnp-2818	218	30	r	r	NOUN
fnp-2818	218	31	,	,	PUNCT
fnp-2818	218	32	hung	hang	VERB
fnp-2818	218	33	c	c	PROPN
fnp-2818	218	34	,	,	PUNCT
fnp-2818	218	35	molinero	molinero	PROPN
fnp-2818	218	36	i	i	PROPN
fnp-2818	218	37	,	,	PUNCT
fnp-2818	218	38	khodakivska	khodakivska	PROPN
fnp-2818	218	39	o	o	PROPN
fnp-2818	218	40	,	,	PUNCT
fnp-2818	218	41	legatt	legatt	ADJ
fnp-2818	218	42	ad	ad	NOUN
fnp-2818	218	43	,	,	PUNCT
fnp-2818	218	44	patel	patel	NOUN
fnp-2818	218	45	p	p	NOUN
fnp-2818	218	46	,	,	PUNCT
fnp-2818	218	47	rosengard	rosengard	PROPN
fnp-2818	218	48	j	j	PROPN
fnp-2818	218	49	,	,	PUNCT
fnp-2818	218	50	rubens	rubens	PROPN
fnp-2818	218	51	e	e	NOUN
fnp-2818	218	52	,	,	PUNCT
fnp-2818	218	53	sugrue	sugrue	PROPN
fnp-2818	218	54	w	w	PROPN
fnp-2818	218	55	,	,	PUNCT
fnp-2818	218	56	yozawitz	yozawitz	PROPN
fnp-2818	218	57	e	e	NOUN
fnp-2818	218	58	,	,	PUNCT
fnp-2818	218	59	mehler	mehler	NOUN
fnp-2818	218	60	mf	mf	NOUN
fnp-2818	218	61	,	,	PUNCT
fnp-2818	218	62	ballaban‐gil	ballaban‐gil	PROPN
fnp-2818	218	63	k	k	PROPN
fnp-2818	218	64	,	,	PUNCT
fnp-2818	218	65	haut	haut	PROPN
fnp-2818	218	66	sr	sr	PROPN
fnp-2818	218	67	,	,	PUNCT
fnp-2818	218	68	moshé	moshé	PROPN
fnp-2818	218	69	sl	sl	PROPN
fnp-2818	218	70	,	,	PUNCT
fnp-2818	218	71	boro	boro	PROPN
fnp-2818	218	72	a.	a.	NOUN
fnp-2818	218	73	eeg	eeg	PROPN
fnp-2818	218	74	findings	finding	NOUN
fnp-2818	218	75	in	in	ADP
fnp-2818	218	76	acutely	acutely	ADV
fnp-2818	218	77	ill	ill	ADJ
fnp-2818	218	78	patients	patient	NOUN
fnp-2818	218	79	investigated	investigate	VERB
fnp-2818	218	80	for	for	ADP
fnp-2818	218	81	sars	sar	NOUN
fnp-2818	218	82	-	-	PUNCT
fnp-2818	218	83	cov-2	cov-2	NOUN
fnp-2818	218	84	/	/	SYM
fnp-2818	218	85	covid-19	covid-19	PROPN
fnp-2818	218	86	:	:	PUNCT
fnp-2818	218	87	a	a	DET
fnp-2818	218	88	small	small	ADJ
fnp-2818	218	89	case	case	NOUN
fnp-2818	218	90	series	series	NOUN
fnp-2818	218	91	preliminary	preliminary	ADJ
fnp-2818	218	92	report	report	NOUN
fnp-2818	218	93	.	.	PUNCT
fnp-2818	219	1	epilepsia	epilepsia	NOUN
fnp-2818	219	2	open	open	NOUN
fnp-2818	219	3	.	.	PUNCT
fnp-2818	220	1	2020	2020	NUM
fnp-2818	220	2	;	;	PUNCT
fnp-2818	220	3	https://doi.org/10.1002/epi4.12399	https://doi.org/10.1002/epi4.12399	NOUN
fnp-2818	220	4	46	46	NUM
fnp-2818	220	5	.	.	PUNCT
fnp-2818	221	1	remy	remy	PROPN
fnp-2818	221	2	ke	ke	PROPN
fnp-2818	221	3	,	,	PUNCT
fnp-2818	221	4	brakenridge	brakenridge	PROPN
fnp-2818	221	5	sc	sc	PROPN
fnp-2818	221	6	,	,	PUNCT
fnp-2818	221	7	francois	francois	PROPN
fnp-2818	221	8	b	b	PROPN
fnp-2818	221	9	,	,	PUNCT
fnp-2818	221	10	daix	daix	PROPN
fnp-2818	221	11	t	t	PROPN
fnp-2818	221	12	,	,	PUNCT
fnp-2818	221	13	deutschman	deutschman	PROPN
fnp-2818	221	14	cs	cs	PROPN
fnp-2818	221	15	,	,	PUNCT
fnp-2818	221	16	monneret	monneret	NOUN
fnp-2818	221	17	g	g	PROPN
fnp-2818	221	18	,	,	PUNCT
fnp-2818	221	19	jeannet	jeannet	NOUN
fnp-2818	221	20	r	r	NOUN
fnp-2818	221	21	,	,	PUNCT
fnp-2818	221	22	laterre	laterre	ADJ
fnp-2818	221	23	pf	pf	PROPN
fnp-2818	221	24	,	,	PUNCT
fnp-2818	221	25	hotchkiss	hotchkiss	PROPN
fnp-2818	221	26	rs	rs	PROPN
fnp-2818	221	27	,	,	PUNCT
fnp-2818	221	28	moldawer	moldawer	NOUN
fnp-2818	221	29	ll	ll	NOUN
fnp-2818	221	30	.	.	PUNCT
fnp-2818	222	1	immunotherapies	immunotherapy	NOUN
fnp-2818	222	2	for	for	ADP
fnp-2818	222	3	covid-19	covid-19	PROPN
fnp-2818	222	4	:	:	PUNCT
fnp-2818	222	5	lessons	lesson	NOUN
fnp-2818	222	6	learned	learn	VERB
fnp-2818	222	7	from	from	ADP
fnp-2818	222	8	sepsis	sepsis	NOUN
fnp-2818	222	9	.	.	PUNCT
fnp-2818	223	1	lancet	lancet	ADJ
fnp-2818	223	2	respiratory	respiratory	ADJ
fnp-2818	223	3	medicine	medicine	NOUN
fnp-2818	223	4	.	.	PUNCT
fnp-2818	224	1	2020;s2213	2020;s2213	NUM
fnp-2818	224	2	-	-	SYM
fnp-2818	224	3	2600(20)30217	2600(20)30217	NUM
fnp-2818	224	4	-	-	SYM
fnp-2818	224	5	4	4	NUM
fnp-2818	224	6	.	.	PUNCT
fnp-2818	224	7	doi:10.1016	doi:10.1016	PROPN
fnp-2818	224	8	/	/	SYM
fnp-2818	224	9	s2213	s2213	PROPN
fnp-2818	224	10	-	-	PUNCT
fnp-2818	224	11	2600(20)30217	2600(20)30217	NUM
fnp-2818	224	12	-	-	SYM
fnp-2818	224	13	4	4	NUM
fnp-2818	224	14	copyright	copyright	NOUN
fnp-2818	224	15	:	:	PUNCT
fnp-2818	224	16	©	©	PROPN
fnp-2818	224	17	2020	2020	NUM
fnp-2818	224	18	the	the	DET
fnp-2818	224	19	author(s	author(s	NOUN
fnp-2818	224	20	)	)	PUNCT
fnp-2818	224	21	.	.	PUNCT
fnp-2818	225	1	this	this	PRON
fnp-2818	225	2	is	be	AUX
fnp-2818	225	3	an	an	DET
fnp-2818	225	4	open	open	ADJ
fnp-2818	225	5	access	access	NOUN
fnp-2818	225	6	article	article	NOUN
fnp-2818	225	7	distributed	distribute	VERB
fnp-2818	225	8	under	under	ADP
fnp-2818	225	9	the	the	DET
fnp-2818	225	10	terms	term	NOUN
fnp-2818	225	11	of	of	ADP
fnp-2818	225	12	the	the	DET
fnp-2818	225	13	creative	creative	ADJ
fnp-2818	225	14	commons	common	NOUN
fnp-2818	225	15	attribution	attribution	NOUN
fnp-2818	225	16	4.0	4.0	NUM
fnp-2818	225	17	international	international	ADJ
fnp-2818	225	18	license	license	NOUN
fnp-2818	225	19	(	(	PUNCT
fnp-2818	225	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-2818	225	21	)	)	PUNCT
fnp-2818	225	22	,	,	PUNCT
fnp-2818	225	23	which	which	PRON
fnp-2818	225	24	permits	permit	VERB
fnp-2818	225	25	unrestricted	unrestricted	ADJ
fnp-2818	225	26	use	use	NOUN
fnp-2818	225	27	,	,	PUNCT
fnp-2818	225	28	distribution	distribution	NOUN
fnp-2818	225	29	,	,	PUNCT
fnp-2818	225	30	and	and	CCONJ
fnp-2818	225	31	reproduction	reproduction	NOUN
fnp-2818	225	32	in	in	ADP
fnp-2818	225	33	any	any	DET
fnp-2818	225	34	medium	medium	NOUN
fnp-2818	225	35	,	,	PUNCT
fnp-2818	225	36	provided	provide	VERB
fnp-2818	225	37	the	the	DET
fnp-2818	225	38	original	original	ADJ
fnp-2818	225	39	author	author	NOUN
fnp-2818	225	40	and	and	CCONJ
fnp-2818	225	41	source	source	NOUN
fnp-2818	225	42	are	be	AUX
fnp-2818	225	43	credited	credit	VERB
fnp-2818	225	44	,	,	PUNCT
fnp-2818	225	45	a	a	DET
fnp-2818	225	46	link	link	NOUN
fnp-2818	225	47	to	to	ADP
fnp-2818	225	48	the	the	DET
fnp-2818	225	49	creative	creative	ADJ
fnp-2818	225	50	commons	common	NOUN
fnp-2818	225	51	license	license	NOUN
fnp-2818	225	52	is	be	AUX
fnp-2818	225	53	provided	provide	VERB
fnp-2818	225	54	,	,	PUNCT
fnp-2818	225	55	and	and	CCONJ
fnp-2818	225	56	any	any	DET
fnp-2818	225	57	changes	change	NOUN
fnp-2818	225	58	are	be	AUX
fnp-2818	225	59	indicated	indicate	VERB
fnp-2818	225	60	.	.	PUNCT
fnp-2818	226	1	the	the	DET
fnp-2818	226	2	creative	creative	ADJ
fnp-2818	226	3	commons	common	NOUN
fnp-2818	226	4	public	public	ADJ
fnp-2818	226	5	domain	domain	NOUN
fnp-2818	226	6	dedication	dedication	NOUN
fnp-2818	226	7	waiver	waiver	NOUN
fnp-2818	226	8	(	(	PUNCT
fnp-2818	226	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-2818	226	10	)	)	PUNCT
fnp-2818	226	11	applies	apply	VERB
fnp-2818	226	12	to	to	ADP
fnp-2818	226	13	the	the	DET
fnp-2818	226	14	data	datum	NOUN
fnp-2818	226	15	made	make	VERB
fnp-2818	226	16	available	available	ADJ
fnp-2818	226	17	in	in	ADP
fnp-2818	226	18	this	this	DET
fnp-2818	226	19	article	article	NOUN
fnp-2818	226	20	,	,	PUNCT
fnp-2818	226	21	unless	unless	SCONJ
fnp-2818	226	22	otherwise	otherwise	ADV
fnp-2818	226	23	stated	state	VERB
fnp-2818	226	24	.	.	PUNCT